CRISPRimmunity

Please click to download your results

Overview of predicted results

Overview of the results

Contig_ID	Contig_def	CRISPR array number	Contig Signature genes	Self targeting spacer number	Target MGE spacer number	Prophage number	Anti-CRISPR protein number
NZ_CP010414	Bifidobacterium breve strain BR3 plasmid pBR3, complete sequence	0 crisprs	NA	0	0	0	0
NZ_CP010413	Bifidobacterium breve strain BR3, complete genome	6 crisprs	WYL,cas3,DEDDh,RT,c2c9_V-U4	1	2	2	0

Results visualization

Click the left colored region to show detailed information

CRISPR-Cas detection and classification

Crispr_ID: NZ_CP010413_1

CRISPR_ID

CRISPR_location

CRISPR_type

Repeat_type

Spacer_info

Cas_protein_info

CRISPR-Cas_info

NZ_CP010413_1

44471-44617

Orphan

Consensus_repeat	Method
CTTAGCGACAGGATTTTAGGAGATT	CRISPRCasFinder

2 spacers

The CRISPR arrays of NZ_CP010413_1

>merge|NZ_CP010413|1|44471-44617|CRISPRCasFinder
CTTAGCGACAGGATTTTAGGAGATTATCCCAGTCGTCCTAAATTACTGTCGCTAAGTGAGTCTTAGTGACAGGATTTTAGGAGATTGGGGTTGGTTTCCTAAATATCTGTCATTGGCTTTGACTCAGTGACAGAATTTTAGGACGAA

>NZ_CP010413|1|1|44471-44617|CRISPRCasFinder
CTTAGCGACAGGATTTTAGGAGATT	ATCCCAGTCGTCCTAAATTACTGTCGCTAAGTGAGT
CTTAGTGACAGGATTTTAGGAGATT	GGGGTTGGTTTCCTAAATATCTGTCATTGGCTTTGA
CTCAGTGACAGAATTTTAGGACGAA

Protein	Signature genes	Signature genes Name	Protein_function
NZ_CP010413.1\|WP_003829782.1\|42158_42986_+\|transcription-termination/antitermination-factor-NusG	unknown	unknown	gnl\|CDD\|180161
NZ_CP010413.1\|WP_003829785.1\|44972_45404_+\|50S-ribosomal-protein-L11	unknown	unknown	gnl\|CDD\|234661
NZ_CP010413.1\|WP_014484321.1\|40363_41569_+\|pyridoxal-phosphate-dependent-aminotransferase	unknown	unknown	gnl\|CDD\|235596
NZ_CP010413.1\|WP_003829776.1\|35613_35865_+\|50S-ribosomal-protein-L27	unknown	unknown	gnl\|CDD\|235464
NZ_CP010413.1\|WP_060618342.1\|55194_64677_+\|type-I-polyketide-synthase	unknown	unknown	gnl\|CDD\|227315
NZ_CP010413.1\|WP_003829786.1\|45419_46112_+\|50S-ribosomal-protein-L1	unknown	unknown	gnl\|CDD\|180071
NZ_CP010413.1\|WP_060618339.1\|35931_37623_+\|GTPase-ObgE	unknown	unknown	gnl\|CDD\|237045
NZ_CP010413.1\|WP_015439251.1\|41898_42126_+\|preprotein-translocase-subunit-SecE	unknown	unknown	gnl\|CDD\|236066
NZ_CP010413.1\|WP_014484311.1\|66075_66300_+\|hypothetical-protein	unknown	unknown	gnl\|CDD\|341042
NZ_CP010413.1\|WP_014484324.1\|35282_35591_+\|50S-ribosomal-protein-L21	unknown	unknown	gnl\|CDD\|235510
NZ_CP010413.1\|WP_003831625.1\|43402_44356_-\|hypothetical-protein	unknown	unknown	unknown
NZ_CP010413.1\|WP_021649514.1\|46385_47243_-\|hypothetical-protein	unknown	unknown	gnl\|CDD\|225306
NZ_CP010413.1\|WP_025300055.1\|51671_53540_+\|biotin/lipoyl-binding-protein	unknown	unknown	gnl\|CDD\|227111
NZ_CP010413.1\|WP_106622436.1\|49598_50558_+\|biotin--acetyl-CoA-carboxylase-ligase	unknown	unknown	gnl\|CDD\|223417
NZ_CP010413.1\|WP_060618340.1\|38959_40222_-\|polysaccharide-deacetylase-family-protein	unknown	unknown	gnl\|CDD\|213024
NZ_CP010413.1\|WP_060618341.1\|47321_49427_-\|hypothetical-protein	unknown	unknown	unknown
NZ_CP010413.1\|WP_015439254.1\|37730_38864_+\|glutamate-5-kinase	unknown	unknown	gnl\|CDD\|235460
NZ_CP010413.1\|WP_003831638.1\|53532_55155_+\|acyl-CoA-carboxylase-subunit-beta	unknown	unknown	gnl\|CDD\|227136
NZ_CP010413.1\|WP_103619690.1\|50559_51102_-\|biotin-transporter-BioY	unknown	unknown	gnl\|CDD\|376871
NZ_CP010413.1\|WP_025301443.1\|32033_35096_+\|Rne/Rng-family-ribonuclease	unknown	unknown	gnl\|CDD\|273254

Protein	Function_ID	Function_description	E-value
NZ_CP010413.1\|WP_003829782.1\|42158_42986_+\|transcription-termination/antitermination-factor-NusG	gnl\|CDD\|180161	PRK05609, nusG, transcription antitermination protein NusG; Validated.	3.58026e-66
NZ_CP010413.1\|WP_060618339.1\|35931_37623_+\|GTPase-ObgE	gnl\|CDD\|237045	PRK12296, obgE, GTPase CgtA; Reviewed.	0
NZ_CP010413.1\|WP_014484321.1\|40363_41569_+\|pyridoxal-phosphate-dependent-aminotransferase	gnl\|CDD\|235596	PRK05764, PRK05764, aspartate aminotransferase; Provisional.	0
NZ_CP010413.1\|WP_003829785.1\|44972_45404_+\|50S-ribosomal-protein-L11	gnl\|CDD\|234661	PRK00140, rplK, 50S ribosomal protein L11; Validated.	8.69761e-91
NZ_CP010413.1\|WP_003829776.1\|35613_35865_+\|50S-ribosomal-protein-L27	gnl\|CDD\|235464	PRK05435, rpmA, 50S ribosomal protein L27; Validated.	5.68869e-49
NZ_CP010413.1\|WP_060618342.1\|55194_64677_+\|type-I-polyketide-synthase	gnl\|CDD\|227315	COG4982, COG4982, 3-oxoacyl-[acyl-carrier protein].	0
NZ_CP010413.1\|WP_003829786.1\|45419_46112_+\|50S-ribosomal-protein-L1	gnl\|CDD\|180071	PRK05424, rplA, 50S ribosomal protein L1; Validated.	1.72993e-143
NZ_CP010413.1\|WP_015439251.1\|41898_42126_+\|preprotein-translocase-subunit-SecE	gnl\|CDD\|236066	PRK07597, secE, preprotein translocase subunit SecE; Reviewed.	2.83757e-12
NZ_CP010413.1\|WP_014484311.1\|66075_66300_+\|hypothetical-protein	gnl\|CDD\|341042	cd17489, MFS_YfcJ_like, Escherichia coli YfcJ, YhhS, and similar transporters of the Major Facilitator Superfamily. This subfamily is composed of Escherichia coli membrane proteins, YfcJ and YhhS, Bacillus subtilis uncharacterized MFS-type transporter YwoG, and similar proteins. YfcJ and YhhS are putative arabinose efflux transporters. YhhS has been implicated glyphosate resistance. YfcJ-like arabinose efflux transporters belong to the bacterial MdtG-like and eukaryotic solute carrier 18 (SLC18) family of the Major Facilitator Superfamily (MFS) of transporters. MFS proteins are thought to function through a single substrate binding site, alternating-access mechanism involving a rocker-switch type of movement.	0.00299051
NZ_CP010413.1\|WP_014484324.1\|35282_35591_+\|50S-ribosomal-protein-L21	gnl\|CDD\|235510	PRK05573, rplU, 50S ribosomal protein L21; Validated.	4.17736e-35
NZ_CP010413.1\|WP_103619690.1\|50559_51102_-\|biotin-transporter-BioY	gnl\|CDD\|376871	pfam02632, BioY, BioY family. A number of bacterial genes are involved in bioconversion of pimelate into dethiobiotin. BioY is a component of the BioMNY transport system involved in biotin uptake in prokaryotes.	6.15074e-26
NZ_CP010413.1\|WP_021649514.1\|46385_47243_-\|hypothetical-protein	gnl\|CDD\|225306	COG2508, COG2508, Regulator of polyketide synthase expression [Signal transduction mechanisms / Secondary metabolites biosynthesis, transport, and catabolism].	1.21655e-16
NZ_CP010413.1\|WP_025300055.1\|51671_53540_+\|biotin/lipoyl-binding-protein	gnl\|CDD\|227111	COG4770, COG4770, Acetyl/propionyl-CoA carboxylase, alpha subunit [Lipid metabolism].	0
NZ_CP010413.1\|WP_106622436.1\|49598_50558_+\|biotin--acetyl-CoA-carboxylase-ligase	gnl\|CDD\|223417	COG0340, BirA, Biotin-(acetyl-CoA carboxylase) ligase [Coenzyme metabolism].	2.57451e-30
NZ_CP010413.1\|WP_060618340.1\|38959_40222_-\|polysaccharide-deacetylase-family-protein	gnl\|CDD\|213024	cd10966, CE4_yadE_5s, Putative catalytic polysaccharide deacetylase domain of uncharacterized protein yadE and similar proteins. This family contains an uncharacterized protein yadE from Escherichia coli and its bacterial homologs. Although its molecular function remains unknown, yadE shows high sequence similarity with the catalytic NodB homology domain of outer membrane lipoprotein PgaB and the surface-attached protein intercellular adhesion protein IcaB. Both PgaB and IcaB are essential in bacterial biofilm formation.	1.05361e-60
NZ_CP010413.1\|WP_015439254.1\|37730_38864_+\|glutamate-5-kinase	gnl\|CDD\|235460	PRK05429, PRK05429, gamma-glutamyl kinase; Provisional.	1.3328e-175
NZ_CP010413.1\|WP_003831638.1\|53532_55155_+\|acyl-CoA-carboxylase-subunit-beta	gnl\|CDD\|227136	COG4799, COG4799, Acetyl-CoA carboxylase, carboxyltransferase component (subunits alpha and beta) [Lipid metabolism].	0
NZ_CP010413.1\|WP_025301443.1\|32033_35096_+\|Rne/Rng-family-ribonuclease	gnl\|CDD\|273254	TIGR00757, Ribonuclease_E/G-like_protein, ribonuclease, Rne/Rng family. This model describes ribonuclease G (formerly CafA, cytoplasmic axial filament protein A), the N-terminal domain of ribonuclease E in which ribonuclease activity resides, and related proteins. In E. coli, both RNase E and RNase G have been shown to play a role in the maturation of the 5' end of 16S RNA. The C-terminal half of RNase E (excluded from the seed alignment for this model) lacks ribonuclease activity but participates in mRNA degradation by organizing the degradosome. [Transcription, Degradation of RNA].	3.03541e-152

>NZ_CP010413.1|WP_003831625.1|43402_44356_-|hypothetical-protein
MKTHKEVAALLQTAQREQRCAIGDGGKLYTALRRRTKIGEVVSPYPNLFAATSYWKSLNVEQQSMHLIRALAKVHPTWTFAGLSAACVYQYEHSYSLHNGTVDIVSPKGANCGGASGLNRIYMARCSQYRCQGILVTSPARTLIDCASLPFDKALAIYDSALRLQHVTKLDVETLIVQTDCNETNVKRLLRYANPLRENGGESWTYARIRQLGFAEPLFQTEFDNPANPEMPYRVDFCWKLHDGRIIVVEYDGIAKYRDTSNPNRANLMAKFEYERQRDTNLKTQGVTSIKHLFYEDVSDLKRLNALLTAIGIPKIR
>NZ_CP010413.1|WP_003829782.1|42158_42986_+|transcription-termination/antitermination-factor-NusG
MSDELNLENLDAALENVDAAADEAPVADAPAEAVESAEPVAEAPVASPETVAESAEEESEVNESEQAEETDAGQKAVDEFSKSLRTLDGKWYVLHTYSGYEKRVKTNIESRVASFGMEDQIFQVEVPMEEVEKHTEKGKKVITRVRVPGYVLIRMWPDENARRVVRETEGVTGFVGPSKDPAPLSRQEVVAMMAPMIASEALKAAGDKPAAAKKRKVEVSYAVGDQVTVTDGPFATMAAVVSDVEPTTQKLTVLVSIFGRDTPVELGFHQVQKLD
>NZ_CP010413.1|WP_015439251.1|41898_42126_+|preprotein-translocase-subunit-SecE
MAKTGTNEKAVKPNVFMRIGLFIKQIIDELRKVVTPTAKELFFWSLAVFIFVLLLMALVTGMDFGLGKATLGIFG
>NZ_CP010413.1|WP_014484321.1|40363_41569_+|pyridoxal-phosphate-dependent-aminotransferase
MAQWQILSDRINTVAPSATLAVDSKAKAMKAAGLDVIGFGAGEPNFPTPANVVKAAADACLDPKNYKYTPTPGLPELREAIAAKVLRDSGYEVSADQVVVTNGGKQAVYEAFQILLNDGDEVIVPTPYWTSYPEAVKLADGVPVEVFAGADVNFEPSLEALEAARTERTKAIIVNSPNNPTGAVWKPETVEAIGRWAVEHHIWIISDEIYEHLNYDDARTTYIGAAVPECRDQLLVLNGVAKTYAMPGWRVGWMVAPAEVAKAATKLQGHMTSNVANISQRAALAAVSGPLDEVYEMRKAFDVRRRAIVAALNDIEGVYCPTPTGAFYAFADITALLGKPLGSNGTVCATSADFAAALLDEAHVAAVPGEAFGAPGYLRFSYALADDDLAEGMKRFKDWAK
>NZ_CP010413.1|WP_060618340.1|38959_40222_-|polysaccharide-deacetylase-family-protein
MAKHHESHDSRGTRRSTVEPRVAYSRNVETHSAHDRQLHYGQHASHRSATAIAAQRTRRIAVLVVAAVVAVALAITVGVVTHGWFARQSAPSTQQQLPTTAHKSLTRKTVPQLDPGNIVIGVNGSETTYVLKGEQYVEGGAHAIEPEDGVLTGNIVTTGTVDTNTPGDYTVQYTVHDSTGHEASATRTVKVVDTMDKQTGGIPVLMYHYVYDPANPPADVDANWIPTTSLEPQLQYLTQNNFYYPSWPEVRAFIDGKHSLPKNSIVMTFDDGEPHFFQYGSPLLAKYKVPATSFVIGADGEALNKMKTYATPYLEYESHSFDMHRAGGTVGHGGRISAMSHQEIVDDLKQSEQVTGSLQAFAYPFGDTTPDAIEAVRETGTLAAFTTQYGWADVGADPMNLPRVRIQGTGSLATFIAAIQ
>NZ_CP010413.1|WP_015439254.1|37730_38864_+|glutamate-5-kinase
MSTPSQAEVRRMIAAAGTIVVKVGSSSLTQPSGHLDPDKLDALTAALAQVRLMGARVVLVSSGAIAAGFGPLGFDERPADVATQQATAAVGQGLLMARYEAAFGRFGIRVGQILITAEDTIRATQYRNVERTLDRLLDLGVVPIINENDSLASNEIRFGDNDRLSALVANLVRAEALVLLTDVDALYTAPPAQPGSRRVEYVPNVIDALGDIQVSGSGSKVGTGGMVTKLEAARVAAVSGIPTVLTCASNAGPAMMGDPVGTVFAPVKARGSSRRLWIGFAAEPRGTIVVDAGAAKAIRGGRASLLAAGALDVHGDFSAGDPVWIDDESGTHLARGLAGFDSEEIPQTLGRNTAQLKRFLGDQYAHPLVHRDNLVLV
>NZ_CP010413.1|WP_060618339.1|35931_37623_+|GTPase-ObgE
MSDFVDRVTVHVRGGDGGNGSAGIRREKYKPLAGPNGGNGGDGGSVVFVADRNATSLLDYRFMPHRTAGNGTMGLGDNKDGSKGEDLILPVPCGTVVFEARGEQGKTKHPGEQLADLRHEGDRVVVAQGGAGGLGNIALANKTRRAPGFALLGELGEERDVILELKSIADVALVGFPSAGKSSLIAAMSAAKPKIADYPFTTLVPNLGVVVAGDSRYTIADVPGLIPGASEGKGLGLEFLRHIERTEIIAHVIDCATLEPDRDPMSDYQALENELALYADKLELPLGAIPIPERPRIVILNKIDVPEAKELAEFVRPEFEKLGLKVFEISTASHEGLKELNFALSELVHEMREEVASREEAEEEARVVIKPLERTGRRPRRADEGGNALDFTVERRELGNGEVFYEVRGAKPERWVMQTNFDNDEAVGYLADRLAKLGVEDELRRKGARPGDEIRIGRGDRMVEFDWDPTISAGAEMLDGSNLGARGKDLRLEEQDPRAHRRSNAERRAQYHEMMDARAAVRDAMMAERKAGHWADPTVDDDRHDETSPFGHGESADDSASEE
>NZ_CP010413.1|WP_003829776.1|35613_35865_+|50S-ribosomal-protein-L27
MAHKKGASSSRNGRDSSPQYLGVKKFGGEAVVAGNIIVRQRGTNFHAGQNVGMGKDHTLFALADGSVKFGVRRDRKVVDVIAA
>NZ_CP010413.1|WP_014484324.1|35282_35591_+|50S-ribosomal-protein-L21
MYAIVKAGGHQEKVEVGDTILVNRLDAKKGDTVEFPVALLVDGAKVTLAAADLAKVSVKAEVVNDEAKGPKINIQKYKNKTGVARRKGHRQPLTIVKITAIA
>NZ_CP010413.1|WP_025301443.1|32033_35096_+|Rne/Rng-family-ribonuclease
MPTENREGFVGDETDNSTVSNTESQASGASEPNAEASQPTRRRRGGRRVVRGTGAAGASLELQVQEHAAPLFEAPALPDADASASAETTDNNASDDEKHPARRTRSRRSADNADYEDRSTRRRAVADDDDEPRPVRRRRAVSDDLEEDDERPIRRRRVASDDFDEDNDRLVRRRRSVIDDLEDDDAPRSSRRRTAVDDSDEDGDRPVRRRRSTTNDRDDRDDEPRSARRTRSRRSSEDAREENPDERVLDVIDALPAGHESARRGKPMTSLLFQEPVLPDMRRDDRDDEEDDGEQRSRSSRRSRAREDEADYEERPSRSRRSSRSDHGDHDDHDDRDDSRNNRRRNETQDDFDADGQSDSRRSRRSRRLNAQERRAAAEVEQIEEDLELDDITYSPIAEEENDEESDSTRTRSRRRRRRGSRNESGASNNDSESSENNGDDSRRRRDDRDERDRDDDEEQTVTRRRRRRRGGKNAESGDEQDDQQLTRRSRKQQYIDEITDVEGSTRLEAKKQRRRDNRRERSRQSQLMEQDFLARRENVDRLMVVREKEHHTQISVVEDNILVEHYVSDIQEVQTVGNIYLGRVQNVLPSMEAAFVDIGQARNGVLYAGEVNWDAARLEGQPRRIELAFKSGDPVLVQVTKDPIGHKGARLTSQVTLAGRFLVLVPSGGMTGVSRKLSERERSRLKGIVSKIAPKDMGVIIRTAAEGASEEAIVKDLESLVRQWERINAKREEFWHGKRPKLLQGEPDVAIRVVRDIFNDDFGKLIVEGDKVYDRIEEYLDTMAPDLKDKLEKWDPAEHEGKDVFDKWQIDSQLRKGMERQVYLPSGGSIVIDRTEAMTTIDVNTGRFIGKGKSLEETVTRCNLEASEEIARQLRLRDIGGMVMIDYVDMVMPANRDLVLRRLVECLARDRTKHQVAEVTSLGLVQMTRKRIGQGLVEAFSEECPTCKGRGFILHDQPTVSADYDDPYALRGGDPFVKTNKHGRGTAPAPEPAGSSADVKAKLAQIAAAAVAANNTEEE
>NZ_CP010413.1|WP_003829785.1|44972_45404_+|50S-ribosomal-protein-L11
MAPKKKVSALIKLQIQAGKANPAPPLGPALGSHGVNIMDFCKAYNAQTQDKMGQVIPVEITVYEDRSFTFVLKTPPAAALLKKAAGIEKGTENPLTHKVGSVTKAQVREIAETKMEDLSARDIEAGMKIIEGTARSMGITVTD
>NZ_CP010413.1|WP_003829786.1|45419_46112_+|50S-ribosomal-protein-L1
MVKRSKKYREAAERVDRNNLYTANEAIALLKSMPSYNFDQTVEAVFRLSVDPRKADQLVRGTVNLPHGTGKTAKVLVFARGPKATEATEAGADIVGDDDLIAKVQGGFLDFDAVVATPDMMGKVGRLGRVLGPRGLMPNPKTGTVTMDVTKAVKDIKGGKIEFRVDKNGNLSFLIGKMSFDESALDENFKAVADEVKRLKPSTVKGRYLTKATITSTMNPGVPVDPNTLA
>NZ_CP010413.1|WP_021649514.1|46385_47243_-|hypothetical-protein
MSDFLELLAADAANSSDFTDRSGISATDRARTVLFECLFNHLADDRVASLFTILGFEHDFTCYAIAGYPARSAARSRVDIEKIVADFGGTCLTAERPITGLTGADNGTGRTAVVALIRPVGAATPEIICNTIAPAFDADRPIALGPQRTGAEGAMRSVQATLYCLKAAPALAATAQSLPRPLRTDDALPERALIGDEDARDELIRVVYGSLTAAGPDDPTLLTVSTFLKYGGSLETCAKELNVHPNTIRYRLKRAAESTGWDATDPREAYVLITAIALGRMATAQ
>NZ_CP010413.1|WP_060618341.1|47321_49427_-|hypothetical-protein
MTSPASSLPAAAAHPRLDRVGAAARWTLAVLACLWLALCTAVGPLYWDFENGTIANWNWTNTVFFVLSFAIYLGLIVIMVRFAAGQRVLPRAISGRLSRAGQQHSNQALEPSQSQSVVADSNVSKRHATVASRFATLGRWITRGTNRFWKLALVFFIGWLWVPTTLLAAFGADIRSQIREFSWAWNQWTGLQQPYIGFFSFVPMDIYPTAHYMWPPDPTYLTDQHNVVLTVFYGAVAAFSRYLTGSNDAGIVALAAGQMLLAVFCCAATANRFLNRPWMGVAQSTKDKNGSSTSTGNVSSTTSARIAQDAAPQLAGGRARFLILVFFLCCPLAVFATISITKSPLFAFSFVWWFGIWYELTQTWKPAGKRKGLTATAPIRLPRHSFVAFVLSTAVMLISAKYAWYIIALQIVLALIADRRRWTTYVVALLIPTMLIHGGISLAISSGAIIGGDPIESRGVQLQMIARVASRNPEGISEEAKKNLSDVFNLDQMADAYSQQDADPVKSSGIQAKKVSYKWRTVTPEDMTNFNKAWFEIVKDNPVIALDALLAKCFGYFNVTDQPYVSMDYYVTSDYVQKNSTWIKSYNHNWRERITGFTRSWGKIPVIGWITHGNFYVVMTLLIGAAEVIRRRWLTLMTHIPLLLLMGVMITAPANNFERHMLPVAFVFGFVVLTYWRESLAERRIARQAQSSASTTMTLPQ
>NZ_CP010413.1|WP_106622436.1|49598_50558_+|biotin--acetyl-CoA-carboxylase-ligase
MGGFVRFFARHRESGRANRGNVVPMMIALQAATPQLPRTKAVADQVVAVGETDSTNALAARMIGDGSLTLPERKGGTLAVGVVATDWQSAGRGRNGHTWISQPGRCSTMSYAVRIPRAIATDESVNGWLQMIAGLVTLDALNGMIKEYGAAPNKQDCFLELKWPNDVFCHGLKLGGLLSELVLLPDGEADDDVVVVFGVGLNLALGASRLPTPQSTSLQLHVSGLPSFNEMRDAVAEREVEGFRERLAAFIADPHGQAEALREEMKAVCWARGRQVEAHFTDGTTLIGEAIGLNEDASLILRTEDGTDHTVRTADVGVL
>NZ_CP010413.1|WP_103619690.1|50559_51102_-|biotin-transporter-BioY
MVAASWKPALFAVLMWLSAAAGAIPIPGTPVPITLQTFVVMLAGLMLPWRQAGSAVAAYLAAGAVGLPVFAGGASTMALVGPSAGFLFGFLPGVIVIALLRGKANTSSASAAALTAGRYLLAALVGGVVVVYAFGFVIQSALTGVPIAAVALASMGFVAGDTIKAVVASLAAAGLSKLGR
>NZ_CP010413.1|WP_025300055.1|51671_53540_+|biotin/lipoyl-binding-protein
MAHIVKKLLIANRGEIALRVVRTAKEMGISTVAVYSEQDRNSRYVDMADEAYLLSGDTYKDTYLNEDLLIDILHKTGADAVHPGYGFLSEVPSFAQKVEDAGAIWVGPHHTALVDLGDKITARRVALRAKVPPVPGLSEPVTDVRTLLDFAHTHGYPIMMKRTDGGGGHGITVVHDDEELRRFYMNHDALQGGDLKEYFIEKFVDKARHVETQSGRDSHGNFTVYSTRDCSLQRRNQKLVEEAPAPFLPEEIVSTLEEYSRRLFTTVGYVGLGTCEFMVTPNGKVYFLEVNPRLQVEHTVSEEVSGLDLVREQLNIAAGGELTRAPEPRGHSFELRITSEDPATNLTPGSGTLEKIQWPAGPGVRIDTGVEQGDTISPKFDSMMGKVIVTAQNRLDAVARVRRVLDELVIEGVPTPIPLFKEIFRNDDFTAENGHPFSVSTKWLERTYLNRTPASASSGQPASLAGAAAPAAPDKSTSETFVIEMNNRRVKLTVPLDIVENITGSARARGAKRPTQPLRGAGLHNVASGAAKANDGAKSGVIASPMQAVVTRINVSEGQQVAKGDLLVVLESMKMENYVYAPAAGEVKKIFVGPADGVEAGDTLVTLDVAKAEDSKKEGGND
>NZ_CP010413.1|WP_003831638.1|53532_55155_+|acyl-CoA-carboxylase-subunit-beta
MTDIMDSPAVKAVTAASATNASQPPAHQPLRTAVVKAAELARAAEERARDKQHAKGKKTARERLDLLFDTGTFEEIGRFQGGNIAGGNAGAAVITGFGQVYGRKVAVYAQDFSVKGGTLGTAEGEKICRLMDMAIDLKVPIVAIVDSGGARIQEGVAALTQYGRIFRKTCEASGFVPQLSLILGPCAGGAVYCPALTDLIIMTRENSNMFVTGPDVVKASTGETISMADLGGGEVHNRVSGVAHYLGEDESDAIDYARTVLAYLPSNSESKPPVYAYAATRAERETAKRLATIVPANERQPYDMLEVIRCIVDYGEFVQVQELFGASALVGFACIDGKPVGIVANQPNVLAGILDVDSSEKVARFVRLCDAFNLPVVTLVDVPGYKPGSDQEHAGIIRRGAKVIYAYANAQVPMVTVVLRKAFGGAYIVMGSKAIGADLNFAWPSSQIAVLGAAGAVNIIHRHDLAKAKASGQDVDALRAKYIKEYETSTVNANLSLEIGQIDGMIDPEQTREVIVESLATLATKRRIKRTTKHHGNQPL
>NZ_CP010413.1|WP_060618342.1|55194_64677_+|type-I-polyketide-synthase
MSTFFLNRLTTEPHALAFAGQSTPWPVALADQTTDPSLDEALRGHVAAANRLLTPAAADLLATTGRPVDLFGFTPNPARLSAAADATASVEGVALTQLGALLDLEHLGYSVAQAKPVAVLGHSQGVLAVHMTRAIEAAGSIEAAGKTLDEILAVAALIGAAGTRRVRELGLNPKYGEASPMLSVKGATREQVEALVKRVNNARGPISIAVTNSDNHHVLSGYPEDLAAFAFETEREHQHQAKLREQKLHGGTVFNPTLEYLEVTLPFHSPLMAEAVEQTVSWAGACGFDQDRTRALAEEVLLNHVDWNARVKALFNAADPAKLWIVDLGPGNTLGKLIGNVVQGTGIGVVEATTLSERSALSTLESEPERTQNWKALAPRVIETPAGAKLVTKFSKLTGKPPVLLPGMTPTTVEPEIVAAAANAGYWAELAGGGQVTAEVFDRHIAALEDELEEGRTVEFNAMFMDRYLWNLQFGSSRIVPKKRASGAPIDGVVVSAGIPELDEAVELIKNLQADGLPYVSFKPGTVDQIRQVVRIAKAVAPTTIMIQVEGGEAGGHHSWEALDDLLAATYAEVRACDNLVLVAGGGIGTPERAADYISGQWAHAYGLPDMPVDGVLIGTAAMTAKEAHTSPEVKQMLVKTPGIPADAKSDDVFAPQAAHWVPSGKSVGGMSSGLSHLHADIYELENDSAECGRLLVRVMKHPEELDSRRKEIIEALNKTAKPYFGDLASMTYLEWAQRFAELAFPWADPTYADRFQHLLQRIEARVSDTDSGEFTSKLFAADGVSADEAAAAGLLTRDGILADPAPALEKLALSYPQTAELKVVPADVAWFPVLVREYPKPMPFVPVIDNDLLRWWGQDQLWQSEDQRYSADSVRAIPGPISVAGITTVDEPIADILGRFENAAIERVKAEQNASESNDFAALGEAVSAEDFIRKSPNISWVGHIADNPAYGTALGDQYYEIRAFDAAAGKYDLDIHLDTYWDNDPDGGTSKHAVRDIVIPLIVEGTELGRVPVVDRERLIPDVYAMLAATAGIGNTAITGDKLTEMPTLSVPSDEGAVTANAVTEGETAQNRPFGTATATYTLSANLGFDHEAATGAALPATLQPSRIAPDALVGPAWPAIYTALGSVYVKGYPVIEGLLNAVHLDHLIELEVNEEDLLKHTGETITLKSWAEDYFESASGRVVTIHVTHTAADGTLLARETERFAIRGRVYSDTLPADAPEFGDAEHAEVAPTPRRLLRRVKVVAPHDMTAFARTSGDFNPIHTSTRGARISGLAAPLVHGMWLSATAQHAVQALDEKGAHYEIAGWTYNMYGMVQLDDTVEISVERVGKVRHGGMTLEVTCRIGGQLVSRGTALVRAPRAAFVYPGQGIQKQGMVLDERAKSAAARDVWERADKLTRAKLGFSILGLVRDNPKELTANGVTYRHPEGLLNLTQFTQVALATVAFAQTARLREAGADIWPAYFAGHSLGEYNALSAFADVIPLETVLELVFHRGSTMHHLIERDAQGRSNYRMGALRPNQFGVDDAHVKEYVESVAKASGEFLEIVNYNLAGQQYAIAGTIAGLKALKADSARRVAAFGGKPAFMLVPGIDVPFHSTLLRKGVPEFRDKLDALLPAYIDYRGRLVDRYIPNLVASPFEMTKEFAAKILEVVPSERIKAALDDPAVWDSYAADDQKLGRLLLTELLSWQFASPVRWIETQALLFGKREQGGLGIEEYVEVGLGNAPTLANLGTKTLRLPEFAGNDTVVYNVGRDEGRVYMTDTDSLVPDDEPEETAAPVETAPAGGSAVAKLGSSAAADAAPAAAAAPAPAAPVSAAPAGAPSGAAVADLPFKASDGIGVLMAYAAKVRLDQIGSNDTTDTLTNGVSSRRNQLLMDISSELGVASVDGAAEATLDKLAQIVNKAAPNYKPFGAVLSEALRDRLRSLFGAAGVKQQYIRDRVANVWQLGEGWVASVLAALLLDTREGSSSRGGDLAKLPTAAVQNKPEADKLIDAAVEVVAQLKGVAVALPSAGGAAGGAVVDSAALDAFAEKVTGSNGVLAATARFVLNELGVAAPAPEESEDENAAVVAAVEAELGSDWPKQVAPRFDANKAILFDDRWASAREDLARAYYDNDPAALNGSFIGLGKTIAAEAQWFADKSNNDELKAAFQKAASEALESVTSDKNASRYANDIAIVTGVSPNSIAAQVVEGLLAGGATVVATSHSFKPSIKAWAKQAYREHATGNAKLWLVPANLSSYRDVDALVDWVGHEQKKTSGATTTILKPAWEPTLFFPFAAPPVHGTLADSGDLFESQARLMLWGVERAIAGFSHIGADANVQHKLHVVLPGSPNRGVFGGDGAYGEVKSAFDAIVNRARAEKVWSSRVTFAHPKIGWVRGTGLMGGNDPLVAVVERHGIHTYSTAQIAAKLLDLCTAESREQALKAPLDVDLTGGLGSEPIDIKALRAEAMADAEKEASSEKAAIEGEKPEGGAAGSTLKALPTPIVTKQAPVDLADWQNVTARPEDEIVIVSVGELGPWGSGRTRAQAELGIHSDGTVDLSAGAVLELAWNMGLLTWADSPKPGWYDTDGNLVPEEDIAERYHDEVVARSGIRPFEEGMGDDYKDGADEEEAEVFLDHDVTFSVPTRDVAAEYVKLDEAHTTIAPDEESGEWNVTRHAGSMIRVPRRATMTRTVGGQFPKGFDPTRWGIPASMVGDVDKIALWNIVTTVDAYLGAGFTPAEILESIHPSLVASTQGTGFGGMMSMRKLYLDRFLNHEIPTDILQEALPNVVAAHVMQSYIGGYGNMIQPVSACATAAVSLEEGVDKIALGKADFVVTGAIDDIGVESVIGFGNMNATANSEEMYGKGIDARFFSRANDRRRGGFLESQGGGTILVTRGDIAEKLGLPVVAVVGFIHSYADGAHTSIPAPGLGALAAGMGGKDSKLVRDLAKLGVSADDIAVVSKHDTSTNANDPNESELHNTLAHAIGRTDGNPLFVISQKTLTGHAKGGACIFQVNGLTQLFKSGVIPANASLDCVDPKLQRDDHMVWIRKPLRIGGGEDEFGRETAGRPVKAGLATSLGFGHVSGFVALVHPGAFEAAVAKADGEAALETWRERANARLAAGQRHLEEGMMGRAALYEPIDNRRFHEDHRGYDHHEVEKAMLLNPDARLGADGYYEA
>NZ_CP010413.1|WP_014484311.1|66075_66300_+|hypothetical-protein
MANVAFGHLFACSGIANSTYYAGIDLGMSLGPIVGGLLYGNAPIQWFYPLSMLAMPAAWLLYAATANYVHGRTR

You can click texts colored in the table to view more detailed information

Click the colored protein region to show detailed information

Crispr_ID: NZ_CP010413_2

CRISPR_ID

CRISPR_location

CRISPR_type

Repeat_type

Spacer_info

Cas_protein_info

CRISPR-Cas_info

NZ_CP010413_2

430395-430837

Orphan

I-C

Consensus_repeat	Method
GTCGCTCCCCATCCGGGGAGCGTGGATTGAAAT	PILER-CR
GTCGCTCCCCATCCGGGGAGCGTGGATTGAAAT	CRT
TCCCCATCCGGGGAGCGTGGATTGAAAT	CRISPRCasFinder

6 spacers

The CRISPR arrays of NZ_CP010413_2

>merge|NZ_CP010413|2|430395-430837|PILER-CR,CRT,CRISPRCasFinder
GTCGCTCCCCATCCGGGGAGCGTGGATTGAAATACGTCCGTGACCGTCACGTTCGCGGCGTCACCATGTCGCTCCCCATCCGGGGAGCGTGGATTGAAATACCTCAGTAGACGTAGCCGTTGCGGCGGGCGCGCGCGTCGCTCCCCATCCGGGGAGCGTGGATTGAAATGTAAATCTCAGGTTGCGCGAAAACACATGTTTCGACGTCGATCCCCATCCGGGGAGCGTGGATTGAAATTGGCTCGCCCACAACTGGTACTAAGGAGAGGGACAGTCGCTCCCCATTCGGGGAGCGTGGATTGAAATCTGTACGGCAAGGCTCAGACCGGCAGCGAGGGCTGGTCGCTCCCCATTCGGGGAGCGTGGATTGAAATCAAGCCCCCATACCCCGCGCAGCCCTCAAATCCAGCGTCGCTCCCCATCTGGGGAGCGTGGGTTCCTAT

>NZ_CP010413|2|1|430395-430768|PILER-CR
GTCGCTCCCCATCCGGGGAGCGTGGATTGAAAT	ACGTCCGTGACCGTCACGTTCGCGGCGTCACCAT
GTCGCTCCCCATCCGGGGAGCGTGGATTGAAAT	ACCTCAGTAGACGTAGCCGTTGCGGCGGGCGCGCGC
GTCGCTCCCCATCCGGGGAGCGTGGATTGAAAT	GTAAATCTCAGGTTGCGCGAAAACACATGTTTCGAC
GTCGATCCCCATCCGGGGAGCGTGGATTGAAAT	TGGCTCGCCCACAACTGGTACTAAGGAGAGGGACA
GTCGCTCCCCATTCGGGGAGCGTGGATTGAAAT	CTGTACGGCAAGGCTCAGACCGGCAGCGAGGGCTG
GTCGCTCCCCATTCGGGGAGCGTGGATTGAAAT

>NZ_CP010413|2|1|430395-430837|CRT
GTCGCTCCCCATCCGGGGAGCGTGGATTGAAAT	ACGTCCGTGACCGTCACGTTCGCGGCGTCACCAT
GTCGCTCCCCATCCGGGGAGCGTGGATTGAAAT	ACCTCAGTAGACGTAGCCGTTGCGGCGGGCGCGCGC
GTCGCTCCCCATCCGGGGAGCGTGGATTGAAAT	GTAAATCTCAGGTTGCGCGAAAACACATGTTTCGAC
GTCGATCCCCATCCGGGGAGCGTGGATTGAAAT	TGGCTCGCCCACAACTGGTACTAAGGAGAGGGACA
GTCGCTCCCCATTCGGGGAGCGTGGATTGAAAT	CTGTACGGCAAGGCTCAGACCGGCAGCGAGGGCTG
GTCGCTCCCCATTCGGGGAGCGTGGATTGAAAT	CAAGCCCCCATACCCCGCGCAGCCCTCAAATCCAGC
GTCGCTCCCCATCTGGGGAGCGTGGGTTCCTAT

>NZ_CP010413|2|2|430400-430837|CRISPRCasFinder
TCCCCATCCGGGGAGCGTGGATTGAAAT	ACGTCCGTGACCGTCACGTTCGCGGCGTCACCATGTCGC
TCCCCATCCGGGGAGCGTGGATTGAAAT	ACCTCAGTAGACGTAGCCGTTGCGGCGGGCGCGCGCGTCGC
TCCCCATCCGGGGAGCGTGGATTGAAAT	GTAAATCTCAGGTTGCGCGAAAACACATGTTTCGACGTCGA
TCCCCATCCGGGGAGCGTGGATTGAAAT	TGGCTCGCCCACAACTGGTACTAAGGAGAGGGACAGTCGC
TCCCCATTCGGGGAGCGTGGATTGAAAT	CTGTACGGCAAGGCTCAGACCGGCAGCGAGGGCTGGTCGC
TCCCCATTCGGGGAGCGTGGATTGAAAT	CAAGCCCCCATACCCCGCGCAGCCCTCAAATCCAGCGTCGC
TCCCCATCTGGGGAGCGTGGGTTCCTAT

Protein	Signature genes	Signature genes Name	Protein_function
NZ_CP010413.1\|WP_016462483.1\|418373_420389_+\|ABC-transporter-ATP-binding-protein	unknown	unknown	gnl\|CDD\|224055
NZ_CP010413.1\|WP_060618416.1\|420567_421593_+\|LacI-family-DNA-binding-transcriptional-regulator	unknown	unknown	gnl\|CDD\|380522
NZ_CP010413.1\|WP_060618417.1\|422803_424204_+\|MFS-transporter	unknown	unknown	gnl\|CDD\|340883
NZ_CP010413.1\|WP_060618423.1\|441125_441821_+\|DedA-family-protein	unknown	unknown	gnl\|CDD\|223659
NZ_CP010413.1\|WP_003830203.1\|415885_416419_+\|MarR-family-transcriptional-regulator	unknown	unknown	gnl\|CDD\|197670
NZ_CP010413.1\|WP_060618958.1\|421812_422775_+\|nucleoside-hydrolase	unknown	unknown	gnl\|CDD\|239116
NZ_CP010413.1\|WP_141670279.1\|424291_425257_+\|ribokinase	unknown	unknown	gnl\|CDD\|238579
NZ_CP010413.1\|WP_060618420.1\|437141_437846_-\|HAD-family-phosphatase	unknown	unknown	gnl\|CDD\|319790
NZ_CP010413.1\|WP_060618415.1\|416415_418377_+\|ABC-transporter-ATP-binding-protein	unknown	unknown	gnl\|CDD\|224055
NZ_CP010413.1\|WP_060618421.1\|437995_440305_-\|primosomal-protein-N'	unknown	unknown	gnl\|CDD\|237844
NZ_CP010413.1\|WP_060618424.1\|441874_443449_+\|proteasome-ATPase	unknown	unknown	gnl\|CDD\|200312
NZ_CP010413.1\|WP_003830251.1\|433378_433663_-\|DNA-directed-RNA-polymerase-subunit-omega	unknown	unknown	gnl\|CDD\|234744
NZ_CP010413.1\|WP_021649100.1\|435989_437003_-\|methionyl-tRNA-formyltransferase	unknown	unknown	gnl\|CDD\|234567
NZ_CP010413.1\|WP_003830252.1\|433830_435693_+\|dihydroxy-acid-dehydratase	unknown	unknown	gnl\|CDD\|237104
NZ_CP010413.1\|WP_060618419.1\|431872_433093_-\|methionine-adenosyltransferase	unknown	unknown	gnl\|CDD\|235374
NZ_CP010413.1\|WP_143247937.1\|440352_441105_-\|phosphoserine-phosphatase-SerB	unknown	unknown	gnl\|CDD\|319803
NZ_CP010413.1\|WP_143247938.1\|429655_430270_+\|transposase-family-protein	unknown	unknown	gnl\|CDD\|379250
NZ_CP010413.1\|WP_060618418.1\|425928_429237_+\|mupirocin-resistant-isoleucine--tRNA-ligase	unknown	unknown	gnl\|CDD\|235681
NZ_CP010413.1\|WP_003833335.1\|413401_415675_+\|glycosyl-hydrolase	unknown	unknown	gnl\|CDD\|185053
NZ_CP010413.1\|WP_060618425.1\|443508_444222_-\|HAD-family-phosphatase	unknown	unknown	gnl\|CDD\|319790

Protein	Function_ID	Function_description	E-value
NZ_CP010413.1\|WP_016462483.1\|418373_420389_+\|ABC-transporter-ATP-binding-protein	gnl\|CDD\|224055	COG1132, MdlB, ABC-type multidrug transport system, ATPase and permease components [Defense mechanisms].	7.23908e-156
NZ_CP010413.1\|WP_060618416.1\|420567_421593_+\|LacI-family-DNA-binding-transcriptional-regulator	gnl\|CDD\|380522	cd06299, PBP1_LacI-like, ligand-binding domain of DNA-binding regulatory protein from Corynebacterium glutamicum produces significant amounts of L-glutamate directly from cheap sugar and ammonia. This group includes the ligand-binding domain of DNA-binding regulatory protein from Corynebacterium glutamicum which has a unique ability to produce significant amounts of L-glutamate directly from cheap sugar and ammonia. This regulatory protein is a member of the LacI-GalR family of bacterial transcription repressors. The LacI-GalR family repressors are composed of two functional domains: an N-terminal HTH (helix-turn-helix) domain, which is responsible for the DNA-binding specificity, and a C-terminal ligand-binding domain, which is homologous to the sugar-binding domain of ABC-type transport systems that contain the type 1 periplasmic binding protein-like fold. As also observed in the periplasmic binding proteins, the C-terminal domain of the bacterial transcription repressor undergoes a conformational change upon ligand binding which in turn changes the DNA binding affinity of the repressor.	4.67307e-97
NZ_CP010413.1\|WP_060618417.1\|422803_424204_+\|MFS-transporter	gnl\|CDD\|340883	cd17325, MFS_MdtG_SLC18_like, bacterial MdtG-like and eukaryotic solute carrier 18 (SLC18) family of the Major Facilitator Superfamily of transporters. This family is composed of eukaryotic solute carrier 18 (SLC18) family transporters and related bacterial multidrug resistance (MDR) transporters including several proteins from Escherichia coli such as multidrug resistance protein MdtG, from Bacillus subtilis such as multidrug resistance proteins 1 (Bmr1) and 2 (Bmr2), and from Staphylococcus aureus such as quinolone resistance protein NorA. The family also includes Escherichia coli arabinose efflux transporters YfcJ and YhhS. MDR transporters are drug/H+ antiporters (DHA) that mediate the efflux of a variety of drugs and toxic compounds, and confer resistance to these compounds. The SLC18 transporter family includes vesicular monoamine transporters (VAT1 and VAT2), vesicular acetylcholine transporter (VAChT), and SLC18B1, which is proposed to be a vesicular polyamine transporter (VPAT). The MdtG/SLC18 family belongs to the Major Facilitator Superfamily (MFS) of membrane transport proteins, which are thought to function through a single substrate binding site, alternating-access mechanism involving a rocker-switch type of movement.	4.06269e-12
NZ_CP010413.1\|WP_060618423.1\|441125_441821_+\|DedA-family-protein	gnl\|CDD\|223659	COG0586, DedA, Uncharacterized membrane-associated protein [Function unknown].	1.32875e-43
NZ_CP010413.1\|WP_003830203.1\|415885_416419_+\|MarR-family-transcriptional-regulator	gnl\|CDD\|197670	smart00347, HTH_MARR, helix_turn_helix multiple antibiotic resistance protein.	1.12734e-12
NZ_CP010413.1\|WP_060618958.1\|421812_422775_+\|nucleoside-hydrolase	gnl\|CDD\|239116	cd02650, nuc_hydro_CaPnhB, NH_hydro_CaPnhB: A subgroup of nucleoside hydrolases similar to Corynebacterium ammoniagenes Purine/pyrimidine nucleoside hydrolase (pnhB). Nucleoside hydrolases cleave the N-glycosidic bond in nucleosides generating ribose and the respective base. These enzymes vary in their substrate specificity. .	3.86464e-116
NZ_CP010413.1\|WP_141670279.1\|424291_425257_+\|ribokinase	gnl\|CDD\|238579	cd01174, ribokinase, Ribokinase catalyses the phosphorylation of ribose to ribose-5-phosphate using ATP. This reaction is the first step in the ribose metabolism. It traps ribose within the cell after uptake and also prepares the sugar for use in the synthesis of nucleotides and histidine, and for entry into the pentose phosphate pathway. Ribokinase is dimeric in solution.	2.82315e-102
NZ_CP010413.1\|WP_060618420.1\|437141_437846_-\|HAD-family-phosphatase	gnl\|CDD\|319790	cd02603, HAD_sEH-N_like, N-terminal lipase phosphatase domain of human soluble epoxide hydrolase, Escherichia coli YihX/HAD4 alpha-D-glucose 1-phosphate phosphatase, and related domains, may be inactive. This family includes the N-terminal phosphatase domain of human soluble epoxide hydrolase (sEH). sEH is a bifunctional enzyme with two distinct enzyme activities, the C-terminal domain has epoxide hydrolysis activity and the N-terminal domain (Ntermphos), which belongs to this family, has lipid phosphatase activity. The latter prefers mono-phosphate esters, and lysophosphatidic acids (LPAs) are the best natural substrates found to date. In addition this family includes Gallus gallus sEH and Xenopus sEH which appears to lack phosphatase activity, and Escherichia coli YihX/HAD4 which selectively hydrolyzes alpha-Glucose-1-P, phosphatase, has significant phosphatase activity against pyridoxal phosphate, and has low beta phosphoglucomutase activity. This family belongs to the haloacid dehalogenase-like (HAD) hydrolases, a large superfamily of diverse enzymes that catalyze carbon or phosphoryl group transfer reactions on a range of substrates, using an active site aspartate in nucleophilic catalysis. Members of this superfamily include 2-L-haloalkanoic acid dehalogenase, azetidine hydrolase, phosphonoacetaldehyde hydrolase, phosphoserine phosphatase, phosphomannomutase, P-type ATPases and many others. HAD hydrolases are found in all three kingdoms of life, and most genomes are predicted to contain multiple HAD-like proteins. Members possess a highly conserved alpha/beta core domain, and many also possess a small cap domain, the fold and function of which is variable. HAD hydrolases are sometimes referred to as belonging to the DDDD superfamily of phosphohydrolases.	6.57301e-46
NZ_CP010413.1\|WP_060618415.1\|416415_418377_+\|ABC-transporter-ATP-binding-protein	gnl\|CDD\|224055	COG1132, MdlB, ABC-type multidrug transport system, ATPase and permease components [Defense mechanisms].	5.49946e-159
NZ_CP010413.1\|WP_060618421.1\|437995_440305_-\|primosomal-protein-N'	gnl\|CDD\|237844	PRK14873, PRK14873, primosomal protein N'.	0
NZ_CP010413.1\|WP_060618424.1\|441874_443449_+\|proteasome-ATPase	gnl\|CDD\|200312	TIGR03689, pup_AAA, proteasome ATPase. In the Actinobacteria, as shown for Mycobacterium tuberculosis, some proteins are modified by ligation between an epsilon-amino group of a lysine side chain and the C-terminal carboxylate of the ubiquitin-like protein Pup. This modification leads to protein degradation by the archaeal-like proteasome found in the Actinobacteria. Members of this protein family belong to the AAA family of ATPases and tend to be clustered with the genes for Pup, the Pup ligase PafA, and structural components of the proteasome. This protein forms hexameric rings with ATPase activity. [Protein fate, Degradation of proteins, peptides, and glycopeptides].	0
NZ_CP010413.1\|WP_003830251.1\|433378_433663_-\|DNA-directed-RNA-polymerase-subunit-omega	gnl\|CDD\|234744	PRK00392, rpoZ, DNA-directed RNA polymerase subunit omega; Reviewed.	1.88678e-17
NZ_CP010413.1\|WP_021649100.1\|435989_437003_-\|methionyl-tRNA-formyltransferase	gnl\|CDD\|234567	PRK00005, fmt, methionyl-tRNA formyltransferase; Reviewed.	2.33225e-126
NZ_CP010413.1\|WP_003830252.1\|433830_435693_+\|dihydroxy-acid-dehydratase	gnl\|CDD\|237104	PRK12448, PRK12448, dihydroxy-acid dehydratase; Provisional.	0
NZ_CP010413.1\|WP_060618419.1\|431872_433093_-\|methionine-adenosyltransferase	gnl\|CDD\|235374	PRK05250, PRK05250, S-adenosylmethionine synthetase; Validated.	0
NZ_CP010413.1\|WP_143247937.1\|440352_441105_-\|phosphoserine-phosphatase-SerB	gnl\|CDD\|319803	cd07500, HAD_PSP, phosphoserine phosphatase (PSP), similar to Methanococcus Jannaschii PSP and Saccharomyces cerevisiae SER2p. This family includes Methanococcus jannaschii PSP, and Saccharomyces cerevisiae phosphoserine phosphatase SER2p, EC 3.1.3.3, which participates in a pathway whereby serine and glycine are synthesized from the glycolytic intermediate 3-phosphoglycerate; phosphoserine phosphatase catalyzes the hydrolysis of phospho-L-serine to L-serine and inorganic phosphate, the third reaction in this pathway. This family belongs to the haloacid dehalogenase-like (HAD) hydrolases, a large superfamily of diverse enzymes that catalyze carbon or phosphoryl group transfer reactions on a range of substrates, using an active site aspartate in nucleophilic catalysis. Members of this superfamily include 2-L-haloalkanoic acid dehalogenase, azetidine hydrolase, phosphonoacetaldehyde hydrolase, phosphoserine phosphatase, phosphomannomutase, P-type ATPases and many others. HAD hydrolases are found in all three kingdoms of life, and most genomes are predicted to contain multiple HAD-like proteins. Members possess a highly conserved alpha/beta core domain, and many also possess a small cap domain, the fold and function of which is variable. HAD hydrolases are sometimes referred to as belonging to the DDDD superfamily of phosphohydrolases.	4.36162e-100
NZ_CP010413.1\|WP_143247938.1\|429655_430270_+\|transposase-family-protein	gnl\|CDD\|379250	pfam13542, HTH_Tnp_ISL3, Helix-turn-helix domain of transposase family ISL3.	6.72513e-05
NZ_CP010413.1\|WP_060618418.1\|425928_429237_+\|mupirocin-resistant-isoleucine--tRNA-ligase	gnl\|CDD\|235681	PRK06039, ileS, isoleucyl-tRNA synthetase; Reviewed.	0
NZ_CP010413.1\|WP_003833335.1\|413401_415675_+\|glycosyl-hydrolase	gnl\|CDD\|185053	PRK15098, PRK15098, beta-glucosidase BglX.	1.3294e-89
NZ_CP010413.1\|WP_060618425.1\|443508_444222_-\|HAD-family-phosphatase	gnl\|CDD\|319790	cd02603, HAD_sEH-N_like, N-terminal lipase phosphatase domain of human soluble epoxide hydrolase, Escherichia coli YihX/HAD4 alpha-D-glucose 1-phosphate phosphatase, and related domains, may be inactive. This family includes the N-terminal phosphatase domain of human soluble epoxide hydrolase (sEH). sEH is a bifunctional enzyme with two distinct enzyme activities, the C-terminal domain has epoxide hydrolysis activity and the N-terminal domain (Ntermphos), which belongs to this family, has lipid phosphatase activity. The latter prefers mono-phosphate esters, and lysophosphatidic acids (LPAs) are the best natural substrates found to date. In addition this family includes Gallus gallus sEH and Xenopus sEH which appears to lack phosphatase activity, and Escherichia coli YihX/HAD4 which selectively hydrolyzes alpha-Glucose-1-P, phosphatase, has significant phosphatase activity against pyridoxal phosphate, and has low beta phosphoglucomutase activity. This family belongs to the haloacid dehalogenase-like (HAD) hydrolases, a large superfamily of diverse enzymes that catalyze carbon or phosphoryl group transfer reactions on a range of substrates, using an active site aspartate in nucleophilic catalysis. Members of this superfamily include 2-L-haloalkanoic acid dehalogenase, azetidine hydrolase, phosphonoacetaldehyde hydrolase, phosphoserine phosphatase, phosphomannomutase, P-type ATPases and many others. HAD hydrolases are found in all three kingdoms of life, and most genomes are predicted to contain multiple HAD-like proteins. Members possess a highly conserved alpha/beta core domain, and many also possess a small cap domain, the fold and function of which is variable. HAD hydrolases are sometimes referred to as belonging to the DDDD superfamily of phosphohydrolases.	7.46682e-35

>NZ_CP010413.1|WP_143247938.1|429655_430270_+|transposase-family-protein
MRQMWGAWPAVRPAGCAPLAASRHRLRQAPAGARAPEGRLRGTRGDRRDGAVARRKSAYTRDLERQVAWLSVHAPRSAVSALMRVDWKSVGPICRRVPLGHRGVLEARREDRPPPLRHPAHHPVRTIQRSPGGRQQQDQDHHQDGLRLQEPRQPHRSGHAQMRRPQPPTPRTPITRKPDQGPTPTQTPEEPFFSYALRDASCAI
>NZ_CP010413.1|WP_060618418.1|425928_429237_+|mupirocin-resistant-isoleucine--tRNA-ligase
MSENVYPKANEGGETAHVAPNPSFPQMEETVLNYWDKDDTFQKSVERNPSGDHSQNEFVFFDGPPFANGLPHYGHLLTGYAKDVIPRYQTMKGRKVNRVFGWDTHGLPAELEAQKELGIDSVDQIEKMGIDKFNDACRASVLKYTHEWQDYVHRQARWVDFEHGYKTLNIPYMESVMWAFKQLYDKGLAYQGYRVLPYCPKDQTPLSAHELRMDADVYQDRQDTTVSVAVKMRDEEDAYAVFWTTTPWTVPTNFAIVVGADIDYVEVRPTEGKFAGKKFYFGKPLLEHYTKELGENYEVVRELKGSELAGRRYYPVFPYFAGEKAETEGNVPGPNGYTIFTADYVDTVEGTGLVHQAPYGEDDMNTLNAHGVKSTDVLDAGCRFTSQCPEYEGMYVFDANLPILRNLRAGDGPLAEIPEDQRAILFQEKSYVHSYPHCWRCATPLIYKPVSSWFVSVTKIKPRLLELNQQINWIPGNVKDGQFGKWLANARDWSISRNRFWGSPIPVWVSDDPKYPRVDVYGSLEELKADFGDYPRDEDGNVNMHRPWIDNLTRVNPDDPTGKSHMHRISDVLDCWFESGSMSFAQFHYPFENKEKFEQHFPADYIVEYIGQTRGWFYLLHVMATALFDRPAFKNVICHGIVLGSDGQKMSKHLRNYPDVNGVFDKYGSDAMRWFLMSSPILRGGNLIVTAEGIRDTVRQVMLPVWSSYYFFTLYANAANGGAGFDARQLRADEVAGLPQMDRYLLARTRRLVERVEKSLNEFAISDACDAVSDFIDVLTNWYIRNTRDRFWNEDANAFNTLYTVLEAFMRVLAPLAPMEAESVWRGLTGGESVHLADWPYVVDEKTGADTELGRVLVDDPALVSAMEKVREVVSGTLSLRKAAKIRVRQPLAKLTVVAEDVDAVKAYDELLKSELNVKDIEFCTMEDAGSRGLKIVHELRVNARAAGPRLGKQVQFAIKASKSGDWSVNASGAPVVSTPSGDLELVEGEYELINRVEEENAAEAAASVSAALPTGGFVILDTALDDDLLAEGYARDAIRVVQDARKAADLDIADRISLVLTVPAADVAKVEQFKDLIAHETLATSFEVKEGAELGVEVAKA
>NZ_CP010413.1|WP_141670279.1|424291_425257_+|ribokinase
MDETLVSLDCIHGAVSVVGSMNADYTVTTERLPKPGETVLGGPLRVLPGGKSGNQAVSAARLGAKVRLFGALGSDANADFLLEALNDTGVDTSYIRHVNGASGTTVITVDAAGENTIVYSPGSNAYVSVEYIQSMRDNLTSADVLGLCLESPMETVTACARLCHDAGLKVLLNDSPFVAELPAELIEASDILLVNEHEMAQLLGIAEPDDDDWGGMDWSDVARQMHDFGFNQAVITLGGDGSVVIDGDDIYRIAPVVVEAIDTTGCGDAFMGTVLAGLASGHSLADSAQLASYVSAYAATGFGAQASYGTAAQIRERFGAK
>NZ_CP010413.1|WP_060618417.1|422803_424204_+|MFS-transporter
MTEQIQSVASIDDFEANRAKTKKALPALLIVFTLGTLMIQAFNLVFQNIGDSLGMSSSASLISTLPGIVLGVVCMLYGTLCDFISPKRMTLFGVVALVAGSLLGFFGSFNFWVVLIARMIQVAGAQVAGSVFLVMTVKYLNDKEKAIYIGIYNAVYYLAAAIGVFAGGFITSFDWKYLFLVPALSVFFIPLLIKNTPDISAKGEKIDSIGILLFAVFAALIAIYFSFPGVGMIIASIVFAVLFVLWIWKGKNPFLGRSFVTNGAYMSILLLQFVLYFFNFACVPIYNVIGERIYNVPLTTVSLCLTLVYIVATIVGCVSGPAINRLGRMRTLVIAIVLMIVGFAGSAIFIKSGFGVLTFLACLFIAGVTAVYTPIYDAASDVLPVEENGRGVGILDLMMNTSASIGVAVYSSLMASDTMGKGGLFGVGSGVEAQTSNMFWIMCTVSVLSMIVLFVFRKSFTAKRNV
>NZ_CP010413.1|WP_060618958.1|421812_422775_+|nucleoside-hydrolase
MKKIILDLDTGIDDTLALSYILGSEDAELIGITGTYGNVLLETGIRNDLNLLEMYGRPDIPVFKGVPHPSDADSFEVPDSSGIFHGRNGTGNVEVPATATRQASDKSAVDFIIESARKYSKEELVYVPTGPSTNIDAAFVKAPDIVDKLTIVMMGGALTQPGNCNPYMEANISMDPKASNRMFSTSADITMIGLDVTMQALMTKKDTQALRDVGTKAGAFLADMTDYYIDISEETDPAFQGGCNLHDPLAAAVALDPTLVTTFPIDLMVETEGPSIGRTIGDPTRLLSQPKNTKVALGVDAERFTSQFMERLLKLAASVD
>NZ_CP010413.1|WP_060618416.1|420567_421593_+|LacI-family-DNA-binding-transcriptional-regulator
MAFVTLKDVAQRAGVSAAAVSQILHNKGRFSSDTRRLVLKTVEEMGYVPDQRARSMRSSDTKTVGLLVPDLRNPYFADLVSSMEDELYARGYSTLIGTSAETVERQDAFIGNLLGQRIDGAIVVPQGVESPGVQSLIKRNLPLVFVDRRVPGVESVPFVVSNPYTGIREAVEELVRLGHRCVGYVSHPSLGSFSVNERETAFRAVASDLLIEGNGVVVACDSTYESRTAAVESLLDAGVSAMLCAYSPDALTMIGVLHDRGVSIGEDMSLVSFDDITAFTLMTPRIAVVSQQAELMGRQGVDLLLCRIRSGVSDEGVTHSVPTMFINRGSVEQGPSAAVAG
>NZ_CP010413.1|WP_016462483.1|418373_420389_+|ABC-transporter-ATP-binding-protein
MSNDQSFKNREPAMGKADPGTIKRIFGYIFQYKWRVVAIVVCILVGAAAQAGSALFLQSLIDTYILPMVGESNPDWAPLLRAISLMGCLYVAGIVTSWAWQWLIITVEQGTLKKIRDDMFAHQQKLPIRYFDSHEHGDIMSHYTNDTDTLRQAISQSFPQMFSSIISAAAALLSMLWLSIPFTAFVIVFTVLLYFIVRKIVSRSGRYFVKQQQWIGDVNAFVEESVNGQKVIKVFNHEDATQKTFDEKNEELFEASAEANTWGNVTMPVVGNMGYLLYILLAIIGAAVSLAGVNDIGLTGVKPLTLGTLVSLLTLSRSFINPIGQVSQQLTMVMMALAGASRIFKLMDEPIEEDKGTVTLVNVELGEDGRTMTEVDHETGHWAWKREIGDDGTRSLKAAEKLKGSAREVAMKAKEQAITSPDGRLTLLRGDVRFTNVTFGYNPDKPVLHDITWFAKPGQKIALVGATGAGKTTVTNLINRFYDIQEGQILYDGISVAGIKKPDLRRSLGIVLQDVNLFTGTVMDNIRYGRLNATDEECIEAARLVNADSFIRMLPKGYDTVLEGDGSGLSQGQRQLISIARAAVADPPALILDEATSSIDTRTEEVVQAGMDNLMKGRTVFVIAHRLSTVRNSDVIMVLDHGNIIERGSHDELIAQKGEYYQLYTGAVELE
>NZ_CP010413.1|WP_060618415.1|416415_418377_+|ABC-transporter-ATP-binding-protein
MSDTAEAIAQARKAVEPDKPKHVLRTLGHSIREYKKASILAPVFVAVEGILEILIPTIMASLIDEGITGGSMPATVKFGVILLVCAMVSLGAGFLSGKYAAVAGAGFAKNLRKDQFEKVQGFSFTNIDRFSTGSIVTRLTTDVTNLQNAYMMIIRLGVRAPIMVVVAWLFSFRISPSISMVFLACIPILAIGLCGLVVLVHPVFERVFHTYDALNNVVDENLQGIRVVKSYNRESFEVSKFGRISQRIFKDFTKAERIMSFNMPIMMVCVYASMILIAWMGAQQIVASGNNAALGLSTGELTSLVTYAMQILMAMMMLSMIFVMVIISQASAERICQVLQEESTVQNPAHPVTDMADGSIEFDHVTFRYSDSSEKPVLDDINLKIRSGMTIGIVGGTGSAKSSLVQLVPRLYDVSSGSLKVGGVDVRDYDIEALRDQVAMVLQKNVLFSGTIAENLRWGNPNATDEEIRHAAQLAQADGFVQEFPDKYDTYIEQGGTNVSGGQRQRLCIARALLKKPKILILDDSTSAVDTKTDKLIRAAFHNEIPDTTKIIIAQRVASVQESDMILVMDSGRIMASGTHEELLTTCDEYRSIYESQTKNQAKTEELAAAEQAATESSAAEPAETVTVTVTMPMADTSAADTNAADTKEGEAR
>NZ_CP010413.1|WP_003830203.1|415885_416419_+|MarR-family-transcriptional-regulator
MDQHILSIEMRAVTKAVDRYLGESMPLSAKETTGGNAHIIMFLARNRNREIYQHTIEQKFCITRSTASRVLALMEKKGLIARESVAHDARCKRIVLTDKADAIVADLKANGERVERLLVDGFSESEKAALRDYVSRMRANIDRAQHEFEHQTLPQSPVVMAPDQDGAEVANTKEENE
>NZ_CP010413.1|WP_003833335.1|413401_415675_+|glycosyl-hydrolase
MSEAIYPSVKDLTLEEKASLTSGGDAWHLQGAEAKGIPGYMITDGPHGLRKSLASSTGETDLDDSVPATCFPPAAGLSSSWNPDLIHKVGEAMAEECIQEKVAVILGPGVNIKRNPLGGRCFEYWSEDPYLAGHEAIGIVEGVQSKGVGTSLKHFAANNQETDRLRVDARISPRALREIYFPAFEHIVKKAQPWTIMCSYNRINGVHSAQNHWLLTDVLRDEWGFDGIVMSDWGADHDRGASLNAGLNLEMPPSYTDDQIVYAVRDGRITPAQLDRMAQGMIDLVNKTRAAMSIDNYRFDVDAHDEVAHQAAIESIVMLKNDDAILPLNAGPVANPSATPQKIAVIGEFARTPRYQGGGSSHITPTKMTSFLDTLAERGIKADFAPGFTLDLEPADPALESEAVETAKNADVVLMFLGLPEAAESEGFDRDTLDMPAKQITLLEQVAAANQNVVVVLSNGSVITVAPWAKNAKGILESWLLGQSGGPALADVIFGQVSPSGKLAQSIPLDINDDPSMLNWPGEEGHVDYGEGVFVGYRYYDTYGKAVDYPFGYGLSYATFEITGVAVAKTGANTATVNATVTNTSDVDAAETVQVYVVPGKADVARPKHELKGFTKVFLKAGESKTVTIDLDERAFAYWSEKYNDWHVEAGEYAIEVGVSSRDIADTVAVALDGDGKTQPLTEWSTYGEWEADPFGAKIVAAVAAAGEAGELPKLPDNAMMRMFLNSMPINSLPTLLGEGGKKIAQFMVDEYAKLSK
>NZ_CP010413.1|WP_060618419.1|431872_433093_-|methionine-adenosyltransferase
MTEEHRLISAESVTEGHPDKVCDQISDAILDDLLAQDPSSHVAVETSAATGVFLVFGEVTSEGYCDVQSKVRETLRNIGYTSSEVGLDADSCGVVVAITEQSAEINQGVARLTGAQETAASREERYEAQGAGDQGVMFGYATDETPTLMPLPIYLAHRLAFRLTEVRKSGEVPHLRPDGKTQVTIEYDDNDRPVRLDTVLISTQHDPEVTQDWLAVELKKHVIAPVLDEVLGSKVPHDNYRQLVNPTGSFVLGGPAADAGLTGRKIIVDTYGGAAHHGGGAFSGKDPSKVDRSAAYATRWVAKNIVAAGLAHKVEIQVAYAIGVADPVSINVETFGTEQGVTRGQIAAAVRKVFDLRPAAIIDELDLKRPIYLKTAAYGHFGRTDVEFPWEKTDKVEELKAAIAGE
>NZ_CP010413.1|WP_003830251.1|433378_433663_-|DNA-directed-RNA-polymerase-subunit-omega
MAFGTDPTPDGLANPPIDDLMQHADSKYALAIFAAKRARQINSYFTQLNEGLLQNVGPLVEYQNNEKPLSIAFREIDEGLLEETLGEDDTNEGN
>NZ_CP010413.1|WP_003830252.1|433830_435693_+|dihydroxy-acid-dehydratase
MTEMRSAKIMSGRVFAGARALYRAAGVSGDDMGKKPIIAIANSFDEFLPGHVHLNKVGRIVSEAIREAGGIPREFNTMAVDDGIAMGHTGMLYSLPSRDIIADTVEYQCNAHCADALICIPNCDKVVPGMLMAALRLNIPTVFVSGGPMEAGTTVLADGTVKSTDLIDVMYATADDSVSDEELLNYEKTVCPTCGSCAGMFTANSMNCLTEAIGLALPGNGTILASHSYRKDLFKRAAQQVVKIAHQYYDDSDDSVLPRSIATKEAFENAMTMDVAMGGSTNTVLHILAMAQSADVDFTLDDIERISHTVPCICKASPSGKWEISDVHRAGGITGILGELERAGKLHTNVHSIDYPTLEAKLADWDIMRPTCTEEAKQMYKAAPGHIISPEPWTHTTLFDSLDTDRVNGAIHDINHPEIHEGGLAVLRGNLAPDGCVVKTAGVPPEIWKFRGPALVVDSQEQAIEVILNDTLKPGMALVIRYEGPKGGPGMQEMLYPTSFVKGKGIGKQVAMLTDGRYSGGSSGLAIGHMAPEAANKGPVALIKNGDIIDIDIEARSVNVELTDEQLDERRRELEAGDGYVAHRDRHVSQALKAYAAFARSADKGATRDPELINKLSGLA
>NZ_CP010413.1|WP_021649100.1|435989_437003_-|methionyl-tRNA-formyltransferase
MLKLVFAGTPDVAVPSLQAFAADSRFEVVGVITRPDAPTGRGRKLTPSPVKAAAVELGLTVIDAKPRSPEFMEALNGLHADIAAVIAYGNILPKSVLDAVPMGWYNLHFSNLPKWRGAAPAQRAIWNGDPTTGADVFKVGEGLDDGPIIASLTVELTGRETSGELLTRLAEEGAPMYVDALAAVGDGTAIFTPQPAEGLEYAHKITVEDARINWADPAETIDRQIRACTPHPGAWTELFAEGLIADSGEANEESADLTTAVKPLTLHILAAQPADQTNPNTPIDLDPGELKVGKKNVWAGTGTGTLELTQVKAQGKKAMRAADWARGAHLSPTACVK
>NZ_CP010413.1|WP_060618420.1|437141_437846_-|HAD-family-phosphatase
MKGWPGEPDMDYDVLVADGEAATNAGKPITDVIFDFGNVLIYWDPAAVLIPRYSQKTIDAFLDNDISGFYDVNDLMDGGTSTEEAIAIMRERKGDKWADILDYYIKNFRDSLTGIVPGARMLVDDLKAAGIGVWGLSNWEASLFHVAEEQCDILQKLDGKLVSGFVKLRKPHKEIYDAALKEFGIKADGALFIDDKAMNIVGSNAAGIRGVRFQNPVKLRELLIANGVNIPDVQ
>NZ_CP010413.1|WP_060618421.1|437995_440305_-|primosomal-protein-N'
MTTSDAQQLTLDGLAPRKRRKRAPAEHTPAEHDPIAQVVLDVQALHLGQTFDYFIDEKDSDAAQPGVLVRVRFGGQRVGGVIWSRTSTSDTPRSSIRYIERVISPDVLVPASMREDIGLIANAYGGTRANILRFAVPPRVAKVETEQRLTASFQRPVGGSLPDNIQGGFAGRGTLPDGTHPSGSSFEVARSVSEGAAQGYRRIAANYGEANVLNDALHGQRFQSFVFDSLPGAQEWQRNMAWMAATSLSAGKSAVVELPTMREVKDLLPVLRNYGLKPFSPTPSGGWIGDVAVLNAQMPAADRYRAYLAVALGQVKVIIGTRAVMYAPVEGPALFAILEDAAYQNMDGMMPYPQARGVMRLRAKSHGGVFVAMSNARTVQSQWENTGPDTVETPVSGYSTAIHPLASPLKDATPWVRWLNRDELARLADATIGARVPHTAVRVLSKALESGPVLLSIPQDSTSEALSCAKCHRQARCAKCSGPLQLPADRSESVPRCQWCGAAAIHWTCPGCGHERMCVVRVGAAGTAAELAGLFRSVPMVLSSKAQGLVRDVPCKPMIVIATPGFEPRVRPVSNERGAAGHEYRAVAILDAWTSLYALGVDARLDTLTAWMRAVSLCAPRSRGGQALILGETDPVIAQSLMMWDSRILASKDLDERMETGMPPTVAAACVWGRRDAVMTLMQRIGALGGDWAVCGELPGMLGPVPIAQPDTVDARELEATADRVKAVVRVPQSQRAELAIRLHRETARHVASREPGELRFRIDPKDLI
>NZ_CP010413.1|WP_143247937.1|440352_441105_-|phosphoserine-phosphatase-SerB
MSQGFSRIESMTQEDVHFIDKSAESEVGALGGSADSVPTLAEPGLLVMDVDSTLIDEEVIDELGEAAGSGEEIAKVTERAMRGELEFCDALRARVALLEGLPVSVFDTVHDKLHFTKGALELINTLHAHGWKVGVVSGGFHEVVDKLAAEGHIDYWIANRLEVADGRLTGKVLGEIVCKTVKLHALREWAKQLDIPMSQTVAVGDGANDIPMIQAASLGIAFCAKPKTQLAADEAINDRDLMHVLDYLRR
>NZ_CP010413.1|WP_060618423.1|441125_441821_+|DedA-family-protein
MELAAALAANPTPICTTSEGGLIGTITEWLITLMETIGGIGVALAIALESVFPPIPSEVILPLAGFTAARGTLSLPGAIIWATIGSLLGAWTLYGISRWVGLHRINRAADKIPGVSRKDVSKANDWFTKYGTWSVLIGRVIPVVRSLISIPAGFNRMNFLQFTGWTLLGSAVWNTILVSAGYLLGDQWCSIQGALGVFEDVVIVAVVVVIVWFAVKKVRTVVRNRKTQHGE
>NZ_CP010413.1|WP_060618424.1|441874_443449_+|proteasome-ATPase
MGEAENLAELNDRLMAKNHALAEALNRAGKELAKAKSQLAQLAQPPLTFATMVKIDSTHTDEDGVQHASAEVISGTRRMIVPVAANVNASRLAAGSTVMLNEKLVLVEQRDADTVGQIRVVKQILDDGRLIVADASGNPVLVRRSSALSLTAISQGDRIIVDPSVRLAIELLPNESDRDLVLEETPDVTFADIGGLDSEIGRIRDAVQLPSQHRALFERYDLKPPKGVLLYGPPGNGKTMIAKAVANALCEGGYDMDGDGSINGREQQVKGVFLSVKGPELLNKYVGESERLIRLIFQRARERAAEGKLVVVFIDEMDSLLRTRGSGVSSDVETTIVPQFLSELDGVESLDNVMVIGASNRVDMIDPAVLRPGRLDVKIRIDRPSGEAAASIVRHYLTDDLPLEQGLDADALSRVLVRDIYTRSERRHLADVRDERGTWNALFLADVVSGASLKNIVDRAKTHAVKASIASGKDVALDATLLGRAVEDEFAETRDSLLDADPVQWARVNGFDAGRVTAIRAVGR
>NZ_CP010413.1|WP_060618425.1|443508_444222_-|HAD-family-phosphatase
MKGWPGESKLNIPFNEVIAYDAAAVHDGQPIANVIFDFGNVLVDWDPQALFMPRYREKRIEDFLDNDISGFYDACDRMDAGASPAEGIAWIRETHSERWAEMLAYYFDNFLDSLTGTIPGMRVLVHDIKTAGLGVWGLSNWQRETIGEAENAYEILRMLNGRVISSEVHMRKPDTAIYMKALESFGIDAETTVFVDDRASNVIGANRAGIRCIRFRDERGLRETLIDAGVPIPAVAE

You can click texts colored in the table to view more detailed information

Click the colored protein region to show detailed information

Crispr_ID: NZ_CP010413_3

CRISPR_ID

CRISPR_location

CRISPR_type

Repeat_type

Spacer_info

Cas_protein_info

CRISPR-Cas_info

NZ_CP010413_3

1827101-1827272

Orphan

Consensus_repeat	Method
CCAGACGCTCGTCCATACGCCGCTGATGGCGTTCAGGACG	PILER-CR

2 spacers

The CRISPR arrays of NZ_CP010413_3

>merge|NZ_CP010413|3|1827101-1827272|PILER-CR
CCATACGCTCGTCCATACGCCGCTGATGGCGTTCAGGACGGTCGAGATGGTGTTGCGCACATTCTGGATGCATGTGGACACCACGCCGCTGATCGCGTTCCAGATGGCGGATGCGACGGACCTGACCGCGTTCCAGACGCTCGTCCATACGCCGCTGATGGCGTTGAGGACG

>NZ_CP010413|3|2|1827101-1827272|PILER-CR
CCATACGCTCGTCCATACGCCGCTGATGGCGTTCAGGACG	GTCGAGATGGTGTTGCGCACATTCTGGATGCATGTGGACACC
ACGCCGCTGATCGCGTTCCAGATGGCGGATGCGACGGACC	TGACCGCGTTCCAGACGCTCGTCCATACGCCG
CTGATGGCGTTGAGGACG

Protein	Signature genes	Signature genes Name	Protein_function
NZ_CP010413.1\|WP_060618785.1\|1832667_1833573_-\|phage-major-capsid-protein	unknown	unknown	gnl\|CDD\|377449
NZ_CP010413.1\|WP_060618770.1\|1816562_1816886_-\|hypothetical-protein	unknown	unknown	unknown
NZ_CP010413.1\|WP_065471130.1\|1817174_1818410_-\|reverse-transcriptase	RT	pfam00078_RT_CAS-I:CAS-III	gnl\|CDD\|238828
NZ_CP010413.1\|WP_060618782.1\|1831557_1831893_-\|hypothetical-protein	unknown	unknown	unknown
NZ_CP010413.1\|WP_060618778.1\|1829914_1830235_-\|hypothetical-protein	unknown	unknown	unknown
NZ_CP010413.1\|WP_060618784.1\|1832353_1832668_-\|hypothetical-protein	unknown	unknown	unknown
NZ_CP010413.1\|WP_016462172.1\|1833618_1834152_-\|hypothetical-protein	unknown	unknown	unknown
NZ_CP010413.1\|WP_060618775.1\|1825641_1826421_-\|hypothetical-protein	unknown	unknown	unknown
NZ_CP010413.1\|WP_060618991.1\|1821295_1821892_-\|hypothetical-protein	unknown	unknown	unknown
NZ_CP010413.1\|WP_060618774.1\|1818823_1820404_-\|hypothetical-protein	unknown	unknown	unknown
NZ_CP010413.1\|WP_060618992.1\|1821901_1825621_-\|phage-tail-protein	unknown	unknown	gnl\|CDD\|377677
NZ_CP010413.1\|WP_003809887.1\|1814567_1814852_+\|hypothetical-protein	unknown	unknown	unknown
NZ_CP010413.1\|WP_060618780.1\|1830908_1831274_-\|hypothetical-protein	unknown	unknown	unknown
NZ_CP010413.1\|WP_060618781.1\|1831270_1831546_-\|hypothetical-protein	unknown	unknown	unknown
NZ_CP010413.1\|WP_060618783.1\|1831889_1832342_-\|hypothetical-protein	unknown	unknown	gnl\|CDD\|286444
NZ_CP010413.1\|WP_060618769.1\|1815265_1816501_-\|LysM-peptidoglycan-binding-domain-containing-protein	unknown	unknown	gnl\|CDD\|119379
NZ_CP010413.1\|WP_003809885.1\|1814311_1814584_+\|BrnT-family-toxin	unknown	unknown	gnl\|CDD\|367913
NZ_CP010413.1\|WP_060618768.1\|1814917_1815181_-\|holin	unknown	unknown	gnl\|CDD\|374894
NZ_CP010413.1\|WP_060618779.1\|1830289_1830877_-\|hypothetical-protein	unknown	unknown	unknown
NZ_CP010413.1\|WP_060618777.1\|1829510_1829903_-\|hypothetical-protein	unknown	unknown	gnl\|CDD\|375127

Protein	Function_ID	Function_description	E-value
NZ_CP010413.1\|WP_060618785.1\|1832667_1833573_-\|phage-major-capsid-protein	gnl\|CDD\|377449	pfam05065, Phage_capsid, Phage capsid family. Family of bacteriophage hypothetical proteins and capsid proteins.	6.24073e-14
NZ_CP010413.1\|WP_060618992.1\|1821901_1825621_-\|phage-tail-protein	gnl\|CDD\|377677	pfam06605, Prophage_tail, Prophage endopeptidase tail. This family is of prophage tail proteins that are probably acting as endopeptidases.	9.42455e-31
NZ_CP010413.1\|WP_060618777.1\|1829510_1829903_-\|hypothetical-protein	gnl\|CDD\|375127	pfam17318, DUF5361, Family of unknown function (DUF5361). This is a family of unknown function found in Bacteria.	0.00120607
NZ_CP010413.1\|WP_060618783.1\|1831889_1832342_-\|hypothetical-protein	gnl\|CDD\|286444	pfam09355, Phage_Gp19, Phage protein Gp19/Gp15/Gp42. This family of proteins are functionally uncharacterized. They are found in a variety of bacteriophage.	9.39276e-13
NZ_CP010413.1\|WP_060618769.1\|1815265_1816501_-\|LysM-peptidoglycan-binding-domain-containing-protein	gnl\|CDD\|119379	cd06417, GH25_LysA-like, LysA is a cell wall endolysin produced by Lactobacillus fermentum, which degrades bacterial cell walls by catalyzing the hydrolysis of 1,4-beta-linkages between N-acetylmuramic acid and N-acetyl-D-glucosamine residues. The N-terminal glycosyl hydrolase family 25 (GH25) domain of LysA has sequence similarity with other murein hydrolase catalytic domains while the C-terminal domain has sequence similarity with putative bacterial cell wall-binding SH3b domains. This domain family also includes LysL of Lactococcus lactis.	1.03656e-105
NZ_CP010413.1\|WP_003809885.1\|1814311_1814584_+\|BrnT-family-toxin	gnl\|CDD\|367913	pfam04365, BrnT_toxin, Ribonuclease toxin, BrnT, of type II toxin-antitoxin system. BrnT is a ribonuclease toxin of a type II toxin-antitoxin system that exhibits a RelE-like fold. The antitoxin that neutralizes this toxin is pfam14384. BrnT is found in bacteria, archaea, bacteriophage, and plasmids. BrnT-BrnA forms a 2:2 tetrameric complex and autoregulates its own expression, which is induced by a number of different environmental stresses. Expression of BrnT alone results in cessation of bacterial growth which can be rescued after subsequent expression of BrnA.	1.6593e-27
NZ_CP010413.1\|WP_060618768.1\|1814917_1815181_-\|holin	gnl\|CDD\|374894	pfam16938, Phage_holin_Dp1, Putative phage holin Dp-1. Phage_holin_Dp1 is a family of putative phage-holins from Gram-positive bacteria, largely Firmicutes, with two probable TMSs. The family shows lytic activity.	1.19212e-15
NZ_CP010413.1\|WP_065471130.1\|1817174_1818410_-\|reverse-transcriptase	gnl\|CDD\|238828	cd01651, RT_G2_intron, RT_G2_intron: Reverse transcriptases (RTs) with group II intron origin. RT transcribes DNA using RNA as template. Proteins in this subfamily are found in bacterial and mitochondrial group II introns. Their most probable ancestor was a retrotransposable element with both gag-like and pol-like genes. This subfamily of proteins appears to have captured the RT sequences from transposable elements, which lack long terminal repeats (LTRs).	4.602e-23

>NZ_CP010413.1|WP_060618775.1|1825641_1826421_-|hypothetical-protein
MLYQRRMRLPHVEDPTLNGVPLERMMLSLSSDGVTIDAAKPTLSMQDMPGRDGRLDLTLTDPTGAACMGDRAITLSLYAIGGEDDILTAKTRLAALAGTIVSLSWRSLPGEYKGRMSLGAWADKWAGGHQIGTLVQAEIDARPYLIGRSRSIALKTGMNTIHVKGNRPCWPTWTLTPASGAKTVSIKDAHGHKLAIASTTAITGRISIDTDPDKRELRVNGNLMAPTLESDYFPLLPGPNTPTLTGCTGTLTYRPLTLI
>NZ_CP010413.1|WP_060618992.1|1821901_1825621_-|phage-tail-protein
MIFDRWGNPLGDLPYVIKALRTRATDGTDTLDITTIGEINKDERIVFQDSMGRWAEYLCQSTQTARAAGMPVTVAYCAGSIAELSRTYIEDKRNRNANAKACLAKALEGTRWTVGTVETGTITGMANLAFYHCTVLEAAQKTADTYGLEVQTEYQPDPTGNQIGRRIIHLVEHRGSANTTKRFEYGKDLTQIKRDIDSGDVITRLYGWGKGIEQTNDQGEATGGYSRKISFADVNNGKPYVQDDQALADWGIVGADGTRHHSEASVDFPDCEDPKELLALTKNALKTRTTPVVSYTADVTALGQAGYSAEGTDVGDSVQIIDTSFTNPLRLEGRILQIEEDLAGSLADTKITLGNIRQSYTQRLAAQQQALDKLVSNSGAWNSAAGGTGPYMKDLIDRINQIMNATGGYTYLKPGQGIYVYDKPEDQNPTQCIHIGGGYWRIADHKNANGNWDFRSLANGKGIFADTIFTGRLSDAAGLNFWDMDTGEFSLSARSTVGGKTVQEYADGALSDANSYTDAAKQAAITEAKRQADAADTAKLAEAKKYAEAKAGEAETAAKAQSKADGEAAKAAAQAYVDALDESLGQRSIFDRLTNNGKTQGIYLSGGLLYLNATYMKTGVLDAALVKAGRLTDKKGLNYWDMDTGEFSLSANSTINGNKASGLATQTQAQKLATDAQTAAKAYADRVGASTLSSAKSDATAKANTALSGAKTYVEAIMAYGSNLVRNPNGNPDHDLDKLGASKLTKTMPATHPEGITSAIHLGNVRDTYFGWPLDTFRGHTFRLSGWAYRKAGNVTSSFGIHWTDTGNGNHWQTIAQSAANANGWTYVSGSYAVPSNAKTARLWMQVDRNTATASDADWYWTGLQCTDETAARSYVDTFEGELTQTYIFNKLTNNGQKQGLYLSNGLLYINATYMKTGVITGKRSYWNLDTGQFVMTDANGNETVHLDGDGADNLLTGTFRTARTGNRVQISPSFKQTEISGTDSLEGAGIQFYHGSGSYQHPYIAVESTTQQEGEVSALTFNGGRRAEHDPGAFARIGERKADDNTTKVGTVFLAAEKDYDSTDPSSRRAYLSLWSPKTGDTTATLAARDPNGLVGIQADIDSGYLYMGGFLGGFSGGRSTFQTAWWEGQNIGAMKYTQYTLTSSNPAKYGSYKAFATVDHRQDDPGLFIATVSDCTASGWSIWVYTPPERVVTNMDASWNRNTSTGVVSNLSINTHYAALFQGNKPYQLHTIGFLKK
>NZ_CP010413.1|WP_060618991.1|1821295_1821892_-|hypothetical-protein
MQVTTINDQPTLLIDRPLTADTTPPAAVTDGMTTITTTPPTPDMRHDAIPLAAIASWRTLLGIETDTEAVAAILHVRDHGEPDPDPQTGETAWTSAYNAIENAINTTTAPADNTPDDPLTAGRNKTRGLLGLPLLPDTATTNPSAEDETDAPTTIALPAGIEPTELGNLLADHADDINDATDRFIESLTQTNDGKDHD
>NZ_CP010413.1|WP_060618774.1|1818823_1820404_-|hypothetical-protein
MANTQKVMTLADTAQLIAKVHKNAAQGVRFSYDSTKGEYGNIAAYFTAHTDGKIYGVKFPKYTYSNTPTGVKTRDNANLTIEISTNDKAGRDDYAALPAFRVWDVNATIGDDGVPHVTAIDGIDTRFKRDGTNGDVYVMTCPGYYKLDSTSTHNEFLYSDTQYDGYTPLPGVLLPDGSKRPCLLFAKYAASLDSSLRPLSVSGVEIDREFGSQNRAIDYALKKGKGYAGRCQGDTFYVQLMLMLKYATKNSDVLGGCWQYTPQTAVTNAETGVKRVIIATSAASGFDIGSTVNVGTDKERNNAGNYSAARARTILSKTNLDANNTALNLDGTPITTTTACFVSSMPWKTGATDKLLGTDGRPSAAFAANHQPIRLQGIELFNGIYESDADLIANAVKDNDNLGRIELYRVFDITKASKTSTANYTKIGEFTARDKTTNDSWRYAEDFTLSNGVIIPTGLNATSTTGMCDAIGANPLTSQGLRQVRRFGGLRGGAACGAFAANLWNDLADRWWNIGGRLSALGRTKA
>NZ_CP010413.1|WP_065471130.1|1817174_1818410_-|reverse-transcriptase
MFVRRAIDHYLKGKRSRRDVTRFLETHPDLDRLAERIADEIREGRYRDTRITYFNRVEPISGKHRVIGRESVRHQIYDHVAVMALQPLFDAKVGRWQTASIPNRGTIDARRAIKRWTRERSSKWFVKLDVRKYYPSIDRTTLKAMLTRDVGDPILLRLVFHLIDRYQGDNGLNIGSHLSQWLANYYLSHAYHWIESPAMTIERTSRRTGEITRRRLITHQLWYMDDLLLIGTSKRDLKIAARRIVRYLKDRLKLDVHEEWNCKRLDLEPIDMVGYTFRPHGRVNIRSGVFLRARRTFSRARRRPMTERLARRCCSYYGYLRNSDSIRYRRRHRIDHTMRRATRYLSTQHRKEKPCSRPYPAPNPSKRSATTRAATDSRTSASAATSPPSCTRTAIPRGRNIPPTRPIPCAT
>NZ_CP010413.1|WP_060618770.1|1816562_1816886_-|hypothetical-protein
MNPIAQQLTVWAATGIITALGGYMLGWWRGYRRKSDAMQTGVRVLLLCKLEQMQREMVANDGIADNTAKQTAQLVYDSYHSLGGNGHGTQVNQDIQDAPIAPRKPQA
>NZ_CP010413.1|WP_060618769.1|1815265_1816501_-|LysM-peptidoglycan-binding-domain-containing-protein
MGKIKNKSKPLQALIAAFVAMLLAATPAIAMADMVGIDVSGWQAENVTCTASYDFAVVKVSQGIGFENSSWRTQAKCVTDRGKSLGLYHYAGGNNAEAEADYFVAKARDYIGRAVLVLDWESYQNAQWGNGDWVRRFAQRVHTLTGVWPMVYVQASALRQIPGDVRANCGLWVAQYASNAPTGYQSRPWNYAIYGEAMRQYTSNGWVNGYNGPLDLNYFRGDTSQWQAYANPAGAAKPATPPQTERPPTQTVDLQALATATIRGDYGNGQQRRDALGANYDRVMAIVNQRLAGVATVAPPQTTQANTTRVTVRSGDTMSGIATRTGLWPLSRWSVPSGNLNLIYPGQVVTYNGGGSVATGSNAPPATRTVTVRAGDTLSGIAARLGISYTQLTGYRSGNPNVIYPGEVLHY
>NZ_CP010413.1|WP_060618768.1|1814917_1815181_-|holin
MTDENTEPKTAGTEPTVPDWLLPNRVYDVLKWLALIVLPAIGVLVQTLGPVWGWTWADQAATTINAVALTIGVVIGASTLKAKASKA
>NZ_CP010413.1|WP_003809887.1|1814567_1814852_+|hypothetical-protein
MTAKTKPDAKAITSDQLEEMFDNGDDILDYVDMSNPVVEHHPPLEKRITLTMPAWMVGELDEEAADLAISRNAVVNTWIADRLRTTRRRETIHA
>NZ_CP010413.1|WP_003809885.1|1814311_1814584_+|BrnT-family-toxin
MEFEYDPAKSAKNLAKHGIDFEAAQRMWDNSKTVTLTAPNPGNDDVRYIVLGMIDGKHWTAITTKRGKRIRIISVRRSRKNEEAYYDSQD
>NZ_CP010413.1|WP_060618777.1|1829510_1829903_-|hypothetical-protein
MLATAPDALEADFQRFYGLNLDLIWTGELPANRAAALAANLPRQSIIWQKLNPRLAWDDQTYLLADIRDSLAFLAWTKTKEASRKGARWRGQLQRPGTVRHEATGGEVMAMDDEQLAAYLAAPRTTIREA
>NZ_CP010413.1|WP_060618778.1|1829914_1830235_-|hypothetical-protein
MAAKQPQDHKTPKNQPRTVEAMGVTLAVSPAIFDDLDMVEYLYDLQAAQEGDGTGAFAIVPFLKKLCGPQYAAMKDALRDPDTGRVSIDKVSEFIAQLLEQVAPNS
>NZ_CP010413.1|WP_060618779.1|1830289_1830877_-|hypothetical-protein
MAETNHNNKKNVSLGKPKKTGCLYYAPAGTALPTDATTALPAAYTCVGYLSEDGVTNATDTDTTDINEMGGIKVLSEISGYGETWQFNMIETNEASLKLRFGTANVTGTADKLTVYHAIPSGESLVLVFEIAMTGNRVKRIVVADGTITEFDDTTYSAGDAIGYGVTMSANPSDLINGATSVEYIANVAAASLSK
>NZ_CP010413.1|WP_060618780.1|1830908_1831274_-|hypothetical-protein
MSLNLEKTVKDWIDADPDGDGLTAYLEVPADRPQRFVTIERVGGRELEYSSHPTIAIQVWAESRWQAAQLATSQVLPRLLDLDLLDPIAAVGVESVIDLPDPGPPPQPRYQITISLDAAAQ
>NZ_CP010413.1|WP_060618781.1|1831270_1831546_-|hypothetical-protein
MAKVKLNLAGFRAVRQSAPIQHAIDQQAALIAARANSMAQVEGATYEAATHVSTPKGSVALATTGHGSEGNVKAMVDNAKHNTLLKSVKQQ
>NZ_CP010413.1|WP_060618782.1|1831557_1831893_-|hypothetical-protein
MRGETITLIHRTKTGEDPGGGIIWNTREEQVDDVLIQDGSQSNSTDPIRPDGIRTAKTIHMPRAWPYRSLRGAKARIDGVEYTVIGDPRPYTGGITPTRWNLTVELADTRG
>NZ_CP010413.1|WP_060618783.1|1831889_1832342_-|hypothetical-protein
MDGYPSTPLNLSDGTTMTQDGGGEDETDDEKPFAQVGDLEARWHALTGDERTSAEALLADASDLIRTTCPRWHTAKPATLKRIACMAVKRAMQAGPDMSGVTQSTQTAGSYSESLSYANPAGDLYLTTSEKEALGGDGEAWAYDMAGGAA
>NZ_CP010413.1|WP_060618784.1|1832353_1832668_-|hypothetical-protein
MAAPLTQTLVVQKTDEADEAGLAIPVRLVKPDGTPFAEGVATVSWDSITGKPATFTPPAPTASARGGVLQQAAEAQLAASADSAAIIAKVNATLTKLKAAGILT
>NZ_CP010413.1|WP_060618785.1|1832667_1833573_-|phage-major-capsid-protein
MALDTSKVLLPKEVATVITKRAKDTSTIAALSPSEPQLFLDKDYMVFTGNSEAEVVAEGAQKSSYEETLTPVVGKRFKVQTTTRVSNELQWADEDAKLEITSKILADQAAAMGRVLDYVIYHAFDPKKKTTLDGFNALAKTAVGVTATDDRVADIDSLAEAVSDEYDINGIAMSKTMANELRKIRVPSTGQRFYPEIPINLQVGNLDGIPAATSGTVNGRLITPATGILAFLGDFRLIRWGMVRDIWSEIIEYGDPDNTGKDLKGVNQIAYRTEAMYSYAILDPKGIAVLKKPTSTGRAAK
>NZ_CP010413.1|WP_016462172.1|1833618_1834152_-|hypothetical-protein
MFLNHTPRHVRFVAAPPEGGMASGGADQPAASSESEDVGEPIDWEAKYKEALGHSRDWEKKAKANKAAADELEKLKEASMTEQEKAAKHVKELEDKVASYETAKQRAEWKAQASAETGVPADVIEGDSLEAMQSHAKRIHELLNPKPKAPAVHGADRQPSGKGPNESMVNYLRNLGL

You can click texts colored in the table to view more detailed information

Click the colored protein region to show detailed information

Crispr_ID: NZ_CP010413_4

CRISPR_ID

CRISPR_location

CRISPR_type

Repeat_type

Spacer_info

Cas_protein_info

CRISPR-Cas_info

NZ_CP010413_4

1834182-1834261

Orphan

Consensus_repeat	Method
CGGGCATTGAAAAAGCCACCCGTGCG	CRISPRCasFinder

1 spacers

The CRISPR arrays of NZ_CP010413_4

>merge|NZ_CP010413|4|1834182-1834261|CRISPRCasFinder
CGGGCATTGAAAAAGCCACCCGTGCGGGTGGCTGAAAACTTGGATGCCCGTCTTCGGGCATTGAAAAAGCCACCCGGCGA

>NZ_CP010413|4|3|1834182-1834261|CRISPRCasFinder
CGGGCATTGAAAAAGCCACCCGTGCG	GGTGGCTGAAAACTTGGATGCCCGTCTT
CGGGCATTGAAAAAGCCACCCGGCGA

Protein	Signature genes	Signature genes Name	Protein_function
NZ_CP010413.1\|WP_060618785.1\|1832667_1833573_-\|phage-major-capsid-protein	unknown	unknown	gnl\|CDD\|377449
NZ_CP010413.1\|WP_060618790.1\|1841268_1841487_-\|hypothetical-protein	unknown	unknown	unknown
NZ_CP010413.1\|WP_060618787.1\|1835654_1837154_-\|phage-portal-protein	unknown	unknown	gnl\|CDD\|377466
NZ_CP010413.1\|WP_060618789.1\|1840634_1840820_-\|hypothetical-protein	unknown	unknown	unknown
NZ_CP010413.1\|WP_060618782.1\|1831557_1831893_-\|hypothetical-protein	unknown	unknown	unknown
NZ_CP010413.1\|WP_060618780.1\|1830908_1831274_-\|hypothetical-protein	unknown	unknown	unknown
NZ_CP010413.1\|WP_060618778.1\|1829914_1830235_-\|hypothetical-protein	unknown	unknown	unknown
NZ_CP010413.1\|WP_010081010.1\|1838948_1839242_-\|hypothetical-protein	unknown	unknown	gnl\|CDD\|372995
NZ_CP010413.1\|WP_016462172.1\|1833618_1834152_-\|hypothetical-protein	unknown	unknown	unknown
NZ_CP010413.1\|WP_060618993.1\|1839647_1840487_-\|hypothetical-protein	unknown	unknown	unknown
NZ_CP010413.1\|WP_060618783.1\|1831889_1832342_-\|hypothetical-protein	unknown	unknown	gnl\|CDD\|286444
NZ_CP010413.1\|WP_060618788.1\|1837153_1838587_-\|terminase	unknown	unknown	gnl\|CDD\|273684
NZ_CP010413.1\|WP_060618784.1\|1832353_1832668_-\|hypothetical-protein	unknown	unknown	unknown
NZ_CP010413.1\|WP_060618781.1\|1831270_1831546_-\|hypothetical-protein	unknown	unknown	unknown
NZ_CP010413.1\|WP_016462171.1\|1834283_1834544_-\|hypothetical-protein	unknown	unknown	unknown
NZ_CP010413.1\|WP_060618779.1\|1830289_1830877_-\|hypothetical-protein	unknown	unknown	unknown
NZ_CP010413.1\|WP_143247902.1\|1840816_1841272_-\|hypothetical-protein	unknown	unknown	unknown
NZ_CP010413.1\|WP_060618786.1\|1834501_1835704_-\|hypothetical-protein	unknown	unknown	unknown
NZ_CP010413.1\|WP_060618777.1\|1829510_1829903_-\|hypothetical-protein	unknown	unknown	gnl\|CDD\|375127
NZ_CP010413.1\|WP_010081009.1\|1838570_1838759_-\|hypothetical-protein	unknown	unknown	unknown

Protein	Function_ID	Function_description	E-value
NZ_CP010413.1\|WP_060618785.1\|1832667_1833573_-\|phage-major-capsid-protein	gnl\|CDD\|377449	pfam05065, Phage_capsid, Phage capsid family. Family of bacteriophage hypothetical proteins and capsid proteins.	6.24073e-14
NZ_CP010413.1\|WP_060618783.1\|1831889_1832342_-\|hypothetical-protein	gnl\|CDD\|286444	pfam09355, Phage_Gp19, Phage protein Gp19/Gp15/Gp42. This family of proteins are functionally uncharacterized. They are found in a variety of bacteriophage.	9.39276e-13
NZ_CP010413.1\|WP_060618787.1\|1835654_1837154_-\|phage-portal-protein	gnl\|CDD\|377466	pfam05133, Phage_prot_Gp6, Phage portal protein, SPP1 Gp6-like. This protein forms a hole, or portal, that enables DNA passage during packaging and ejection. It also forms the junction between the phage head (capsid) and the tail proteins. During SPP1 morphogenesis, Gp6 participates in the procapsid assembly reaction. This family also includes the old Pfam family Phage_min_cap (PF05126).	5.13623e-23
NZ_CP010413.1\|WP_010081010.1\|1838948_1839242_-\|hypothetical-protein	gnl\|CDD\|372995	pfam14279, HNH_5, HNH endonuclease. This domain is related to other HNH domain families such as pfam01844. Suggesting that these proteins have a nucleic acid cleaving function.	0.00276634
NZ_CP010413.1\|WP_060618788.1\|1837153_1838587_-\|terminase	gnl\|CDD\|273684	TIGR01547, Uncharacterized_protein_YqaT, phage terminase, large subunit, PBSX family. This model detects members of a highly divergent family of the large subunit of phage terminase. All members are encoded by phage genomes or within prophage regions of bacterial genomes. This is a distinct family from pfam03354. [Mobile and extrachromosomal element functions, Prophage functions].	2.24099e-06
NZ_CP010413.1\|WP_060618777.1\|1829510_1829903_-\|hypothetical-protein	gnl\|CDD\|375127	pfam17318, DUF5361, Family of unknown function (DUF5361). This is a family of unknown function found in Bacteria.	0.00120607

>NZ_CP010413.1|WP_016462172.1|1833618_1834152_-|hypothetical-protein
MFLNHTPRHVRFVAAPPEGGMASGGADQPAASSESEDVGEPIDWEAKYKEALGHSRDWEKKAKANKAAADELEKLKEASMTEQEKAAKHVKELEDKVASYETAKQRAEWKAQASAETGVPADVIEGDSLEAMQSHAKRIHELLNPKPKAPAVHGADRQPSGKGPNESMVNYLRNLGL
>NZ_CP010413.1|WP_060618785.1|1832667_1833573_-|phage-major-capsid-protein
MALDTSKVLLPKEVATVITKRAKDTSTIAALSPSEPQLFLDKDYMVFTGNSEAEVVAEGAQKSSYEETLTPVVGKRFKVQTTTRVSNELQWADEDAKLEITSKILADQAAAMGRVLDYVIYHAFDPKKKTTLDGFNALAKTAVGVTATDDRVADIDSLAEAVSDEYDINGIAMSKTMANELRKIRVPSTGQRFYPEIPINLQVGNLDGIPAATSGTVNGRLITPATGILAFLGDFRLIRWGMVRDIWSEIIEYGDPDNTGKDLKGVNQIAYRTEAMYSYAILDPKGIAVLKKPTSTGRAAK
>NZ_CP010413.1|WP_060618784.1|1832353_1832668_-|hypothetical-protein
MAAPLTQTLVVQKTDEADEAGLAIPVRLVKPDGTPFAEGVATVSWDSITGKPATFTPPAPTASARGGVLQQAAEAQLAASADSAAIIAKVNATLTKLKAAGILT
>NZ_CP010413.1|WP_060618783.1|1831889_1832342_-|hypothetical-protein
MDGYPSTPLNLSDGTTMTQDGGGEDETDDEKPFAQVGDLEARWHALTGDERTSAEALLADASDLIRTTCPRWHTAKPATLKRIACMAVKRAMQAGPDMSGVTQSTQTAGSYSESLSYANPAGDLYLTTSEKEALGGDGEAWAYDMAGGAA
>NZ_CP010413.1|WP_060618782.1|1831557_1831893_-|hypothetical-protein
MRGETITLIHRTKTGEDPGGGIIWNTREEQVDDVLIQDGSQSNSTDPIRPDGIRTAKTIHMPRAWPYRSLRGAKARIDGVEYTVIGDPRPYTGGITPTRWNLTVELADTRG
>NZ_CP010413.1|WP_060618781.1|1831270_1831546_-|hypothetical-protein
MAKVKLNLAGFRAVRQSAPIQHAIDQQAALIAARANSMAQVEGATYEAATHVSTPKGSVALATTGHGSEGNVKAMVDNAKHNTLLKSVKQQ
>NZ_CP010413.1|WP_060618780.1|1830908_1831274_-|hypothetical-protein
MSLNLEKTVKDWIDADPDGDGLTAYLEVPADRPQRFVTIERVGGRELEYSSHPTIAIQVWAESRWQAAQLATSQVLPRLLDLDLLDPIAAVGVESVIDLPDPGPPPQPRYQITISLDAAAQ
>NZ_CP010413.1|WP_060618779.1|1830289_1830877_-|hypothetical-protein
MAETNHNNKKNVSLGKPKKTGCLYYAPAGTALPTDATTALPAAYTCVGYLSEDGVTNATDTDTTDINEMGGIKVLSEISGYGETWQFNMIETNEASLKLRFGTANVTGTADKLTVYHAIPSGESLVLVFEIAMTGNRVKRIVVADGTITEFDDTTYSAGDAIGYGVTMSANPSDLINGATSVEYIANVAAASLSK
>NZ_CP010413.1|WP_060618778.1|1829914_1830235_-|hypothetical-protein
MAAKQPQDHKTPKNQPRTVEAMGVTLAVSPAIFDDLDMVEYLYDLQAAQEGDGTGAFAIVPFLKKLCGPQYAAMKDALRDPDTGRVSIDKVSEFIAQLLEQVAPNS
>NZ_CP010413.1|WP_060618777.1|1829510_1829903_-|hypothetical-protein
MLATAPDALEADFQRFYGLNLDLIWTGELPANRAAALAANLPRQSIIWQKLNPRLAWDDQTYLLADIRDSLAFLAWTKTKEASRKGARWRGQLQRPGTVRHEATGGEVMAMDDEQLAAYLAAPRTTIREA
>NZ_CP010413.1|WP_016462171.1|1834283_1834544_-|hypothetical-protein
MATDSQCEAAYRRLRPYCDVLEEAEELDYGLAAGEQYYALSWLIAAILENHVTVPQEPLLDAFGLLEDEDKDEYASALDKELAQPT
>NZ_CP010413.1|WP_060618786.1|1834501_1835704_-|hypothetical-protein
MDSNSLPPSNLSPAQRKAFNSHLNDLWDDYQDELSDLIIEAKTMVPNSLYFGDDPTGQARLQLEDYARKANLIVQDYYRNVRAAWAEAAGITMPDYKEAQVSSDRAFWQIVGGYNNTMHVGAKFTDVINGRSKAGLTMDHLWAVNTQGYTEDDWARLAKDIINETARLTGRFTAQNDPTRPKYARVPQGKTCAFCAMLASRGFVYASEDTAGKWNRYHHDCDCKIVPSWGETKLEGYDPDKFKRMYKAAKSRAGTSETNAVMKTMNHMFPDELTSGVFELSAEWPAEVIQPRAKTWDHVFENHGPDATVPGKTHFPKEWDEKKIKWAVEETVVAPDLVIPAGRERQTLYKIVEDEIVRVWLQKTRNTGGRFTVHTAHPVVPQQKEKLWQQIRNAKPHTGG
>NZ_CP010413.1|WP_060618787.1|1835654_1837154_-|phage-portal-protein
MPATDHNGLAITNPATQDAYLAVQSANITRIKGVEDDDMPTIQKLLTTWRDHYARNMLRAEYYQARYRYNGVAYSIPKQMRALAKPMIGWPNKAVRALADLNVFEGFDAPDPLQAQVDELVDDNAWDTDVSEAITSAYIHGCSFITVYEDPDEPGRILMLPRSADWSAGIWDRRRRRLGSALTITDKDDRTGRITAFTAWLPGKVYEIDDSEGQWTARTIETHLDRPSVVPLVNDAQSYHPLGNSRITRTLMNLTDFGLRTMVRMEATAEFYAAPRVWFIGASKKFTDDTWSSIVSVMNGMPANKNGDKPTMQQLQQASMTPHADMLRTIALMVSSETDIPVNDLGITMDNPASAEAMAEAERKLSRTADRQNKRFGRALKEAMSIALAYQGADPDALRELRPIWAPVKETSDAARADWYQKVASTNPDFADSDVGLTRAGLTLDEIKAHRAYEKQKRTEAAVDTLRARLHAADQTATGTEAENGQQQPAAEQPQPGAA
>NZ_CP010413.1|WP_060618788.1|1837153_1838587_-|terminase
MNMRIDGASCQIIPDDLYTSGEPSLNRLAAAAGDRFDVWQRQINRIILAKSADGFWSARNTVLSIPRQTGKTYDIGWIAIHRAARTPGMRIVWTAQHFSVIKDTFESLCAIVLRPEMSGLVDPDHGISLAAGKEEIRFRNGSRIFFRARERGALRGVKKIALLVIDEAQHLSDSAMASMLPTQNRAWNPQTIYMGTPPGPRDNGEAFTRLRDKARAGRTHSTLYVEFTADRDADPLDRDQWRKANPSYPSHTSDESIANLWENLTGDDFRREALGIWDEHALSQAIDRRQWEEATIERRRPGGVMSFGIDMNPQRTRLTIGACMRYDDNTAHIELAEYRDTNHDGTMWAVNLIDKVWEQTAALVIDGQSPATALLPDLAQAGVTVTVTAATDMGRACGRLQDMLRDGTLTHLPEDGQQPLWQAAAKATTRPIGKNGLFGWNRPDDDTDISPLNAVTLALHGAMTTRRDPTQETETWF
>NZ_CP010413.1|WP_010081009.1|1838570_1838759_-|hypothetical-protein
MRNLIAEKLDEGSISSRDLASLTKRLADMSAEIEAIDKASNGHDPAMQALDTEDERLDEHED
>NZ_CP010413.1|WP_010081010.1|1838948_1839242_-|hypothetical-protein
MRADCYICHRPIDYELKAPHPYSFVVDETIALARGGTLTHDNSGPAHRWCNAIKGTHSLAWARERVAQLIAQGKAPQRIAPVSAGPIRCSDWFGGGE
>NZ_CP010413.1|WP_060618993.1|1839647_1840487_-|hypothetical-protein
MEQRTCAACGKAAGAANLCKECVKDWAKRLAWLLKAGMPALQQIAYKQATTRERSPRHGNRAYAAPPVNEAAQALYSAVETHLQLTGGMLGVKPIGHDRYDRPRTLMQWADITRLLLHHMPDLARLDTAGDLYADLIRLSEKVETATTHAGERRLVGVCPDCLNTKGDDDEPIRTPIYAARSARYAVCPECGAWLDLKRVRLEYLRGAGLMHITRTQADAARWVRENTGVSVTGKDLANWRSRGKMPSTRRIDRHYWEWNIMELLACAQDRAERDGGDV
>NZ_CP010413.1|WP_060618789.1|1840634_1840820_-|hypothetical-protein
MRVTEGVRKIIVEWHGKGVPPEETARSLRIPIDEVKAIILQAHPASAPEKPAGIGDNRRES
>NZ_CP010413.1|WP_143247902.1|1840816_1841272_-|hypothetical-protein
MSIDLTQQALNALADAGLGNDSPAEAYVIGYTQGHDDALALAIQLERSINRRPFMPDEAERLAMRLHEQVGDCPIAHESGKAMDDSEREWWVNLAASAWTLIDGTHPECFGRFTVVALSYGGAIRKCMRRVAQMCAKHSACEQLDRQEARA
>NZ_CP010413.1|WP_060618790.1|1841268_1841487_-|hypothetical-protein
MTRIRIMCDRTDGTTIKLGDIETDKTGNTIYSAHRSLTQDDMYRYTATLALLRWITHLEQFSQITNQTKEDA

You can click texts colored in the table to view more detailed information

Click the colored protein region to show detailed information

Crispr_ID: NZ_CP010413_6

CRISPR_ID

CRISPR_location

CRISPR_type

Repeat_type

Spacer_info

Cas_protein_info

CRISPR-Cas_info

NZ_CP010413_6

2045465-2045539

Orphan

Consensus_repeat	Method
CCTCAGCGGGGCAAAACCACCAG	CRISPRCasFinder

1 spacers

The CRISPR arrays of NZ_CP010413_6

>merge|NZ_CP010413|6|2045465-2045539|CRISPRCasFinder
CCTCAGCGGAGCTATCCCGCCAAGAGCTGGTAAAAAAGCACCGCTAACAACGCACCAGCGGAGCAAAACCACCAG

>NZ_CP010413|6|5|2045465-2045539|CRISPRCasFinder
CCTCAGCGGAGCTATCCCGCCAA	GAGCTGGTAAAAAAGCACCGCTAACAACG
CACCAGCGGAGCAAAACCACCAG

Protein	Signature genes	Signature genes Name	Protein_function
NZ_CP010413.1\|WP_025220998.1\|2056711_2057779_-\|class-II-fructose-bisphosphate-aldolase	unknown	unknown	gnl\|CDD\|236406
NZ_CP010413.1\|WP_003832407.1\|2043410_2044778_-\|MHS-family-MFS-transporter	unknown	unknown	gnl\|CDD\|340927
NZ_CP010413.1\|WP_060618858.1\|2052437_2053478_-\|CrcB-family-protein	unknown	unknown	gnl\|CDD\|223317
NZ_CP010413.1\|WP_008783494.1\|2039394_2040180_+\|hypothetical-protein	unknown	unknown	unknown
NZ_CP010413.1\|WP_025220997.1\|2057841_2058777_-\|EamA-family-transporter	unknown	unknown	gnl\|CDD\|273359
NZ_CP010413.1\|WP_003827961.1\|2052042_2052438_-\|CrcB-family-protein	unknown	unknown	gnl\|CDD\|376809
NZ_CP010413.1\|WP_025221010.1\|2035045_2036077_+\|LacI-family-transcriptional-regulator	unknown	unknown	gnl\|CDD\|224525
NZ_CP010413.1\|WP_060618859.1\|2053664_2055248_-\|ClC-family-H(+)/Cl(-)-exchange-transporter	unknown	unknown	gnl\|CDD\|238504
NZ_CP010413.1\|WP_060619000.1\|2029759_2034172_-\|collagen-binding-protein	unknown	unknown	gnl\|CDD\|380024
NZ_CP010413.1\|WP_060618855.1\|2026594_2027554_-\|class-C-sortase	unknown	unknown	gnl\|CDD\|320676
NZ_CP010413.1\|WP_025220999.1\|2055271_2056558_-\|adenylosuccinate-synthase	unknown	unknown	gnl\|CDD\|234904
NZ_CP010413.1\|WP_003832411.1\|2040482_2041535_-\|ketol-acid-reductoisomerase	unknown	unknown	gnl\|CDD\|235491
NZ_CP010413.1\|WP_003827968.1\|2041962_2043015_-\|ketol-acid-reductoisomerase	unknown	unknown	gnl\|CDD\|235491
NZ_CP010413.1\|WP_014483280.1\|2050682_2051768_-\|LacI-family-transcriptional-regulator	unknown	unknown	gnl\|CDD\|380514
NZ_CP010413.1\|WP_003832415.1\|2038369_2039398_+\|membrane-protein	unknown	unknown	gnl\|CDD\|197670
NZ_CP010413.1\|WP_003827964.1\|2048729_2050256_-\|sucrose-phosphorylase	unknown	unknown	gnl\|CDD\|237528
NZ_CP010413.1\|WP_060618856.1\|2027810_2029655_-\|isopeptide-forming-domain-containing-fimbrial-protein	unknown	unknown	gnl\|CDD\|374637
NZ_CP010413.1\|WP_003827966.1\|2045768_2046821_-\|LacI-family-transcriptional-regulator	unknown	unknown	gnl\|CDD\|380514
NZ_CP010413.1\|WP_060618857.1\|2036348_2038163_+\|glycoside-hydrolase-family-13-protein	unknown	unknown	gnl\|CDD\|200471
NZ_CP010413.1\|WP_019727681.1\|2046890_2048525_-\|MFS-transporter	unknown	unknown	gnl\|CDD\|349949

Protein	Function_ID	Function_description	E-value
NZ_CP010413.1\|WP_025220998.1\|2056711_2057779_-\|class-II-fructose-bisphosphate-aldolase	gnl\|CDD\|236406	PRK09197, PRK09197, fructose-bisphosphate aldolase; Provisional.	0
NZ_CP010413.1\|WP_003832407.1\|2043410_2044778_-\|MHS-family-MFS-transporter	gnl\|CDD\|340927	cd17369, MFS_ShiA_like, Shikimate transporter and similar proteins of the Major Facilitator Superfamily. This subfamily is composed of Escherichia coli shikimate transporter (ShiA), inner membrane metabolite transport protein YhjE, and other putative metabolite transporters. ShiA is involved in the uptake of shikimate, an aromatic compound involved in siderophore biosynthesis. It has been suggested that YhjE may mediate the uptake of osmoprotectants. The ShiA-like subfamily belongs to the Metazoan Synaptic Vesicle Glycoprotein 2 (SV2) and related small molecule transporter family (SV2-like) of the Major Facilitator Superfamily (MFS) of membrane transport proteins. MFS proteins are thought to function through a single substrate binding site, alternating-access mechanism involving a rocker-switch type of movement.	5.4999e-175
NZ_CP010413.1\|WP_060618858.1\|2052437_2053478_-\|CrcB-family-protein	gnl\|CDD\|223317	COG0239, CrcB, Integral membrane protein possibly involved in chromosome condensation [Cell division and chromosome partitioning].	5.08097e-23
NZ_CP010413.1\|WP_003827961.1\|2052042_2052438_-\|CrcB-family-protein	gnl\|CDD\|376809	pfam02537, CRCB, CrcB-like protein, Camphor Resistance (CrcB). CRCB is a family of bacterial integral membrane proteins with four TMs.. Over expression in E. coli also leads to camphor resistance.	1.40631e-21
NZ_CP010413.1\|WP_025220997.1\|2057841_2058777_-\|EamA-family-transporter	gnl\|CDD\|273359	TIGR00950, Uncharacterized_inner_membrane_transporter_YicL, Carboxylate/Amino Acid/Amine Transporter. [Transport and binding proteins, Amino acids, peptides and amines].	4.3401e-19
NZ_CP010413.1\|WP_025221010.1\|2035045_2036077_+\|LacI-family-transcriptional-regulator	gnl\|CDD\|224525	COG1609, PurR, Transcriptional regulators [Transcription].	3.23852e-78
NZ_CP010413.1\|WP_060618859.1\|2053664_2055248_-\|ClC-family-H(+)/Cl(-)-exchange-transporter	gnl\|CDD\|238504	cd01031, EriC, ClC chloride channel EriC. This domain is found in the EriC chloride transporters that mediate the extreme acid resistance response in eubacteria and archaea. This response allows bacteria to survive in the acidic environments by decarboxylation-linked proton utilization. As shown for Escherichia coli EriC, these channels can counterbalance the electric current produced by the outwardly directed virtual proton pump linked to amino acid decarboxylation. The EriC proteins belong to the ClC superfamily of chloride ion channels, which share a unique double-barreled architecture and voltage-dependent gating mechanism. The voltage-dependent gating is conferred by the permeating anion itself, acting as the gating charge. In Escherichia coli EriC, a glutamate residue that protrudes into the pore is thought to participate in gating by binding to a Cl- ion site within the selectivity filter.	7.33452e-156
NZ_CP010413.1\|WP_060619000.1\|2029759_2034172_-\|collagen-binding-protein	gnl\|CDD\|380024	pfam17802, SpaA, Prealbumin-like fold domain. This entry contains a prealbumin-like domain from a wide variety of bacterial surface proteins. This entry corresponds to domain 1 and domain 3 of SpaA from Corynebacterium diphtheriae. Some members of this family contain an isopeptide bond.	9.61537e-12
NZ_CP010413.1\|WP_060618855.1\|2026594_2027554_-\|class-C-sortase	gnl\|CDD\|320676	cd05827, Sortase_C, Sortase domain found in class C sortases. Class C sortases are membrane-bound cysteine transpeptidases broadly distributed in Gram-positive bacteria (mainly present in Firmicutes and Actinobacteria). They function as pilin polymerases responsible for the assembly of pili, which are multi-subunit hair-like fibres that extend from the cell surface to promote microbial adhesion and biofilm formation. First, one or more class C sortases form the long thin shaft of the pilus through linking together pilin subunits via isopeptide bonds. The base of the pilus is then anchored to the cell wall by a housekeeping sortase or, in some cases, the class C sortase itself. Depending upon the organism both the number and type of sortase enzymes involved varies, and in some cases, accessory factors appear to be needed. In three-component spaA pilus from Corynebacterium diphtheriae, the prototypical class C sortase (named Cd-SrtA) catalyzes polymerization of the SpaA-type pilus, consisting of the shaft pilin SpaA, tip pilin SpaC and minor pilin SpaB. The pilus shaft is then attached to the cell wall by a housekeeping class E sortase, Cd-SrtF. In the absence of Cd-SrtF, Cd-SrtA attaches the pilus to the cell wall, albeit at a reduced rate. Cd-SrtA can recognize two distinct sorting signals (LPLTG in SpaA and SpaC, and LAFTG in SpaB) and it can employ lysine residues that originate from different proteins (either Lys190 within the pilin motif of SpaA or Lys139 in SpaB). However, Cd-SrtA cannot be able to polymerize the major pilin subunit SpaH, even though it contains LPLTG motif. In two-component pili of prototypical Bacillus cereus, the class C sortase (named Bc-SrtD) cleaves related sorting signals within a major pilin protein BcpA (LPVTG) and a minor tip pilin BcpB (IPNTG), and catalyzes a transpeptidation that joins the threonine residues in each signal to the side-chain of Lys162 in BcpA (located within a pilin motif). Unlike the SpaA pilus in C. diphtheriae, in B. cereus Bc-SrtD is unable to covalently attach the pilus to the cell wall without the help of the housekeeping sortase.	1.01492e-85
NZ_CP010413.1\|WP_025220999.1\|2055271_2056558_-\|adenylosuccinate-synthase	gnl\|CDD\|234904	PRK01117, PRK01117, adenylosuccinate synthetase; Provisional.	0
NZ_CP010413.1\|WP_003832411.1\|2040482_2041535_-\|ketol-acid-reductoisomerase	gnl\|CDD\|235491	PRK05479, PRK05479, ketol-acid reductoisomerase; Provisional.	0
NZ_CP010413.1\|WP_003827968.1\|2041962_2043015_-\|ketol-acid-reductoisomerase	gnl\|CDD\|235491	PRK05479, PRK05479, ketol-acid reductoisomerase; Provisional.	0
NZ_CP010413.1\|WP_014483280.1\|2050682_2051768_-\|LacI-family-transcriptional-regulator	gnl\|CDD\|380514	cd06291, PBP1_Qymf-like, ligand binding domain of the lacI-like transcription regulator from a novel metal-reducing bacterium Alkaliphilus Metalliredigens (strain Qymf) and its close homologs. This group includes the ligand binding domain of the lacI-like transcription regulator from a novel metal-reducing bacterium Alkaliphilus metalliredigens (strain Qymf) and its close homologs. Qymf is a strict anaerobe that could be grown in the presence of borax and its cells are straight rods that produce endospores. This group is a member of the LacI-GalR family repressors that are composed of two functional domains: an N-terminal HTH (helix-turn-helix) domain, which is responsible for the DNA-binding specificity, and a C-terminal ligand-binding domain, which is homologous to the sugar-binding domain of ABC-type transport systems that contain the type 1 periplasmic binding protein-like fold. As also observed in the periplasmic binding proteins, the C-terminal domain of the bacterial transcription repressor undergoes a conformational change upon ligand binding which in turn changes the DNA binding affinity of the repressor.	2.57412e-79
NZ_CP010413.1\|WP_003832415.1\|2038369_2039398_+\|membrane-protein	gnl\|CDD\|197670	smart00347, HTH_MARR, helix_turn_helix multiple antibiotic resistance protein.	0.00485944
NZ_CP010413.1\|WP_003827964.1\|2048729_2050256_-\|sucrose-phosphorylase	gnl\|CDD\|237528	PRK13840, PRK13840, sucrose phosphorylase; Provisional.	0
NZ_CP010413.1\|WP_060618856.1\|2027810_2029655_-\|isopeptide-forming-domain-containing-fimbrial-protein	gnl\|CDD\|374637	pfam16569, GramPos_pilinBB, Gram-positive pilin backbone subunit 2, Cna-B-like domain. GramPos_pilinBB is one of the major backbone units of Gram-positive pili, such as those from S.pneumoniae. There are three major pilin subunits that form the polymeric backbone of the pilin from S. pneumoniae, constructed of three transthyretin-like, CnaB, domains along with a crucial N-terminal domain, D1. The three Cna-B like domains are stabilized by internal Lys-Asn isopeptdie bonds, Gram-positive pili are formed from a single chain of covalently linked subunit proteins (pilins), usually comprising an adhesin at the distal tip, a major pilin that forms the polymer shaft and a minor pilin that mediates cell wall anchoring at the base.	1.93209e-10
NZ_CP010413.1\|WP_003827966.1\|2045768_2046821_-\|LacI-family-transcriptional-regulator	gnl\|CDD\|380514	cd06291, PBP1_Qymf-like, ligand binding domain of the lacI-like transcription regulator from a novel metal-reducing bacterium Alkaliphilus Metalliredigens (strain Qymf) and its close homologs. This group includes the ligand binding domain of the lacI-like transcription regulator from a novel metal-reducing bacterium Alkaliphilus metalliredigens (strain Qymf) and its close homologs. Qymf is a strict anaerobe that could be grown in the presence of borax and its cells are straight rods that produce endospores. This group is a member of the LacI-GalR family repressors that are composed of two functional domains: an N-terminal HTH (helix-turn-helix) domain, which is responsible for the DNA-binding specificity, and a C-terminal ligand-binding domain, which is homologous to the sugar-binding domain of ABC-type transport systems that contain the type 1 periplasmic binding protein-like fold. As also observed in the periplasmic binding proteins, the C-terminal domain of the bacterial transcription repressor undergoes a conformational change upon ligand binding which in turn changes the DNA binding affinity of the repressor.	8.45619e-77
NZ_CP010413.1\|WP_060618857.1\|2036348_2038163_+\|glycoside-hydrolase-family-13-protein	gnl\|CDD\|200471	cd11332, AmyAc_OligoGlu_TS, Alpha amylase catalytic domain found in oligo-1,6-glucosidase (also called isomaltase; sucrase-isomaltase; alpha-limit dextrinase), trehalose synthase (also called maltose alpha-D-glucosyltransferase), and related proteins. Oligo-1,6-glucosidase (EC 3.2.1.10) hydrolyzes the alpha-1,6-glucosidic linkage of isomaltooligosaccharides, pannose, and dextran. Unlike alpha-1,4-glucosidases (EC 3.2.1.20), it fails to hydrolyze the alpha-1,4-glucosidic bonds of maltosaccharides. Trehalose synthase (EC 5.4.99.16) catalyzes the isomerization of maltose to produce trehalulose. The Alpha-amylase family comprises the largest family of glycoside hydrolases (GH), with the majority of enzymes acting on starch, glycogen, and related oligo- and polysaccharides. These proteins catalyze the transformation of alpha-1,4 and alpha-1,6 glucosidic linkages with retention of the anomeric center. The protein is described as having 3 domains: A, B, C. A is a (beta/alpha) 8-barrel; B is a loop between the beta 3 strand and alpha 3 helix of A; C is the C-terminal extension characterized by a Greek key. The majority of the enzymes have an active site cleft found between domains A and B where a triad of catalytic residues (Asp, Glu and Asp) performs catalysis. Other members of this family have lost the catalytic activity as in the case of the human 4F2hc, or only have 2 residues that serve as the catalytic nucleophile and the acid/base, such as Thermus A4 beta-galactosidase with 2 Glu residues (GH42) and human alpha-galactosidase with 2 Asp residues (GH31). The family members are quite extensive and include: alpha amylase, maltosyltransferase, cyclodextrin glycotransferase, maltogenic amylase, neopullulanase, isoamylase, 1,4-alpha-D-glucan maltotetrahydrolase, 4-alpha-glucotransferase, oligo-1,6-glucosidase, amylosucrase, sucrose phosphorylase, and amylomaltase.	0
NZ_CP010413.1\|WP_019727681.1\|2046890_2048525_-\|MFS-transporter	gnl\|CDD\|349949	cd06174, MFS, Major Facilitator Superfamily. The Major Facilitator Superfamily (MFS) is a large and diverse group of secondary transporters that includes uniporters, symporters, and antiporters. MFS proteins facilitate the transport across cytoplasmic or internal membranes of a variety of substrates including ions, sugar phosphates, drugs, neurotransmitters, nucleosides, amino acids, and peptides. They do so using the electrochemical potential of the transported substrates. Uniporters transport a single substrate, while symporters and antiporters transport two substrates in the same or in opposite directions, respectively, across membranes. MFS proteins are typically 400 to 600 amino acids in length, and the majority contain 12 transmembrane alpha helices (TMs) connected by hydrophilic loops. The N- and C-terminal halves of these proteins display weak similarity and may be the result of a gene duplication/fusion event. Based on kinetic studies and the structures of a few bacterial superfamily members, GlpT (glycerol-3-phosphate transporter), LacY (lactose permease), and EmrD (multidrug transporter), MFS proteins are thought to function through a single substrate binding site, alternating-access mechanism involving a rocker-switch type of movement. Bacterial members function primarily for nutrient uptake, and as drug-efflux pumps to confer antibiotic resistance. Some MFS proteins have medical significance in humans such as the glucose transporter Glut4, which is impaired in type II diabetes, and glucose-6-phosphate transporter (G6PT), which causes glycogen storage disease when mutated.	2.1416e-13

>NZ_CP010413.1|WP_003832407.1|2043410_2044778_-|MHS-family-MFS-transporter
MTAAVEETGLGQAAGKAATLVRDSVKTVIAASMVGTAIEFYDFYAYGTAAANYFPHIFFSDKANPTVALLMSLLTFAIAFIARPLGSLVFGHFGDRMGRKTTLVVSLMTMGVGTFLIGCLPTYDQVGVAAVAILCLLRFIQGIGLGGEWSGAALVATENAPEDKRALYGSFPELGAPIGFFLSNGTYFVLESFNDQSAMLAWGWRVPFLLSAILVIVGLVVRVHMEETPIFRMAQEQKKVVKSPLTEVFRKSWRQVLQATFLVAVTYTLFYTLATWSLAWGTKDTANGGGSLGFTNQEYLLMLMISICVFALFIVLSCLYADKLGRRRVLTFSSCALVVFAVLFPFLLDGQVVGQHNFFANMVFLCVGFALMGIAFGPIGAFLPELFDANVRYSGSGIGYNLAAIVGAAFVPTIATWLAHNWGVHSVGLYLAVMAVCCLVSVLTCKETKDVDFTK
>NZ_CP010413.1|WP_003827968.1|2041962_2043015_-|ketol-acid-reductoisomerase
MAATIWYEKDADLSVFDGKKVAILGYGSQGHAHALNLRDSGVDVVVGLRPSSKSVEFAKEQGLEVKPVGEAVAEADVVMILLPDQYQAKVYEEEVEPNLKPGAALAFAHGFNIHYGYIKPSEDHPVFMVAPKGPGHIVRREYAAGRGVPVVVAVEQDPDGKTWPLCLAYAKALGALRAGAIKTTFTEETETDLFGEQDVLMGGINHLCDLGFDVLTEAGYQPEIAYFEVFHELKMLVDLANEGGLNKARWSCSDTAQYGDYTSTVITDETKKRMQYQLKRIQDGSFAKEFMDDQAAGAPKFKKLQEEFSHPHLETVGPKLRAMFSWNNAEAKDKDEAESFNGKIARTQVQ
>NZ_CP010413.1|WP_003832411.1|2040482_2041535_-|ketol-acid-reductoisomerase
MAAQIWYENDGDLSVLEGKKVAIIGYGSQGHAHALNLRDSGVDVVVGLRPTSKSVDFAKEQGLEVKSVAEASAEADVIMILAPDQYQRTIWANDIEPNIKPGAAVAFAHGFNIHYGYIKPTEDHPVFMVAPKGPGHIVRREYAAGRGVPVVVAVEQDPRGDGWALTLAYAKALGALRAGAIKTTFKEETETDLFGEQNVLMGGVNKLVEMGFEVLTDAGYQPEIAYFEVCHELKMLVDLMNEGGLNKARWSCSDTAQYGDYTNTVINEDCRKRMEYHLQRIQDGSFAKEFIDDQDAGAPHFKELQEKYSNERIETVGPKLRAMFSWNKDGVKDADEANSFTGKIARAQVQ
>NZ_CP010413.1|WP_008783494.1|2039394_2040180_+|hypothetical-protein
MTQGLQLIRTAFAGYEDSYVIIGGTACDIIMTDNELDFRATKDIDMVLIAEGHLREFAQRLWSFIRDGGYTSITKNSAQPHLYRFMHPSTYGYPTMIELFSRHPDFPIVPNSFLTPLHIANDVSSLSAIMLNDSYYRLLQQGRESIQGISVLNEKYLIPFKAKAWLDLNAREQHGEHVDGKDLKKHKYDVFRLAQLLAPEDRVSLNDEAYHDLADFLGKISHETLPIKQLGIRGTQQDIIDLIAGVYQLSIPPRDELPTTR
>NZ_CP010413.1|WP_003832415.1|2038369_2039398_+|membrane-protein
MDAEHYIRETLGLPCQITSWDGTASLPLFLTNGRTFSKLTIDNTSMLIASGEAHPFSITRVTADASRLEQRTDLPIVFQFPRLSAYQRKALIQNHVPFIVPGTQLYIPSLGMVFTQRISSRPLENAQDIEVRPFSPATQLVWLYLLYSNESKVQSDIARALQFTEAQVSVAVTLLEQLAFVHRTKQGRSNSVELLTSRQTSRLDLLKSSWHLLKSPIFSKYTVTNRNRQMIADELIPAGEFALSRRTQLATPKLRIYAVERHWLKQHNKELCIIDPALEKVPDNAYILELWRYDPRLLAQYTQEDYLADPISTALTLGEIADERLEDAIQESIRNTFSGATI
>NZ_CP010413.1|WP_060618857.1|2036348_2038163_+|glycoside-hydrolase-family-13-protein
MTANNLNDDWWKQAVVYQIYPRSFKDVNGDGIGDIAGVTEKMDYLKNLGVDAIWLSPFYPSDLADGGYDVIDYRNVDPRLGTMDDFDAMAKAAHEAGIKVIVDIVPNHTADKHVFFKEALAAEPGSPARDRYIFRDGRGEHGELPPNDWQSFFGGPAWARVADGQWYLHLFDKAQPDVNWKNPDIHEEFKKTLRFWSDHGTDGFRIDVAHGLAKDLESKPLEELGREYSVVGVLNHDFSHPLFDRREVHDIYREWRKVFNEYDPPRFAVAEAWVVPEHQHLYASMDELGQSFNFDFAQASWYADEFREAIDAGLKAAAETGGSTTTWVMNNHDVPRSPSRYGLPQVKGAPYHQLPHDWLLRNGTTYPEDRELGTRRARAAALMELGLPGAAYIYQGEELGLFEVADIPWDRLEDPTAFHTAQATMDKGRDGCRVPIPWTAANEPTLADFSRPIPADDGTGENHVPLCAAGQFGTGASFGFSPATRAEGVTPAADPHLPQPLWFKDYAVDVEQADPDSMLALYRAALAIRQESLTATRDTTAEQVDMGDDVVAYTRAAVGGRVFTSITNFGNAPVALPNGSVVLASGPLTPEGQLPTDTSAWVVQ
>NZ_CP010413.1|WP_025221010.1|2035045_2036077_+|LacI-family-transcriptional-regulator
MTKASIQAVAKEAGVSVSTVSRTFAKPDLVLPETRDKVMAAAEKLDYSISRSAAALKSGQSFRIALLASETITTWFNANIFAGLDSVLRPAGYDTVAYPMRNAEERHDFFADLPVRRNADAVIVSSFNIEPAEVERLKHMHVPIIGINIPSTDGFDSGVSIDDRTATRAAVEHLIALGHRGIAFVGGTPAETNMRYSAESRLQGVLDAQAAHPELTVTNLQVPRGATETSAALNAVLTAPAGTTAFCFEDDELALPVLYRLRQYGKRVPQDISIVGFDDVEMSQAVGLTTMHQDPFAMGADAGRMALEAIAGGPIEPAFIQPDAPLVLRETTAPPAAPVPAQG
>NZ_CP010413.1|WP_060619000.1|2029759_2034172_-|collagen-binding-protein
MGTEANPATERDSGVATWVGGDMYVGKKSDNLTNADGPDASYSAEAEGLTVVNGKLMLHPQKNSWNGQGFRFGVAGFGTQYRPAEGSTALVVGGNTVTVMDSATSTADVKAWNKPGFIDGHSHVGSLSGSQSDIWGNGSTSSIGSYNGASVNWQKDKSGNTQNQDAGNLTKVSVKATDGGAATDKDFSKDTFYQGYVVDDIVSPLAKQNKTGTVSSSISTLSELPRHKYNYYKEGTNAASGISYTFKYDDTTKYGTGRGIAPTTSYTNREKLITFTGTNNASMEVFNLDASMLRDTDGNGTLYRGVGFAFTNIADTASVVINVTGNAGNISFHNGWQFWWNGAEISDGYSNYNNTDDLKRKSAAYDKASQKILWNFSNTDNLTIYGGVANEDGTNTNADKITQDDAAAAMMGSIIVRGNFESHVSTNGRVYTGGDFSMYNPYKAWTFNQAGANDGDSASVLDMDQERHNFPWNGSYTESCSAIAWQKADESGTLLGGTTWAVYGKYDDAASGKNALLTVQDNAFYDKDSADGRFTVEGLKPNATYYIKEVSAGNDYQLNTNVYYVATGDSSATPVNVTQSVTKTDGAYTYGSADMTDGKIVNKKNGHEVSWSKVDADTNKELAGSQWQIQQVKDGAAAKSWKVTDNTSKATGVTVNPTSATLDSTNGWKTDLTAAVDPKDALQEVAWTFTDKDGNAVDSPTVAVLARTGNLKATVTGISSIDTTVYVKACSVSNPEVCSALVAIKVKAMSVKDFTVKDSSNRTVENNSTITAAAVDSTLTFAASSTPAVPITWESSNKSVATVTSSGENGQKATVTMTGFGSAVITAKAGDKKVSFTVKVPSTTVYFKKSLMNWSKYYVYYNAGNNNWKFVEMSQSCGDYVYAILPKQSPGTEFLFHGDDENTSTNKWYQGSNKSDFKFTGNEVQVVNLYNDSQVSTAPAGCPASAAAAAQSNDAAVLNENAVVTPADDPQPSDADGVAENAIDDGAKAISCTAADGENGRPGVKCDMDTAAGKFKVGGLDAGTYWLHETTAPDGYTINKTLYQFTIDANGNVTWNGGWASGKATGAIDEKLKPGDNNAISDTPTEVTWNKVDTKGGKLAGSQWKIVGPSPATDVYCVADNVTVDANGATTPAGIEFTGCTGEKLSDAANTADEAGVITVRGLPVGTYTLTETKAPDGYVATTTVYTLTISDTKASTVVAQTATDRPTTRSGGNREAAANVPNASAPVNIQIPVKKSVKYTSWPKDSNGNYVNFNFKIEATKSTVDANPAAPMPAECSSSDATKNDCTISLAPKSDADDLSNVIAKFGKMTFTDANLAAAAGDASDYAKTYTYKIAEIVPDSADAVENLRYSKAEYQVVVTLKQAKDSSGKLSGLSVSATMTRIKDDSGNAEAGGGKIIGTWSSTSTGSSAGTAVEATFVNTKVLTGLPATGADWTGRLVLLVGDGFILVGVLIAGGYQLAKRRREEDSD
>NZ_CP010413.1|WP_060618856.1|2027810_2029655_-|isopeptide-forming-domain-containing-fimbrial-protein
MNTIFKRVISGAAALGIAVSGLAIGVSTAYAADPTTGSITINKSDAGQVDHSFDGWHLASLTNVTKDSAGKINGFLIDTDDHMARTIVAAMTSGQKDAYEKDANYYSDDPAVANPMGYLVEKVFKDTSGKALSELTSPWGGDSSALRAFAKSLSKELAKAGAPAADKTGDSALKTGENKELKQGLWFLKDVTTTDDTKGTNSIPIITPTTFDGADSWGTVTLKNTTPTIDKKLVDSKGDGTYTPNTQPDYAVGDDVYYELTSTVPVYTGYDIDSTMKDATKTRIFKINDTASKALTVSAGTVIESVKLTPAQGTAVTLVKDKDYTVTVAGYGDVNTPDTDAYKGGHVTTIDLGKYVNKAEGSKSATTADGILEGATVTVIVKAKLNKGALISNPGNLQKNPNKVDLEYSNRPEEVDHAHKVPGPEVPVYAYKFDILKTDKAGTTKLPGAKFTVKAVSGTSTHDGKYLGSYGENGWSYLDSEPAVAATDGVFTTDKDGKINVSGLDAGTYEVHEIAPPDGYTAISLPKFQFTITPTVGDEDAGCKTITAVALSLAKGADERASLSQGGKTLNIWNAKNITELPRTGGAGLAMIVAVGALFIAASGIFALRARRKA
>NZ_CP010413.1|WP_060618855.1|2026594_2027554_-|class-C-sortase
MRSSTGTKQSGTRTQSRVFTVLSVLFLLIGFAIITTPFVMRAISEYQQNATVQQTQREVDGWPYPQAENQLKTAREYNKKLAAGGQAAIGEVKDPFAGNAGQSTTSGADDSMAAKDQEYQSLLDAGQGVMGSIRIPKIDVNLPIYHGTSEDALAVGAGHLYGTSLPVGGKSTHSVITGHRGLPNSLLFTRLDEMKKGDAFYIEVMGKKLGYKVDRITVIKPDDSSKLRITKGEDRVTLMTCTPYGVNSHRLLVSGVRAEIPEEVPDPDDVHGINTTWLALGAIVFLAMLFAFIVILMRRKQKRDREFAGLARHAARPTK
>NZ_CP010413.1|WP_003827966.1|2045768_2046821_-|LacI-family-transcriptional-regulator
MVGMRDVAKTAGVSLSTVSLVVNNTGYVSDDMRAKVEAAMRQLNYIPNELARNLYRNRTNTIGVIMPTIAHPFFATLTAHLQREFAARDLKTLLCSIADADKGEGEYVDMLQRHMMDGIVMAAHTEHPGGYWTSIHRPIVAFDRTLGEGVPAVRSDHEQGGRLIARQLIDSGARHVVLVGGPRSQFAEATTFPTIRYHLTVERMLADAGIACDYVEAGIVADICAHEATARAIFERYSDVDAIVGSDLVASVALQEALRRGISVPRDLQIIAYDGTFMAETAGMRLTAVRQDFPAVAAALASRMDSQIAADNGTTSAAAAEGGNAVAANGGQSTSEDIISVTLIPGETTR
>NZ_CP010413.1|WP_019727681.1|2046890_2048525_-|MFS-transporter
MLEPYVRPGIDDRPDLDKALSPEDKDAVARLAIKDRRRPPEASADQPEAQAVRLAAAGSSAAAAAAASVDAPAPDLSSAYLDMRDPMVAANGQRPTAVQVSRLNWGFFVASILVGAPWAALNTIAMPNAVARLFDYDTASAISVTINPSTGRPLPVATDLVVPLAVLVVVGVVASMFAMPLVSALSDRTRIPLGRRTPWMVAGGVLCALITLVLGQNTGLVVLCFFWALMQFAYAMISVPLASAISERVPDKFRPCIERWHGIGVMLGQALGVCMGALGVMFDSFTPFAYTAVLFAVSGILTVIMLPKEPSSQEQPHQRFESSQVFDQLRPPAHAPAFARVFAARVCMMTGVGLTGVFLWYLVRFWVYGKAVVFTSAPLTIPAGLLIAGMAAATLIGAALASWAAGPISEKIEERNVATTAVVAASCLLYAIGVAVAWGLGVWSTGTARENGMLLFALISGFAFGVYDALGLELVMNALPDPRNAGHDLGIYALANSVGLALAAIIGAVLVSAFASSFGYYLLFPSAIVMVFLAGIITLSSKAE
>NZ_CP010413.1|WP_003827964.1|2048729_2050256_-|sucrose-phosphorylase
MKNKVQLIAYADRLGDGTLSSMTDILRTRFDGVYDGVHVLPFFTPFDGADAGFDPIDHTKVDPRLGSWDDVAELSKTHGIMVDAIVNHMSWESAQFQDVLKNGEHSEYYPMFLTMSSVFPNGATEEDLAGIYRPRPGLPFTHYKFAGKTRLVWVSFTPQQVDIDTDSAKGWEYLMSIFDQMAASHVRYIRLDAVGYGAKEAGTSCFMTPKTFKLISRLREEGVKRGLEILIEVHSYYKKQVEIASKVDRVYDFALPPLLLHSLFTGHVEPVVHWTEIRPNNAVTVLDTHDGIGVIDIGSDQLDRSLKGLVPDEDVDNLVNTIHANTHGESQAATGAAASNLDLYQVNSTYYSALGCNDQHYLAARAVQFFLPGVPQVYYVGALAGRNDMELLRKTNNGRDINRHYYSTAEIDENLERPVVKALNALAKFRNELPAFNGEFSYEADGDTSITFRWIAADGKTKAALIFEPGRGLGTDNTTPVASLAWTDAAGDHETDDLLSNPPIADID
>NZ_CP010413.1|WP_014483280.1|2050682_2051768_-|LacI-family-transcriptional-regulator
MVGMRDVAKKAGVSLSTVSLVVNGNGYVSDDMRERVRKAMQLLNYVPNELARNLYHNRTNLVGVIVPTIRHPFFATFTAHLQHALAAQGLRTMLCSTADEADGEIQYVDMLRRHMMDGIVMCAHTSHPGDYWTSIHRPIVAFDRVLGDGISSIGSDHEQGGRLIAQMLIRNGAKHVVMIGGPRDQFFDLAARGEVEEGPFDLGKTTFPTVRYYLTLEQELTSAGVKYEYVEAGEVMDFAGYHRAVSNALDKVTTDGVDAVVSSDIGASFCVREALSRGISIPDELQIVAYDGTYLTDLAGMKLTAVAQDFSAIAQSTADHIVQAIANEEVAAANASRRDIPKPFEPNVLIPMTLVPGDTTR
>NZ_CP010413.1|WP_003827961.1|2052042_2052438_-|CrcB-family-protein
MMWMICLFGGLGAMARYVLDVSIQQGWNRENRRTNRNFPLSTLVINGVASLCAGIAMMSYYSQSVDMDTVMMFVVGFLGGFSTFSTALNEVVSLIRQRRFTLALGYGIATVAVPLICVATGFGIALLANPA
>NZ_CP010413.1|WP_060618858.1|2052437_2053478_-|CrcB-family-protein
MESQEQSPGDVVTAGEDSHPITQAIDTVEVMHAGATAPAANTMDPPTIPLAPMKRMQARFNPLADGLMYVVVFVGGFVGVGCRHALDMLLPSVSGTPFVVGTFVSNMVACFLFAMLTEFMATASWLRRRVRQVVSRGVGLGLLGGLSTMSGVMLETMEGLHERHIASALGYLAGNFAGGLLTAAAGVVLMQALLSRSTRKRVRGAFSAVSVSDSAESDTQGVRHVKVADVARSAAQAAMEAAQTAQQIAQTGQVPRVETPTVPPPASQPMQTGRVPQVPPLVVPQLAQSSQPLLREPDTPDLGQLPEIKQSQPIQQPANPLPPSFEPKPITAEISLVADPTTGEVR
>NZ_CP010413.1|WP_060618859.1|2053664_2055248_-|ClC-family-H(+)/Cl(-)-exchange-transporter
MTGNDAAHDIRRLIPRFDHLKWKMAAAGIVIGLVSGLLVVVYRLGIEYGTDASRWIYARIRETPWLIAPWAVAAVAAALAIAWMVGKEPMAGGSGIPQTNGVVICGLKMRWQTILPVRFVGGLLGALFGLSLGREGPSIQIGASGAQCVSHRLRGRRREDMQEHYLVTAGAAAGLSAAFSAPLSGMMFALEGVHRSFSPAILMGATAASLTADFVSKYCFGLRPVLDFGDIGQLSLEEYVWLIPLGLVAGLVGSLMNRSLLGFQTLYDKLPAWSRPMIAIAIALPVGIWLPDVLGGGSNLIDTAEHARVGLGMLCLLFVAKMLFTSTSFGSGAPGGIFMPILAVGSLAGGICGEVLHRFGDLPSDAVAVFAVCVMTGTLAASVKTPITSILLAVEMSGTLTHMLPVAAVAFIALLVSDLLRTKPIYGELLERYVRAQGMQMAIASHVGSGIMELPLEMGAIADGKRVRDVRWPSGCLIIGLRRGESEIVPCGDTRLRAGDYLVVLFSGEEEREVRPAMRRLCDARLD
>NZ_CP010413.1|WP_025220999.1|2055271_2056558_-|adenylosuccinate-synthase
MPGIVLIGAQWGDEGKGKATDLIGTKVDYVARFNGGNNAGHSVVVGDESYALHLLPSGIINPNLTPVIGNGVVVDPEVLFEEIDGLESRGIDCSHLLVSEAAHIIAPYHRTLDKVTERFLGKHKIGTTGRGIGPAYADKINRIGIRVHDLFNADHLHDKVEASLHQKNQMLVKLYNRRAIDVDQTTEELLKLGERLKPYVANTGLILNKALDEGKTVLFEGAQATMLDVDHGTYPFVTSSNPTAGGACTGTGVGPTKITRVIGVAKAYVTRVGEGPFPTELLDESGEWLRQQGHEFGVTTGRPRRCGWFDAVVNRYASQVNGLTDIVLTKLDVLTGLKEIPLCVAYDVDGERHDDMPTDQAEFAAAKPIYESMPGWDEDISQIHDFNDLPKTCQDYVKRLEDLSGCRISVIGTGPQRDHVIQINSLVD
>NZ_CP010413.1|WP_025220998.1|2056711_2057779_-|class-II-fructose-bisphosphate-aldolase
MTIATPERYAEMLDAARRGGYAYPAINVTSSQTLNAALKGFADAESDGIIQVSVGAAAYLSGIGVNDRVTGSLALAAFAHEVAAKYPNITIALHTDHCAKQYLDEWVRPLLAHEADQVAHGQEPTFQSHMWDGSTVPLKENLDIAEELLAKSQAAHTVLEIEIGAVGGEEDGHFAEIDERLYSTPADGLEVARRLGLGERGRYMAAFTFGNVHGSYKPGVVKLRPALLGEIQARVARAVAEGELPSAAGMVDFPNGKPFELVFHGGSGSRPEEIAEAVSHGVIKMNIDTDTQYSFTRPIADHVFENYDKVLKIDGEVGEKRFYDPRSWGRKAEESMSARVVEACKQLGSAGKALK
>NZ_CP010413.1|WP_025220997.1|2057841_2058777_-|EamA-family-transporter
MCEPKAAATNGQPTPTLECTPHDIFVGAGLALAGGVFWGVNATVSKLLMNDYHADPLWIACVRELLAGVIFLVCAGIFTPDKFINSLKDYRSYPRLLLCAFFCVLMVQVSYLKAIDWTNSGTATVLQTLNLLVVLVFVCIMGKRLPGKRESIGVILAFVGTVLIATGGDLSQLSLPLPGLLWGLTDAVCTSLLAILPIALMAKWGNFMANGVMFIVSGLMLLPLVRPWTTAPALDWFGIGLMAFTVVFGTFGAYWLFLGGTQRCGAMRATMLGTSEPVTATITGVLFAGAVFTPTDLVGFAMIIIMVFLVR

You can click texts colored in the table to view more detailed information

Click the colored protein region to show detailed information

Crispr_ID: NZ_CP010413_5

CRISPR_ID

CRISPR_location

CRISPR_type

Repeat_type

Spacer_info

Cas_protein_info

CRISPR-Cas_info

NZ_CP010413_5

2045205-2045384

Orphan

Consensus_repeat	Method
CCTCAGCGGGGCAAAACCACCAG	CRISPRCasFinder

3 spacers

The CRISPR arrays of NZ_CP010413_5

>merge|NZ_CP010413|5|2045205-2045384|CRISPRCasFinder
CCTGTGCGGCGCAAAATCGCCAGCAATTGGCATAAAAGCGTTGCTCAGCACCCCTCAACGACGCAAAACCACCAGTAACTGGAAACTTCGTGCCACTGACAGCTCCTCAGCGGGGCAAAACCACCAGTACATGGGGGCTCCGCACCATCCACAACCCCTCAGCGGGGCAAAACCACCAGC

>NZ_CP010413|5|4|2045205-2045384|CRISPRCasFinder
CCTGTGCGGCGCAAAATCGCCAG	CAATTGGCATAAAAGCGTTGCTCAGCACC
CCTCAACGACGCAAAACCACCAG	TAACTGGAAACTTCGTGCCACTGACAGCT
CCTCAGCGGGGCAAAACCACCAG	TACATGGGGGCTCCGCACCATCCACAACC
CCTCAGCGGGGCAAAACCACCAGC

Protein	Signature genes	Signature genes Name	Protein_function
NZ_CP010413.1\|WP_025220998.1\|2056711_2057779_-\|class-II-fructose-bisphosphate-aldolase	unknown	unknown	gnl\|CDD\|236406
NZ_CP010413.1\|WP_003832407.1\|2043410_2044778_-\|MHS-family-MFS-transporter	unknown	unknown	gnl\|CDD\|340927
NZ_CP010413.1\|WP_060618858.1\|2052437_2053478_-\|CrcB-family-protein	unknown	unknown	gnl\|CDD\|223317
NZ_CP010413.1\|WP_008783494.1\|2039394_2040180_+\|hypothetical-protein	unknown	unknown	unknown
NZ_CP010413.1\|WP_025220997.1\|2057841_2058777_-\|EamA-family-transporter	unknown	unknown	gnl\|CDD\|273359
NZ_CP010413.1\|WP_003827961.1\|2052042_2052438_-\|CrcB-family-protein	unknown	unknown	gnl\|CDD\|376809
NZ_CP010413.1\|WP_025221010.1\|2035045_2036077_+\|LacI-family-transcriptional-regulator	unknown	unknown	gnl\|CDD\|224525
NZ_CP010413.1\|WP_060618859.1\|2053664_2055248_-\|ClC-family-H(+)/Cl(-)-exchange-transporter	unknown	unknown	gnl\|CDD\|238504
NZ_CP010413.1\|WP_060619000.1\|2029759_2034172_-\|collagen-binding-protein	unknown	unknown	gnl\|CDD\|380024
NZ_CP010413.1\|WP_060618855.1\|2026594_2027554_-\|class-C-sortase	unknown	unknown	gnl\|CDD\|320676
NZ_CP010413.1\|WP_025220999.1\|2055271_2056558_-\|adenylosuccinate-synthase	unknown	unknown	gnl\|CDD\|234904
NZ_CP010413.1\|WP_003832411.1\|2040482_2041535_-\|ketol-acid-reductoisomerase	unknown	unknown	gnl\|CDD\|235491
NZ_CP010413.1\|WP_003827968.1\|2041962_2043015_-\|ketol-acid-reductoisomerase	unknown	unknown	gnl\|CDD\|235491
NZ_CP010413.1\|WP_014483280.1\|2050682_2051768_-\|LacI-family-transcriptional-regulator	unknown	unknown	gnl\|CDD\|380514
NZ_CP010413.1\|WP_003832415.1\|2038369_2039398_+\|membrane-protein	unknown	unknown	gnl\|CDD\|197670
NZ_CP010413.1\|WP_003827964.1\|2048729_2050256_-\|sucrose-phosphorylase	unknown	unknown	gnl\|CDD\|237528
NZ_CP010413.1\|WP_060618856.1\|2027810_2029655_-\|isopeptide-forming-domain-containing-fimbrial-protein	unknown	unknown	gnl\|CDD\|374637
NZ_CP010413.1\|WP_003827966.1\|2045768_2046821_-\|LacI-family-transcriptional-regulator	unknown	unknown	gnl\|CDD\|380514
NZ_CP010413.1\|WP_060618857.1\|2036348_2038163_+\|glycoside-hydrolase-family-13-protein	unknown	unknown	gnl\|CDD\|200471
NZ_CP010413.1\|WP_019727681.1\|2046890_2048525_-\|MFS-transporter	unknown	unknown	gnl\|CDD\|349949

Protein	Function_ID	Function_description	E-value
NZ_CP010413.1\|WP_025220998.1\|2056711_2057779_-\|class-II-fructose-bisphosphate-aldolase	gnl\|CDD\|236406	PRK09197, PRK09197, fructose-bisphosphate aldolase; Provisional.	0
NZ_CP010413.1\|WP_003832407.1\|2043410_2044778_-\|MHS-family-MFS-transporter	gnl\|CDD\|340927	cd17369, MFS_ShiA_like, Shikimate transporter and similar proteins of the Major Facilitator Superfamily. This subfamily is composed of Escherichia coli shikimate transporter (ShiA), inner membrane metabolite transport protein YhjE, and other putative metabolite transporters. ShiA is involved in the uptake of shikimate, an aromatic compound involved in siderophore biosynthesis. It has been suggested that YhjE may mediate the uptake of osmoprotectants. The ShiA-like subfamily belongs to the Metazoan Synaptic Vesicle Glycoprotein 2 (SV2) and related small molecule transporter family (SV2-like) of the Major Facilitator Superfamily (MFS) of membrane transport proteins. MFS proteins are thought to function through a single substrate binding site, alternating-access mechanism involving a rocker-switch type of movement.	5.4999e-175
NZ_CP010413.1\|WP_060618858.1\|2052437_2053478_-\|CrcB-family-protein	gnl\|CDD\|223317	COG0239, CrcB, Integral membrane protein possibly involved in chromosome condensation [Cell division and chromosome partitioning].	5.08097e-23
NZ_CP010413.1\|WP_003827961.1\|2052042_2052438_-\|CrcB-family-protein	gnl\|CDD\|376809	pfam02537, CRCB, CrcB-like protein, Camphor Resistance (CrcB). CRCB is a family of bacterial integral membrane proteins with four TMs.. Over expression in E. coli also leads to camphor resistance.	1.40631e-21
NZ_CP010413.1\|WP_025220997.1\|2057841_2058777_-\|EamA-family-transporter	gnl\|CDD\|273359	TIGR00950, Uncharacterized_inner_membrane_transporter_YicL, Carboxylate/Amino Acid/Amine Transporter. [Transport and binding proteins, Amino acids, peptides and amines].	4.3401e-19
NZ_CP010413.1\|WP_025221010.1\|2035045_2036077_+\|LacI-family-transcriptional-regulator	gnl\|CDD\|224525	COG1609, PurR, Transcriptional regulators [Transcription].	3.23852e-78
NZ_CP010413.1\|WP_060618859.1\|2053664_2055248_-\|ClC-family-H(+)/Cl(-)-exchange-transporter	gnl\|CDD\|238504	cd01031, EriC, ClC chloride channel EriC. This domain is found in the EriC chloride transporters that mediate the extreme acid resistance response in eubacteria and archaea. This response allows bacteria to survive in the acidic environments by decarboxylation-linked proton utilization. As shown for Escherichia coli EriC, these channels can counterbalance the electric current produced by the outwardly directed virtual proton pump linked to amino acid decarboxylation. The EriC proteins belong to the ClC superfamily of chloride ion channels, which share a unique double-barreled architecture and voltage-dependent gating mechanism. The voltage-dependent gating is conferred by the permeating anion itself, acting as the gating charge. In Escherichia coli EriC, a glutamate residue that protrudes into the pore is thought to participate in gating by binding to a Cl- ion site within the selectivity filter.	7.33452e-156
NZ_CP010413.1\|WP_060619000.1\|2029759_2034172_-\|collagen-binding-protein	gnl\|CDD\|380024	pfam17802, SpaA, Prealbumin-like fold domain. This entry contains a prealbumin-like domain from a wide variety of bacterial surface proteins. This entry corresponds to domain 1 and domain 3 of SpaA from Corynebacterium diphtheriae. Some members of this family contain an isopeptide bond.	9.61537e-12
NZ_CP010413.1\|WP_060618855.1\|2026594_2027554_-\|class-C-sortase	gnl\|CDD\|320676	cd05827, Sortase_C, Sortase domain found in class C sortases. Class C sortases are membrane-bound cysteine transpeptidases broadly distributed in Gram-positive bacteria (mainly present in Firmicutes and Actinobacteria). They function as pilin polymerases responsible for the assembly of pili, which are multi-subunit hair-like fibres that extend from the cell surface to promote microbial adhesion and biofilm formation. First, one or more class C sortases form the long thin shaft of the pilus through linking together pilin subunits via isopeptide bonds. The base of the pilus is then anchored to the cell wall by a housekeeping sortase or, in some cases, the class C sortase itself. Depending upon the organism both the number and type of sortase enzymes involved varies, and in some cases, accessory factors appear to be needed. In three-component spaA pilus from Corynebacterium diphtheriae, the prototypical class C sortase (named Cd-SrtA) catalyzes polymerization of the SpaA-type pilus, consisting of the shaft pilin SpaA, tip pilin SpaC and minor pilin SpaB. The pilus shaft is then attached to the cell wall by a housekeeping class E sortase, Cd-SrtF. In the absence of Cd-SrtF, Cd-SrtA attaches the pilus to the cell wall, albeit at a reduced rate. Cd-SrtA can recognize two distinct sorting signals (LPLTG in SpaA and SpaC, and LAFTG in SpaB) and it can employ lysine residues that originate from different proteins (either Lys190 within the pilin motif of SpaA or Lys139 in SpaB). However, Cd-SrtA cannot be able to polymerize the major pilin subunit SpaH, even though it contains LPLTG motif. In two-component pili of prototypical Bacillus cereus, the class C sortase (named Bc-SrtD) cleaves related sorting signals within a major pilin protein BcpA (LPVTG) and a minor tip pilin BcpB (IPNTG), and catalyzes a transpeptidation that joins the threonine residues in each signal to the side-chain of Lys162 in BcpA (located within a pilin motif). Unlike the SpaA pilus in C. diphtheriae, in B. cereus Bc-SrtD is unable to covalently attach the pilus to the cell wall without the help of the housekeeping sortase.	1.01492e-85
NZ_CP010413.1\|WP_025220999.1\|2055271_2056558_-\|adenylosuccinate-synthase	gnl\|CDD\|234904	PRK01117, PRK01117, adenylosuccinate synthetase; Provisional.	0
NZ_CP010413.1\|WP_003832411.1\|2040482_2041535_-\|ketol-acid-reductoisomerase	gnl\|CDD\|235491	PRK05479, PRK05479, ketol-acid reductoisomerase; Provisional.	0
NZ_CP010413.1\|WP_003827968.1\|2041962_2043015_-\|ketol-acid-reductoisomerase	gnl\|CDD\|235491	PRK05479, PRK05479, ketol-acid reductoisomerase; Provisional.	0
NZ_CP010413.1\|WP_014483280.1\|2050682_2051768_-\|LacI-family-transcriptional-regulator	gnl\|CDD\|380514	cd06291, PBP1_Qymf-like, ligand binding domain of the lacI-like transcription regulator from a novel metal-reducing bacterium Alkaliphilus Metalliredigens (strain Qymf) and its close homologs. This group includes the ligand binding domain of the lacI-like transcription regulator from a novel metal-reducing bacterium Alkaliphilus metalliredigens (strain Qymf) and its close homologs. Qymf is a strict anaerobe that could be grown in the presence of borax and its cells are straight rods that produce endospores. This group is a member of the LacI-GalR family repressors that are composed of two functional domains: an N-terminal HTH (helix-turn-helix) domain, which is responsible for the DNA-binding specificity, and a C-terminal ligand-binding domain, which is homologous to the sugar-binding domain of ABC-type transport systems that contain the type 1 periplasmic binding protein-like fold. As also observed in the periplasmic binding proteins, the C-terminal domain of the bacterial transcription repressor undergoes a conformational change upon ligand binding which in turn changes the DNA binding affinity of the repressor.	2.57412e-79
NZ_CP010413.1\|WP_003832415.1\|2038369_2039398_+\|membrane-protein	gnl\|CDD\|197670	smart00347, HTH_MARR, helix_turn_helix multiple antibiotic resistance protein.	0.00485944
NZ_CP010413.1\|WP_003827964.1\|2048729_2050256_-\|sucrose-phosphorylase	gnl\|CDD\|237528	PRK13840, PRK13840, sucrose phosphorylase; Provisional.	0
NZ_CP010413.1\|WP_060618856.1\|2027810_2029655_-\|isopeptide-forming-domain-containing-fimbrial-protein	gnl\|CDD\|374637	pfam16569, GramPos_pilinBB, Gram-positive pilin backbone subunit 2, Cna-B-like domain. GramPos_pilinBB is one of the major backbone units of Gram-positive pili, such as those from S.pneumoniae. There are three major pilin subunits that form the polymeric backbone of the pilin from S. pneumoniae, constructed of three transthyretin-like, CnaB, domains along with a crucial N-terminal domain, D1. The three Cna-B like domains are stabilized by internal Lys-Asn isopeptdie bonds, Gram-positive pili are formed from a single chain of covalently linked subunit proteins (pilins), usually comprising an adhesin at the distal tip, a major pilin that forms the polymer shaft and a minor pilin that mediates cell wall anchoring at the base.	1.93209e-10
NZ_CP010413.1\|WP_003827966.1\|2045768_2046821_-\|LacI-family-transcriptional-regulator	gnl\|CDD\|380514	cd06291, PBP1_Qymf-like, ligand binding domain of the lacI-like transcription regulator from a novel metal-reducing bacterium Alkaliphilus Metalliredigens (strain Qymf) and its close homologs. This group includes the ligand binding domain of the lacI-like transcription regulator from a novel metal-reducing bacterium Alkaliphilus metalliredigens (strain Qymf) and its close homologs. Qymf is a strict anaerobe that could be grown in the presence of borax and its cells are straight rods that produce endospores. This group is a member of the LacI-GalR family repressors that are composed of two functional domains: an N-terminal HTH (helix-turn-helix) domain, which is responsible for the DNA-binding specificity, and a C-terminal ligand-binding domain, which is homologous to the sugar-binding domain of ABC-type transport systems that contain the type 1 periplasmic binding protein-like fold. As also observed in the periplasmic binding proteins, the C-terminal domain of the bacterial transcription repressor undergoes a conformational change upon ligand binding which in turn changes the DNA binding affinity of the repressor.	8.45619e-77
NZ_CP010413.1\|WP_060618857.1\|2036348_2038163_+\|glycoside-hydrolase-family-13-protein	gnl\|CDD\|200471	cd11332, AmyAc_OligoGlu_TS, Alpha amylase catalytic domain found in oligo-1,6-glucosidase (also called isomaltase; sucrase-isomaltase; alpha-limit dextrinase), trehalose synthase (also called maltose alpha-D-glucosyltransferase), and related proteins. Oligo-1,6-glucosidase (EC 3.2.1.10) hydrolyzes the alpha-1,6-glucosidic linkage of isomaltooligosaccharides, pannose, and dextran. Unlike alpha-1,4-glucosidases (EC 3.2.1.20), it fails to hydrolyze the alpha-1,4-glucosidic bonds of maltosaccharides. Trehalose synthase (EC 5.4.99.16) catalyzes the isomerization of maltose to produce trehalulose. The Alpha-amylase family comprises the largest family of glycoside hydrolases (GH), with the majority of enzymes acting on starch, glycogen, and related oligo- and polysaccharides. These proteins catalyze the transformation of alpha-1,4 and alpha-1,6 glucosidic linkages with retention of the anomeric center. The protein is described as having 3 domains: A, B, C. A is a (beta/alpha) 8-barrel; B is a loop between the beta 3 strand and alpha 3 helix of A; C is the C-terminal extension characterized by a Greek key. The majority of the enzymes have an active site cleft found between domains A and B where a triad of catalytic residues (Asp, Glu and Asp) performs catalysis. Other members of this family have lost the catalytic activity as in the case of the human 4F2hc, or only have 2 residues that serve as the catalytic nucleophile and the acid/base, such as Thermus A4 beta-galactosidase with 2 Glu residues (GH42) and human alpha-galactosidase with 2 Asp residues (GH31). The family members are quite extensive and include: alpha amylase, maltosyltransferase, cyclodextrin glycotransferase, maltogenic amylase, neopullulanase, isoamylase, 1,4-alpha-D-glucan maltotetrahydrolase, 4-alpha-glucotransferase, oligo-1,6-glucosidase, amylosucrase, sucrose phosphorylase, and amylomaltase.	0
NZ_CP010413.1\|WP_019727681.1\|2046890_2048525_-\|MFS-transporter	gnl\|CDD\|349949	cd06174, MFS, Major Facilitator Superfamily. The Major Facilitator Superfamily (MFS) is a large and diverse group of secondary transporters that includes uniporters, symporters, and antiporters. MFS proteins facilitate the transport across cytoplasmic or internal membranes of a variety of substrates including ions, sugar phosphates, drugs, neurotransmitters, nucleosides, amino acids, and peptides. They do so using the electrochemical potential of the transported substrates. Uniporters transport a single substrate, while symporters and antiporters transport two substrates in the same or in opposite directions, respectively, across membranes. MFS proteins are typically 400 to 600 amino acids in length, and the majority contain 12 transmembrane alpha helices (TMs) connected by hydrophilic loops. The N- and C-terminal halves of these proteins display weak similarity and may be the result of a gene duplication/fusion event. Based on kinetic studies and the structures of a few bacterial superfamily members, GlpT (glycerol-3-phosphate transporter), LacY (lactose permease), and EmrD (multidrug transporter), MFS proteins are thought to function through a single substrate binding site, alternating-access mechanism involving a rocker-switch type of movement. Bacterial members function primarily for nutrient uptake, and as drug-efflux pumps to confer antibiotic resistance. Some MFS proteins have medical significance in humans such as the glucose transporter Glut4, which is impaired in type II diabetes, and glucose-6-phosphate transporter (G6PT), which causes glycogen storage disease when mutated.	2.1416e-13

>NZ_CP010413.1|WP_003832407.1|2043410_2044778_-|MHS-family-MFS-transporter
MTAAVEETGLGQAAGKAATLVRDSVKTVIAASMVGTAIEFYDFYAYGTAAANYFPHIFFSDKANPTVALLMSLLTFAIAFIARPLGSLVFGHFGDRMGRKTTLVVSLMTMGVGTFLIGCLPTYDQVGVAAVAILCLLRFIQGIGLGGEWSGAALVATENAPEDKRALYGSFPELGAPIGFFLSNGTYFVLESFNDQSAMLAWGWRVPFLLSAILVIVGLVVRVHMEETPIFRMAQEQKKVVKSPLTEVFRKSWRQVLQATFLVAVTYTLFYTLATWSLAWGTKDTANGGGSLGFTNQEYLLMLMISICVFALFIVLSCLYADKLGRRRVLTFSSCALVVFAVLFPFLLDGQVVGQHNFFANMVFLCVGFALMGIAFGPIGAFLPELFDANVRYSGSGIGYNLAAIVGAAFVPTIATWLAHNWGVHSVGLYLAVMAVCCLVSVLTCKETKDVDFTK
>NZ_CP010413.1|WP_003827968.1|2041962_2043015_-|ketol-acid-reductoisomerase
MAATIWYEKDADLSVFDGKKVAILGYGSQGHAHALNLRDSGVDVVVGLRPSSKSVEFAKEQGLEVKPVGEAVAEADVVMILLPDQYQAKVYEEEVEPNLKPGAALAFAHGFNIHYGYIKPSEDHPVFMVAPKGPGHIVRREYAAGRGVPVVVAVEQDPDGKTWPLCLAYAKALGALRAGAIKTTFTEETETDLFGEQDVLMGGINHLCDLGFDVLTEAGYQPEIAYFEVFHELKMLVDLANEGGLNKARWSCSDTAQYGDYTSTVITDETKKRMQYQLKRIQDGSFAKEFMDDQAAGAPKFKKLQEEFSHPHLETVGPKLRAMFSWNNAEAKDKDEAESFNGKIARTQVQ
>NZ_CP010413.1|WP_003832411.1|2040482_2041535_-|ketol-acid-reductoisomerase
MAAQIWYENDGDLSVLEGKKVAIIGYGSQGHAHALNLRDSGVDVVVGLRPTSKSVDFAKEQGLEVKSVAEASAEADVIMILAPDQYQRTIWANDIEPNIKPGAAVAFAHGFNIHYGYIKPTEDHPVFMVAPKGPGHIVRREYAAGRGVPVVVAVEQDPRGDGWALTLAYAKALGALRAGAIKTTFKEETETDLFGEQNVLMGGVNKLVEMGFEVLTDAGYQPEIAYFEVCHELKMLVDLMNEGGLNKARWSCSDTAQYGDYTNTVINEDCRKRMEYHLQRIQDGSFAKEFIDDQDAGAPHFKELQEKYSNERIETVGPKLRAMFSWNKDGVKDADEANSFTGKIARAQVQ
>NZ_CP010413.1|WP_008783494.1|2039394_2040180_+|hypothetical-protein
MTQGLQLIRTAFAGYEDSYVIIGGTACDIIMTDNELDFRATKDIDMVLIAEGHLREFAQRLWSFIRDGGYTSITKNSAQPHLYRFMHPSTYGYPTMIELFSRHPDFPIVPNSFLTPLHIANDVSSLSAIMLNDSYYRLLQQGRESIQGISVLNEKYLIPFKAKAWLDLNAREQHGEHVDGKDLKKHKYDVFRLAQLLAPEDRVSLNDEAYHDLADFLGKISHETLPIKQLGIRGTQQDIIDLIAGVYQLSIPPRDELPTTR
>NZ_CP010413.1|WP_003832415.1|2038369_2039398_+|membrane-protein
MDAEHYIRETLGLPCQITSWDGTASLPLFLTNGRTFSKLTIDNTSMLIASGEAHPFSITRVTADASRLEQRTDLPIVFQFPRLSAYQRKALIQNHVPFIVPGTQLYIPSLGMVFTQRISSRPLENAQDIEVRPFSPATQLVWLYLLYSNESKVQSDIARALQFTEAQVSVAVTLLEQLAFVHRTKQGRSNSVELLTSRQTSRLDLLKSSWHLLKSPIFSKYTVTNRNRQMIADELIPAGEFALSRRTQLATPKLRIYAVERHWLKQHNKELCIIDPALEKVPDNAYILELWRYDPRLLAQYTQEDYLADPISTALTLGEIADERLEDAIQESIRNTFSGATI
>NZ_CP010413.1|WP_060618857.1|2036348_2038163_+|glycoside-hydrolase-family-13-protein
MTANNLNDDWWKQAVVYQIYPRSFKDVNGDGIGDIAGVTEKMDYLKNLGVDAIWLSPFYPSDLADGGYDVIDYRNVDPRLGTMDDFDAMAKAAHEAGIKVIVDIVPNHTADKHVFFKEALAAEPGSPARDRYIFRDGRGEHGELPPNDWQSFFGGPAWARVADGQWYLHLFDKAQPDVNWKNPDIHEEFKKTLRFWSDHGTDGFRIDVAHGLAKDLESKPLEELGREYSVVGVLNHDFSHPLFDRREVHDIYREWRKVFNEYDPPRFAVAEAWVVPEHQHLYASMDELGQSFNFDFAQASWYADEFREAIDAGLKAAAETGGSTTTWVMNNHDVPRSPSRYGLPQVKGAPYHQLPHDWLLRNGTTYPEDRELGTRRARAAALMELGLPGAAYIYQGEELGLFEVADIPWDRLEDPTAFHTAQATMDKGRDGCRVPIPWTAANEPTLADFSRPIPADDGTGENHVPLCAAGQFGTGASFGFSPATRAEGVTPAADPHLPQPLWFKDYAVDVEQADPDSMLALYRAALAIRQESLTATRDTTAEQVDMGDDVVAYTRAAVGGRVFTSITNFGNAPVALPNGSVVLASGPLTPEGQLPTDTSAWVVQ
>NZ_CP010413.1|WP_025221010.1|2035045_2036077_+|LacI-family-transcriptional-regulator
MTKASIQAVAKEAGVSVSTVSRTFAKPDLVLPETRDKVMAAAEKLDYSISRSAAALKSGQSFRIALLASETITTWFNANIFAGLDSVLRPAGYDTVAYPMRNAEERHDFFADLPVRRNADAVIVSSFNIEPAEVERLKHMHVPIIGINIPSTDGFDSGVSIDDRTATRAAVEHLIALGHRGIAFVGGTPAETNMRYSAESRLQGVLDAQAAHPELTVTNLQVPRGATETSAALNAVLTAPAGTTAFCFEDDELALPVLYRLRQYGKRVPQDISIVGFDDVEMSQAVGLTTMHQDPFAMGADAGRMALEAIAGGPIEPAFIQPDAPLVLRETTAPPAAPVPAQG
>NZ_CP010413.1|WP_060619000.1|2029759_2034172_-|collagen-binding-protein
MGTEANPATERDSGVATWVGGDMYVGKKSDNLTNADGPDASYSAEAEGLTVVNGKLMLHPQKNSWNGQGFRFGVAGFGTQYRPAEGSTALVVGGNTVTVMDSATSTADVKAWNKPGFIDGHSHVGSLSGSQSDIWGNGSTSSIGSYNGASVNWQKDKSGNTQNQDAGNLTKVSVKATDGGAATDKDFSKDTFYQGYVVDDIVSPLAKQNKTGTVSSSISTLSELPRHKYNYYKEGTNAASGISYTFKYDDTTKYGTGRGIAPTTSYTNREKLITFTGTNNASMEVFNLDASMLRDTDGNGTLYRGVGFAFTNIADTASVVINVTGNAGNISFHNGWQFWWNGAEISDGYSNYNNTDDLKRKSAAYDKASQKILWNFSNTDNLTIYGGVANEDGTNTNADKITQDDAAAAMMGSIIVRGNFESHVSTNGRVYTGGDFSMYNPYKAWTFNQAGANDGDSASVLDMDQERHNFPWNGSYTESCSAIAWQKADESGTLLGGTTWAVYGKYDDAASGKNALLTVQDNAFYDKDSADGRFTVEGLKPNATYYIKEVSAGNDYQLNTNVYYVATGDSSATPVNVTQSVTKTDGAYTYGSADMTDGKIVNKKNGHEVSWSKVDADTNKELAGSQWQIQQVKDGAAAKSWKVTDNTSKATGVTVNPTSATLDSTNGWKTDLTAAVDPKDALQEVAWTFTDKDGNAVDSPTVAVLARTGNLKATVTGISSIDTTVYVKACSVSNPEVCSALVAIKVKAMSVKDFTVKDSSNRTVENNSTITAAAVDSTLTFAASSTPAVPITWESSNKSVATVTSSGENGQKATVTMTGFGSAVITAKAGDKKVSFTVKVPSTTVYFKKSLMNWSKYYVYYNAGNNNWKFVEMSQSCGDYVYAILPKQSPGTEFLFHGDDENTSTNKWYQGSNKSDFKFTGNEVQVVNLYNDSQVSTAPAGCPASAAAAAQSNDAAVLNENAVVTPADDPQPSDADGVAENAIDDGAKAISCTAADGENGRPGVKCDMDTAAGKFKVGGLDAGTYWLHETTAPDGYTINKTLYQFTIDANGNVTWNGGWASGKATGAIDEKLKPGDNNAISDTPTEVTWNKVDTKGGKLAGSQWKIVGPSPATDVYCVADNVTVDANGATTPAGIEFTGCTGEKLSDAANTADEAGVITVRGLPVGTYTLTETKAPDGYVATTTVYTLTISDTKASTVVAQTATDRPTTRSGGNREAAANVPNASAPVNIQIPVKKSVKYTSWPKDSNGNYVNFNFKIEATKSTVDANPAAPMPAECSSSDATKNDCTISLAPKSDADDLSNVIAKFGKMTFTDANLAAAAGDASDYAKTYTYKIAEIVPDSADAVENLRYSKAEYQVVVTLKQAKDSSGKLSGLSVSATMTRIKDDSGNAEAGGGKIIGTWSSTSTGSSAGTAVEATFVNTKVLTGLPATGADWTGRLVLLVGDGFILVGVLIAGGYQLAKRRREEDSD
>NZ_CP010413.1|WP_060618856.1|2027810_2029655_-|isopeptide-forming-domain-containing-fimbrial-protein
MNTIFKRVISGAAALGIAVSGLAIGVSTAYAADPTTGSITINKSDAGQVDHSFDGWHLASLTNVTKDSAGKINGFLIDTDDHMARTIVAAMTSGQKDAYEKDANYYSDDPAVANPMGYLVEKVFKDTSGKALSELTSPWGGDSSALRAFAKSLSKELAKAGAPAADKTGDSALKTGENKELKQGLWFLKDVTTTDDTKGTNSIPIITPTTFDGADSWGTVTLKNTTPTIDKKLVDSKGDGTYTPNTQPDYAVGDDVYYELTSTVPVYTGYDIDSTMKDATKTRIFKINDTASKALTVSAGTVIESVKLTPAQGTAVTLVKDKDYTVTVAGYGDVNTPDTDAYKGGHVTTIDLGKYVNKAEGSKSATTADGILEGATVTVIVKAKLNKGALISNPGNLQKNPNKVDLEYSNRPEEVDHAHKVPGPEVPVYAYKFDILKTDKAGTTKLPGAKFTVKAVSGTSTHDGKYLGSYGENGWSYLDSEPAVAATDGVFTTDKDGKINVSGLDAGTYEVHEIAPPDGYTAISLPKFQFTITPTVGDEDAGCKTITAVALSLAKGADERASLSQGGKTLNIWNAKNITELPRTGGAGLAMIVAVGALFIAASGIFALRARRKA
>NZ_CP010413.1|WP_060618855.1|2026594_2027554_-|class-C-sortase
MRSSTGTKQSGTRTQSRVFTVLSVLFLLIGFAIITTPFVMRAISEYQQNATVQQTQREVDGWPYPQAENQLKTAREYNKKLAAGGQAAIGEVKDPFAGNAGQSTTSGADDSMAAKDQEYQSLLDAGQGVMGSIRIPKIDVNLPIYHGTSEDALAVGAGHLYGTSLPVGGKSTHSVITGHRGLPNSLLFTRLDEMKKGDAFYIEVMGKKLGYKVDRITVIKPDDSSKLRITKGEDRVTLMTCTPYGVNSHRLLVSGVRAEIPEEVPDPDDVHGINTTWLALGAIVFLAMLFAFIVILMRRKQKRDREFAGLARHAARPTK
>NZ_CP010413.1|WP_003827966.1|2045768_2046821_-|LacI-family-transcriptional-regulator
MVGMRDVAKTAGVSLSTVSLVVNNTGYVSDDMRAKVEAAMRQLNYIPNELARNLYRNRTNTIGVIMPTIAHPFFATLTAHLQREFAARDLKTLLCSIADADKGEGEYVDMLQRHMMDGIVMAAHTEHPGGYWTSIHRPIVAFDRTLGEGVPAVRSDHEQGGRLIARQLIDSGARHVVLVGGPRSQFAEATTFPTIRYHLTVERMLADAGIACDYVEAGIVADICAHEATARAIFERYSDVDAIVGSDLVASVALQEALRRGISVPRDLQIIAYDGTFMAETAGMRLTAVRQDFPAVAAALASRMDSQIAADNGTTSAAAAEGGNAVAANGGQSTSEDIISVTLIPGETTR
>NZ_CP010413.1|WP_019727681.1|2046890_2048525_-|MFS-transporter
MLEPYVRPGIDDRPDLDKALSPEDKDAVARLAIKDRRRPPEASADQPEAQAVRLAAAGSSAAAAAAASVDAPAPDLSSAYLDMRDPMVAANGQRPTAVQVSRLNWGFFVASILVGAPWAALNTIAMPNAVARLFDYDTASAISVTINPSTGRPLPVATDLVVPLAVLVVVGVVASMFAMPLVSALSDRTRIPLGRRTPWMVAGGVLCALITLVLGQNTGLVVLCFFWALMQFAYAMISVPLASAISERVPDKFRPCIERWHGIGVMLGQALGVCMGALGVMFDSFTPFAYTAVLFAVSGILTVIMLPKEPSSQEQPHQRFESSQVFDQLRPPAHAPAFARVFAARVCMMTGVGLTGVFLWYLVRFWVYGKAVVFTSAPLTIPAGLLIAGMAAATLIGAALASWAAGPISEKIEERNVATTAVVAASCLLYAIGVAVAWGLGVWSTGTARENGMLLFALISGFAFGVYDALGLELVMNALPDPRNAGHDLGIYALANSVGLALAAIIGAVLVSAFASSFGYYLLFPSAIVMVFLAGIITLSSKAE
>NZ_CP010413.1|WP_003827964.1|2048729_2050256_-|sucrose-phosphorylase
MKNKVQLIAYADRLGDGTLSSMTDILRTRFDGVYDGVHVLPFFTPFDGADAGFDPIDHTKVDPRLGSWDDVAELSKTHGIMVDAIVNHMSWESAQFQDVLKNGEHSEYYPMFLTMSSVFPNGATEEDLAGIYRPRPGLPFTHYKFAGKTRLVWVSFTPQQVDIDTDSAKGWEYLMSIFDQMAASHVRYIRLDAVGYGAKEAGTSCFMTPKTFKLISRLREEGVKRGLEILIEVHSYYKKQVEIASKVDRVYDFALPPLLLHSLFTGHVEPVVHWTEIRPNNAVTVLDTHDGIGVIDIGSDQLDRSLKGLVPDEDVDNLVNTIHANTHGESQAATGAAASNLDLYQVNSTYYSALGCNDQHYLAARAVQFFLPGVPQVYYVGALAGRNDMELLRKTNNGRDINRHYYSTAEIDENLERPVVKALNALAKFRNELPAFNGEFSYEADGDTSITFRWIAADGKTKAALIFEPGRGLGTDNTTPVASLAWTDAAGDHETDDLLSNPPIADID
>NZ_CP010413.1|WP_014483280.1|2050682_2051768_-|LacI-family-transcriptional-regulator
MVGMRDVAKKAGVSLSTVSLVVNGNGYVSDDMRERVRKAMQLLNYVPNELARNLYHNRTNLVGVIVPTIRHPFFATFTAHLQHALAAQGLRTMLCSTADEADGEIQYVDMLRRHMMDGIVMCAHTSHPGDYWTSIHRPIVAFDRVLGDGISSIGSDHEQGGRLIAQMLIRNGAKHVVMIGGPRDQFFDLAARGEVEEGPFDLGKTTFPTVRYYLTLEQELTSAGVKYEYVEAGEVMDFAGYHRAVSNALDKVTTDGVDAVVSSDIGASFCVREALSRGISIPDELQIVAYDGTYLTDLAGMKLTAVAQDFSAIAQSTADHIVQAIANEEVAAANASRRDIPKPFEPNVLIPMTLVPGDTTR
>NZ_CP010413.1|WP_003827961.1|2052042_2052438_-|CrcB-family-protein
MMWMICLFGGLGAMARYVLDVSIQQGWNRENRRTNRNFPLSTLVINGVASLCAGIAMMSYYSQSVDMDTVMMFVVGFLGGFSTFSTALNEVVSLIRQRRFTLALGYGIATVAVPLICVATGFGIALLANPA
>NZ_CP010413.1|WP_060618858.1|2052437_2053478_-|CrcB-family-protein
MESQEQSPGDVVTAGEDSHPITQAIDTVEVMHAGATAPAANTMDPPTIPLAPMKRMQARFNPLADGLMYVVVFVGGFVGVGCRHALDMLLPSVSGTPFVVGTFVSNMVACFLFAMLTEFMATASWLRRRVRQVVSRGVGLGLLGGLSTMSGVMLETMEGLHERHIASALGYLAGNFAGGLLTAAAGVVLMQALLSRSTRKRVRGAFSAVSVSDSAESDTQGVRHVKVADVARSAAQAAMEAAQTAQQIAQTGQVPRVETPTVPPPASQPMQTGRVPQVPPLVVPQLAQSSQPLLREPDTPDLGQLPEIKQSQPIQQPANPLPPSFEPKPITAEISLVADPTTGEVR
>NZ_CP010413.1|WP_060618859.1|2053664_2055248_-|ClC-family-H(+)/Cl(-)-exchange-transporter
MTGNDAAHDIRRLIPRFDHLKWKMAAAGIVIGLVSGLLVVVYRLGIEYGTDASRWIYARIRETPWLIAPWAVAAVAAALAIAWMVGKEPMAGGSGIPQTNGVVICGLKMRWQTILPVRFVGGLLGALFGLSLGREGPSIQIGASGAQCVSHRLRGRRREDMQEHYLVTAGAAAGLSAAFSAPLSGMMFALEGVHRSFSPAILMGATAASLTADFVSKYCFGLRPVLDFGDIGQLSLEEYVWLIPLGLVAGLVGSLMNRSLLGFQTLYDKLPAWSRPMIAIAIALPVGIWLPDVLGGGSNLIDTAEHARVGLGMLCLLFVAKMLFTSTSFGSGAPGGIFMPILAVGSLAGGICGEVLHRFGDLPSDAVAVFAVCVMTGTLAASVKTPITSILLAVEMSGTLTHMLPVAAVAFIALLVSDLLRTKPIYGELLERYVRAQGMQMAIASHVGSGIMELPLEMGAIADGKRVRDVRWPSGCLIIGLRRGESEIVPCGDTRLRAGDYLVVLFSGEEEREVRPAMRRLCDARLD
>NZ_CP010413.1|WP_025220999.1|2055271_2056558_-|adenylosuccinate-synthase
MPGIVLIGAQWGDEGKGKATDLIGTKVDYVARFNGGNNAGHSVVVGDESYALHLLPSGIINPNLTPVIGNGVVVDPEVLFEEIDGLESRGIDCSHLLVSEAAHIIAPYHRTLDKVTERFLGKHKIGTTGRGIGPAYADKINRIGIRVHDLFNADHLHDKVEASLHQKNQMLVKLYNRRAIDVDQTTEELLKLGERLKPYVANTGLILNKALDEGKTVLFEGAQATMLDVDHGTYPFVTSSNPTAGGACTGTGVGPTKITRVIGVAKAYVTRVGEGPFPTELLDESGEWLRQQGHEFGVTTGRPRRCGWFDAVVNRYASQVNGLTDIVLTKLDVLTGLKEIPLCVAYDVDGERHDDMPTDQAEFAAAKPIYESMPGWDEDISQIHDFNDLPKTCQDYVKRLEDLSGCRISVIGTGPQRDHVIQINSLVD
>NZ_CP010413.1|WP_025220998.1|2056711_2057779_-|class-II-fructose-bisphosphate-aldolase
MTIATPERYAEMLDAARRGGYAYPAINVTSSQTLNAALKGFADAESDGIIQVSVGAAAYLSGIGVNDRVTGSLALAAFAHEVAAKYPNITIALHTDHCAKQYLDEWVRPLLAHEADQVAHGQEPTFQSHMWDGSTVPLKENLDIAEELLAKSQAAHTVLEIEIGAVGGEEDGHFAEIDERLYSTPADGLEVARRLGLGERGRYMAAFTFGNVHGSYKPGVVKLRPALLGEIQARVARAVAEGELPSAAGMVDFPNGKPFELVFHGGSGSRPEEIAEAVSHGVIKMNIDTDTQYSFTRPIADHVFENYDKVLKIDGEVGEKRFYDPRSWGRKAEESMSARVVEACKQLGSAGKALK
>NZ_CP010413.1|WP_025220997.1|2057841_2058777_-|EamA-family-transporter
MCEPKAAATNGQPTPTLECTPHDIFVGAGLALAGGVFWGVNATVSKLLMNDYHADPLWIACVRELLAGVIFLVCAGIFTPDKFINSLKDYRSYPRLLLCAFFCVLMVQVSYLKAIDWTNSGTATVLQTLNLLVVLVFVCIMGKRLPGKRESIGVILAFVGTVLIATGGDLSQLSLPLPGLLWGLTDAVCTSLLAILPIALMAKWGNFMANGVMFIVSGLMLLPLVRPWTTAPALDWFGIGLMAFTVVFGTFGAYWLFLGGTQRCGAMRATMLGTSEPVTATITGVLFAGAVFTPTDLVGFAMIIIMVFLVR

You can click texts colored in the table to view more detailed information

Click the colored protein region to show detailed information

Self-targeting detection

CRISPR_ID	Spacer_Info	Spacer_region	Spacer_length	Hit_ID	Protospacer_location	Mismatch	Identity
NZ_CP010413_1	1.1\|44496\|36\|NZ_CP010413\|CRISPRCasFinder	44496-44531	36	NZ_CP010413.1	43159-43194	1	0.972

1. spacer 1.1|44496|36|NZ_CP010413|CRISPRCasFinder matches to position: 43159-43194, mismatch: 1, identity: 0.972

atcccagtcgtcctaaattactgtcgctaagtgagt	CRISPR spacer
atcccagtcgtcctaaatttctgtcgctaagtgagt	Protospacer
******************* ****************

MGE targeting detection<

CRISPR_ID	Spacer_Info	Spacer_region	Spacer_length	Hit_phage_ID	Hit_phage_def	Protospacer_location	Mismatch	Identity
NZ_CP010413_2	2.1\|430428\|34\|NZ_CP010413\|PILER-CR,CRT	430428-430461	34	NZ_AP022593	Mycolicibacterium arabiense strain JCM 18538 plasmid pJCM18538, complete sequence	267411-267444	8	0.765
NZ_CP010413_3	3.2\|1827223\|32\|NZ_CP010413\|PILER-CR	1827223-1827254	32	NZ_AP022338	Mameliella alba strain KU6B plasmid pKUB257, complete sequence	221650-221681	8	0.75
NZ_CP010413_3	3.2\|1827223\|32\|NZ_CP010413\|PILER-CR	1827223-1827254	32	NZ_CP015038	Burkholderia cenocepacia strain 895 plasmid pBcp895-1, complete sequence	166502-166533	9	0.719
NZ_CP010413_2	2.1\|430428\|34\|NZ_CP010413\|PILER-CR,CRT	430428-430461	34	NZ_CP018784	Curtobacterium pusillum strain AA3 plasmid pCPAA3, complete sequence	363569-363602	10	0.706

1. spacer 2.1|430428|34|NZ_CP010413|PILER-CR,CRT matches to NZ_AP022593 (Mycolicibacterium arabiense strain JCM 18538 plasmid pJCM18538, complete sequence) position: , mismatch: 8, identity: 0.765

acgtccgtgaccgtcacgttcgcggcgtcaccat	CRISPR spacer
tcgccgaagaccgtcacgttctcggggtcaccac	Protospacer
 **.* . ************* *** *******.

2. spacer 3.2|1827223|32|NZ_CP010413|PILER-CR matches to NZ_AP022338 (Mameliella alba strain KU6B plasmid pKUB257, complete sequence) position: , mismatch: 8, identity: 0.75

cagatggcggatgcgacggacctgaccgcgtt	CRISPR spacer
gagatggcggatgccacggtcctgatgggtgt	Protospacer
 ************* **** *****. *   *

3. spacer 3.2|1827223|32|NZ_CP010413|PILER-CR matches to NZ_CP015038 (Burkholderia cenocepacia strain 895 plasmid pBcp895-1, complete sequence) position: , mismatch: 9, identity: 0.719

cagatggcggatgcgacggacctgaccgcgtt	CRISPR spacer
aacccggcgtatgcggcggacctgaccgacct	Protospacer
 *  .**** *****.************  .*

4. spacer 2.1|430428|34|NZ_CP010413|PILER-CR,CRT matches to NZ_CP018784 (Curtobacterium pusillum strain AA3 plasmid pCPAA3, complete sequence) position: , mismatch: 10, identity: 0.706

acgtccgtgaccgtcacgttcgcggcgtcaccat	CRISPR spacer
gggaccgtgaccgtcacgttcgctccgtcggtcc	Protospacer
. * *******************  ****. . .

Prophage detection

Region

Region Position

Protein_number

Hit_taxonomy

Key_proteins

Att_site

Prophage annotation

DBSCAN-SWA_1

923497 : 969261

Bifidobacterium_phage(59.09%)

coat,tRNA,integrase,portal,terminase,transposase,tail

attL 928591:928607|attR 948745:948761

The bacterium proteins that are colored denote the protein is present at specific phage-related keywords (such as 'capsid', 'head', 'integrase', 'plate', 'tail', 'fiber', 'coat', 'transposase', 'portal', 'terminase', 'protease' or 'lysin' and 'tRNA')

Protein_ID	Protein_Def	Hit_ID	Hit_Def	E-value	Identity
WP_003829356.1\|923497_925531_-\|tRNA	threonine--tRNA ligase	A0A2K9L6B6	Tupanvirus	2.3e-110	36.9
WP_103619788.1\|926322_927186_+	PAC2 family protein	NA	NA	NA	NA
WP_003829353.1\|927336_928221_-	undecaprenyl-diphosphate phosphatase	NA	NA	NA	NA
WP_025301234.1\|928371_929163_+	phosphotransferase	NA	NA	NA	NA
928591:928607	attL	NA	NA	NA	NA
WP_016462961.1\|929382_930558_-\|integrase	site-specific integrase	A0A0E3XBN7	Gordonia_phage	1.9e-56	38.7
WP_032734778.1\|930635_931172_+	DUF2335 domain-containing protein	NA	NA	NA	NA
WP_143247961.1\|931295_932105_-	hypothetical protein	NA	NA	NA	NA
WP_016462964.1\|932121_932547_-	hypothetical protein	I3NLD5	Bifidobacterium_phage	2.7e-21	44.2
WP_016462965.1\|932543_933554_-	virulence RhuM family protein	Q9JMN3	Wolbachia_phage	9.4e-73	43.8
WP_143247960.1\|933652_934087_-	hypothetical protein	NA	NA	NA	NA
WP_022527507.1\|934353_935034_-	hypothetical protein	NA	NA	NA	NA
WP_060618546.1\|935063_935336_+	hypothetical protein	NA	NA	NA	NA
WP_060618548.1\|935543_936161_-	hypothetical protein	I3NLD1	Bifidobacterium_phage	9.0e-18	43.4
WP_060618549.1\|936327_936783_-	hypothetical protein	NA	NA	NA	NA
WP_016462971.1\|936869_937115_+	hypothetical protein	NA	NA	NA	NA
WP_060618550.1\|937370_937634_+	hypothetical protein	NA	NA	NA	NA
WP_060618551.1\|937648_937918_+	hypothetical protein	NA	NA	NA	NA
WP_060618965.1\|937920_938496_+	single-stranded DNA-binding protein	A6N1Y1	Microbacterium_phage	2.7e-40	59.5
WP_060618552.1\|938505_938913_+	hypothetical protein	NA	NA	NA	NA
WP_060618553.1\|939045_940464_+	ParB/RepB/Spo0J family partition protein	I3NLC2	Bifidobacterium_phage	1.0e-69	39.2
WP_060618554.1\|940467_941613_+	hypothetical protein	NA	NA	NA	NA
WP_052828284.1\|941609_942014_+	hypothetical protein	NA	NA	NA	NA
WP_032746516.1\|942038_942248_+	hypothetical protein	NA	NA	NA	NA
WP_052828285.1\|942244_942832_+	hypothetical protein	I3NLB8	Bifidobacterium_phage	9.5e-25	35.5
WP_052829187.1\|942828_943023_+	hypothetical protein	NA	NA	NA	NA
WP_052828287.1\|943015_943336_+	hypothetical protein	NA	NA	NA	NA
WP_052828288.1\|943442_943718_+	hypothetical protein	NA	NA	NA	NA
WP_131211567.1\|943817_944000_+	hypothetical protein	NA	NA	NA	NA
WP_052828289.1\|944073_944877_+	hypothetical protein	NA	NA	NA	NA
WP_052828290.1\|944949_945153_-	hypothetical protein	I3NLD9	Bifidobacterium_phage	7.0e-20	69.4
WP_155466432.1\|945145_945310_-	hypothetical protein	NA	NA	NA	NA
WP_032734780.1\|946189_946726_+	hypothetical protein	NA	NA	NA	NA
WP_016462991.1\|946718_947843_+	hypothetical protein	A0A1C9EHW4	Gordonia_phage	3.8e-107	54.3
WP_060618555.1\|947829_948486_+\|terminase	terminase	A0A1C9EHV3	Gordonia_phage	1.1e-58	54.6
WP_060618556.1\|948485_949979_+\|portal	phage portal protein	D7NW49	Streptomyces_phage	6.1e-60	31.7
948745:948761	attR	NA	NA	NA	NA
WP_060618557.1\|949920_951081_+	hypothetical protein	NA	NA	NA	NA
WP_032737230.1\|951104_951719_+	hypothetical protein	NA	NA	NA	NA
WP_060618558.1\|951735_952593_+\|coat	coat protein	E5DV53	Deep-sea_thermophilic_phage	1.8e-61	49.0
WP_007056616.1\|952659_953244_+	hypothetical protein	NA	NA	NA	NA
WP_016462998.1\|953240_953663_+	hypothetical protein	I3NL96	Bifidobacterium_phage	6.3e-39	86.4
WP_106622479.1\|953664_954054_+	hypothetical protein	I3NL95	Bifidobacterium_phage	3.2e-37	62.3
WP_060618559.1\|954050_954467_+	hypothetical protein	I3NL94	Bifidobacterium_phage	5.1e-41	60.9
WP_060618560.1\|954539_955073_+	hypothetical protein	I3NL93	Bifidobacterium_phage	2.2e-81	87.2
WP_016463002.1\|955248_955743_+	hypothetical protein	I3NL92	Bifidobacterium_phage	4.6e-57	71.2
WP_016463003.1\|955814_956111_+	hypothetical protein	I3NL91	Bifidobacterium_phage	2.3e-35	65.3
WP_060618561.1\|956127_959466_+\|tail	phage tail tape measure protein	I3NL90	Bifidobacterium_phage	3.9e-192	48.4
WP_016463005.1\|959462_960359_+	hypothetical protein	NA	NA	NA	NA
WP_060618562.1\|960422_961367_+	hypothetical protein	NA	NA	NA	NA
WP_016463007.1\|961366_962575_+	hypothetical protein	NA	NA	NA	NA
WP_060618563.1\|962585_965819_+	hypothetical protein	NA	NA	NA	NA
WP_052829195.1\|965837_966134_+	hypothetical protein	NA	NA	NA	NA
WP_143247959.1\|966163_966532_+	hypothetical protein	NA	NA	NA	NA
WP_081000307.1\|966567_967074_+	hypothetical protein	I3NL83	Bifidobacterium_phage	2.7e-28	62.1
WP_032738804.1\|967045_967807_-	ATPase AAA	A0A059NT77	Lactococcus_phage	1.9e-33	37.9
WP_080790637.1\|967803_969261_-\|transposase	IS21 family transposase	NA	NA	NA	NA

DBSCAN-SWA_2

1784852 : 1838587

Bifidobacterium_phage(18.75%)

protease,integrase,portal,terminase,transposase,capsid,holin,tail

attL 1773465:1773483|attR 1823424:1823442

Protein_ID	Protein_Def	Hit_ID	Hit_Def	E-value	Identity
1773465:1773483	attL	NA	NA	NA	NA
WP_095256842.1\|1784852_1785179_+\|transposase	transposase	NA	NA	NA	NA
WP_019727793.1\|1785310_1786744_+	aspartate ammonia-lyase	NA	NA	NA	NA
WP_016462205.1\|1786924_1787716_+	mechanosensitive ion channel	NA	NA	NA	NA
WP_052789170.1\|1787847_1788885_-\|protease	CPBP family intramembrane metalloprotease	NA	NA	NA	NA
WP_015438392.1\|1789301_1790621_-	ABC transporter ATP-binding protein	G3M9Y6	Bacillus_virus	2.2e-29	36.8
WP_044051860.1\|1790617_1791490_-	ABC transporter permease subunit	NA	NA	NA	NA
WP_003828197.1\|1791525_1792464_-	ABC transporter permease subunit	NA	NA	NA	NA
WP_060618761.1\|1792475_1793642_-	ABC transporter substrate-binding protein	NA	NA	NA	NA
WP_052828920.1\|1793907_1795095_-	D-alanine--D-alanine ligase	NA	NA	NA	NA
WP_003831442.1\|1795140_1796142_-	NAD(P)-dependent glycerol-3-phosphate dehydrogenase	NA	NA	NA	NA
WP_143247920.1\|1796334_1797288_-	1-acyl-sn-glycerol-3-phosphate acyltransferase	NA	NA	NA	NA
WP_016462199.1\|1797413_1797803_-	hypothetical protein	NA	NA	NA	NA
WP_060618762.1\|1798483_1799110_+	hypothetical protein	NA	NA	NA	NA
WP_014483422.1\|1799248_1800220_-	tetratricopeptide repeat protein	NA	NA	NA	NA
WP_050824600.1\|1800444_1801449_-	hypothetical protein	NA	NA	NA	NA
WP_060618763.1\|1801448_1802687_-	hypothetical protein	NA	NA	NA	NA
WP_003828186.1\|1802788_1803742_+	peptidylprolyl isomerase	NA	NA	NA	NA
WP_060618764.1\|1803872_1804577_-	endonuclease NucS	NA	NA	NA	NA
WP_021649479.1\|1804660_1804954_-	F0F1 ATP synthase subunit epsilon	NA	NA	NA	NA
WP_015438381.1\|1804953_1806426_-	F0F1 ATP synthase subunit beta	NA	NA	NA	NA
WP_025221132.1\|1806434_1807358_-	F0F1 ATP synthase subunit gamma	NA	NA	NA	NA
WP_003828181.1\|1807361_1808993_-	F0F1 ATP synthase subunit alpha	NA	NA	NA	NA
WP_015438380.1\|1809061_1809898_-	F0F1 ATP synthase subunit delta	NA	NA	NA	NA
WP_060618765.1\|1809932_1810451_-	F0F1 ATP synthase subunit B	NA	NA	NA	NA
WP_003828178.1\|1810516_1810747_-	ATP synthase F0 subunit C	NA	NA	NA	NA
WP_060618766.1\|1810850_1811660_-	F0F1 ATP synthase subunit A	NA	NA	NA	NA
WP_014483418.1\|1812004_1813039_-	homoserine O-succinyltransferase	NA	NA	NA	NA
WP_060618767.1\|1813437_1814262_+\|integrase	tyrosine-type recombinase/integrase	A0A1B3B212	Gordonia_phage	3.2e-55	44.4
WP_003809885.1\|1814311_1814584_+	BrnT family toxin	NA	NA	NA	NA
WP_003809887.1\|1814567_1814852_+	hypothetical protein	NA	NA	NA	NA
WP_060618768.1\|1814917_1815181_-\|holin	holin	C9E2L0	Enterococcus_phage	1.2e-08	50.8
WP_060618769.1\|1815265_1816501_-	LysM peptidoglycan-binding domain-containing protein	Q8LTJ6	Lactococcus_phage	6.4e-39	44.1
WP_060618770.1\|1816562_1816886_-	hypothetical protein	I3NL84	Bifidobacterium_phage	5.8e-16	69.8
WP_065471130.1\|1817174_1818410_-	reverse transcriptase	D6PSR5	Lactobacillus_phage	1.0e-28	28.0
WP_060618774.1\|1818823_1820404_-	hypothetical protein	NA	NA	NA	NA
WP_060618991.1\|1821295_1821892_-	hypothetical protein	NA	NA	NA	NA
WP_060618992.1\|1821901_1825621_-\|tail	phage tail protein	I3NL88	Bifidobacterium_phage	2.5e-179	62.8
1823424:1823442	attR	NA	NA	NA	NA
WP_060618775.1\|1825641_1826421_-	hypothetical protein	I3NL89	Bifidobacterium_phage	8.7e-42	37.0
WP_060618776.1\|1826440_1829509_-	tape measure protein	R9QN01	Lactococcus_phage	1.8e-74	42.4
WP_060618777.1\|1829510_1829903_-	hypothetical protein	NA	NA	NA	NA
WP_060618778.1\|1829914_1830235_-	hypothetical protein	NA	NA	NA	NA
WP_060618779.1\|1830289_1830877_-	hypothetical protein	A0A141E164	Streptococcus_phage	7.0e-20	38.0
WP_060618780.1\|1830908_1831274_-	hypothetical protein	NA	NA	NA	NA
WP_060618781.1\|1831270_1831546_-	hypothetical protein	NA	NA	NA	NA
WP_060618782.1\|1831557_1831893_-	hypothetical protein	Q7Y4I1	Streptococcus_phage	2.5e-06	30.8
WP_060618783.1\|1831889_1832342_-	hypothetical protein	A0A1D8ETI1	Propionibacterium_phage	7.3e-25	51.7
WP_060618784.1\|1832353_1832668_-	hypothetical protein	NA	NA	NA	NA
WP_060618785.1\|1832667_1833573_-\|capsid	phage major capsid protein	A0A0H4INI2	Propionibacterium_phage	1.2e-34	33.4
WP_016462172.1\|1833618_1834152_-	hypothetical protein	NA	NA	NA	NA
WP_016462171.1\|1834283_1834544_-	hypothetical protein	NA	NA	NA	NA
WP_060618786.1\|1834501_1835704_-	hypothetical protein	A0A1D8EU68	Propionibacterium_phage	4.5e-21	45.8
WP_060618787.1\|1835654_1837154_-\|portal	phage portal protein	A0A068F3B8	Mycobacterium_phage	2.8e-57	33.7
WP_060618788.1\|1837153_1838587_-\|terminase	terminase	V5R8Y1	Arthrobacter_phage	2.4e-85	38.4

Anti-CRISPR protein detection

Acr ID	Acr position	Acr size	Homology with known anti	Neighbor HTH/AcRanker	Neighbor Aca	In prophage	Protospacer in prophage

Overview of predicted results

Overview of the results

Cas Category Instructions

Results visualization

1. NZ_CP010413

Click the left colored region to show detailed information

CRISPR-Cas detection and classification

Click the colored protein region to show detailed information

Click the colored protein region to show detailed information

Click the colored protein region to show detailed information

Click the colored protein region to show detailed information

Click the colored protein region to show detailed information

Click the colored protein region to show detailed information

Self-targeting detection

MGE targeting detection<

Prophage detection

Anti-CRISPR protein detection